BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy3123
(585 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3CQV|A Chain A, Crystal Structure Of Reverb Beta In Complex With Heme
Length = 199
Score = 172 bits (437), Expect = 4e-43, Method: Compositional matrix adjust.
Identities = 86/196 (43%), Positives = 129/196 (65%), Gaps = 2/196 (1%)
Query: 103 LACPLN--PNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAG 160
L CP + P P + E+ ++FS F+P +++VVEFAKRIPGF L DQV LLKAG
Sbjct: 2 LVCPXSKSPYVDPHKSGHEIWEEFSXSFTPAVKEVVEFAKRIPGFRDLSQHDQVNLLKAG 61
Query: 161 VFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDT 220
FEVL VR A +FD++ ++ L+G+ D +HS A L++S F+F+E+LN L LSD
Sbjct: 62 TFEVLXVRFASLFDAKERTVTFLSGKKYSVDDLHSXGAGDLLNSXFEFSEKLNALQLSDE 121
Query: 221 EIGLFSSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDL 280
E LF+++V++S RSG+ N VE ++ L L ++ +NHP + ++ +L+ LPDL
Sbjct: 122 EXSLFTAVVLVSADRSGIENVNSVEALQETLIRALRTLIXKNHPNEASIFTKLLLKLPDL 181
Query: 281 RTLNQLHSEKLVAFQM 296
R+LN HSE+L+AF++
Sbjct: 182 RSLNNXHSEELLAFKV 197
>pdb|2V0V|A Chain A, Crystal Structure Of Rev-Erb Beta
pdb|2V0V|B Chain B, Crystal Structure Of Rev-Erb Beta
pdb|2V0V|C Chain C, Crystal Structure Of Rev-Erb Beta
pdb|2V0V|D Chain D, Crystal Structure Of Rev-Erb Beta
Length = 194
Score = 171 bits (433), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 83/189 (43%), Positives = 128/189 (67%)
Query: 108 NPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
+P P + E+ ++FS F+P +++VVEFAKRIPGF L DQV LLKAG FEVL+V
Sbjct: 4 SPYVDPHKSGHEIWEEFSMSFTPAVKEVVEFAKRIPGFRDLSQHDQVNLLKAGTFEVLMV 63
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSS 227
R A +FD++ ++ L + D +HS A L++SMF+F+E+LN L LSD E+ LF++
Sbjct: 64 RFASLFDAKERTVTFLGSKKYSVDDLHSMGAGDLLNSMFEFSEKLNALQLSDEEMSLFTA 123
Query: 228 IVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLH 287
+V++S RSG+ N VE ++ L L ++ +NHP + ++ +L+ LPDLR+LN +H
Sbjct: 124 VVLVSADRSGIENVNSVEALQETLIRALRTLIMKNHPNEASIFTKLLLKLPDLRSLNNMH 183
Query: 288 SEKLVAFQM 296
SE+L+AF++
Sbjct: 184 SEELLAFKV 192
>pdb|2V7C|A Chain A, Crystal Structure Of Rev-Erb Beta
pdb|2V7C|B Chain B, Crystal Structure Of Rev-Erb Beta
Length = 194
Score = 171 bits (432), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 83/189 (43%), Positives = 126/189 (66%)
Query: 108 NPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
+P P + E+ ++FS F+P +++VVEFAKRIPGF L DQV LLKAG FEVL V
Sbjct: 4 SPYVDPHKSGHEIWEEFSXSFTPAVKEVVEFAKRIPGFRDLSQHDQVNLLKAGTFEVLXV 63
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSS 227
R A +FD++ ++ L+G+ D +HS A L++S F+F+E+LN L LSD E LF++
Sbjct: 64 RFASLFDAKERTVTFLSGKKYSVDDLHSXGAGDLLNSXFEFSEKLNALQLSDEEXSLFTA 123
Query: 228 IVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLH 287
+V++S RSG+ N VE ++ L L ++ +NHP + ++ +L+ LPDLR+LN H
Sbjct: 124 VVLVSADRSGIENVNSVEALQETLIRALRTLIXKNHPNEASIFTKLLLKLPDLRSLNNXH 183
Query: 288 SEKLVAFQM 296
SE+L+AF++
Sbjct: 184 SEELLAFKV 192
>pdb|3N00|A Chain A, Crystal Structure Of A Deletion Mutant Of Human Reverba
Ligand Binding Domain Bound With An Ncor Id1 Peptide
Determined To 2.60a
Length = 245
Score = 157 bits (397), Expect = 1e-38, Method: Compositional matrix adjust.
Identities = 88/233 (37%), Positives = 138/233 (59%), Gaps = 8/233 (3%)
Query: 64 MLSTVVRAHLDTCAFTADKIEPMLRRAREHPTYTACPSTLACPLNPNSHPLQGQQELLQD 123
++S V RAH + + DK+ P P P+ + QE+ +D
Sbjct: 18 VISQVARAHREIFTYAHDKLG-------SSPGNFNANHASGSPY-PHGRSGRTVQEIWED 69
Query: 124 FSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICL 183
FS F+P +R+VVEFAK IPGF L DQVTLLKAG FEVL+VR A +F+ + +++ L
Sbjct: 70 FSMSFTPAVREVVEFAKHIPGFRDLSQHDQVTLLKAGTFEVLMVRFASLFNVKDQTVMFL 129
Query: 184 NGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKEL 243
+ + + L+ +MFDF+E+LN L L++ E+GLF+++V++S RSG+ N
Sbjct: 130 SRTTYSLQELGAMGMGDLLSAMFDFSEKLNSLALTEEELGLFTAVVLVSADRSGMENSAS 189
Query: 244 VERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
VE+++ L L ++ +N P + + +L+ LPDLRTLN +HSEKL++F++
Sbjct: 190 VEQLQETLLRALRALVLKNRPLETSRFTKLLLKLPDLRTLNNMHSEKLLSFRV 242
>pdb|1N4H|A Chain A, Characterization Of Ligands For The Orphan Nuclear
Receptor Rorbeta
Length = 259
Score = 127 bits (318), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 75/233 (32%), Positives = 128/233 (54%), Gaps = 15/233 (6%)
Query: 63 RMLSTVVRAHLDTCAFTADKIEPMLRRAREHPTYTACPSTLACPLNPNSHPLQGQQELLQ 122
R+ ++++HL+TC +T +++ + + + A S + ++ L Q
Sbjct: 14 RIAQNIIKSHLETCQYTMEELHQLAWQTHTYEEIKAYQS-------------KSREALWQ 60
Query: 123 DFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMIC 182
+ + + I+ VVEFAKRI GF LC +DQ+ LLK+G EV+LVR+ F+ N+++
Sbjct: 61 QCAIQITHAIQYVVEFAKRITGFMELCQNDQILLLKSGCLEVVLVRMCRAFNPLNNTVL- 119
Query: 183 LNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKE 242
G+ + + L++ FDFA+ L L L++ EI LFSS V+ISP R+ L
Sbjct: 120 FEGKYGGMQMFKALGSDDLVNEAFDFAKNLCSLQLTEEEIALFSSAVLISPDRAWLLEPR 179
Query: 243 LVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQ 295
V++++ K+ L HV+ +NH + L A+LI+ +P + + LH EKL F+
Sbjct: 180 KVQKLQEKIYFALQHVIQKNHLDDETL-AKLIAKIPTITAVCNLHGEKLQVFK 231
>pdb|1K4W|A Chain A, X-Ray Structure Of The Orphan Nuclear Receptor Ror Beta
Ligand-Binding Domain In The Active Conformation
Length = 252
Score = 126 bits (316), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 75/233 (32%), Positives = 128/233 (54%), Gaps = 15/233 (6%)
Query: 63 RMLSTVVRAHLDTCAFTADKIEPMLRRAREHPTYTACPSTLACPLNPNSHPLQGQQELLQ 122
R+ ++++HL+TC +T +++ + + + A S + ++ L Q
Sbjct: 14 RIAQNIIKSHLETCQYTMEELHQLAWQTHTYEEIKAYQS-------------KSREALWQ 60
Query: 123 DFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMIC 182
+ + + I+ VVEFAKRI GF LC +DQ+ LLK+G EV+LVR+ F+ N+++
Sbjct: 61 QCAIQITHAIQYVVEFAKRITGFMELCQNDQILLLKSGCLEVVLVRMCRAFNPLNNTVL- 119
Query: 183 LNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKE 242
G+ + + L++ FDFA+ L L L++ EI LFSS V+ISP R+ L
Sbjct: 120 FEGKYGGMQMFKALGSDDLVNEAFDFAKNLCSLQLTEEEIALFSSAVLISPDRAWLLEPR 179
Query: 243 LVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQ 295
V++++ K+ L HV+ +NH + L A+LI+ +P + + LH EKL F+
Sbjct: 180 KVQKLQEKIYFALQHVIQKNHLDDETL-AKLIAKIPTITAVCNLHGEKLQVFK 231
>pdb|1NQ7|A Chain A, Characterization Of Ligands For The Orphan Nuclear
Receptor Rorbeta
Length = 244
Score = 126 bits (316), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 75/233 (32%), Positives = 128/233 (54%), Gaps = 15/233 (6%)
Query: 63 RMLSTVVRAHLDTCAFTADKIEPMLRRAREHPTYTACPSTLACPLNPNSHPLQGQQELLQ 122
R+ ++++HL+TC +T +++ + + + A S + ++ L Q
Sbjct: 7 RIAQNIIKSHLETCQYTMEELHQLAWQTHTYEEIKAYQS-------------KSREALWQ 53
Query: 123 DFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMIC 182
+ + + I+ VVEFAKRI GF LC +DQ+ LLK+G EV+LVR+ F+ N+++
Sbjct: 54 QCAIQITHAIQYVVEFAKRITGFMELCQNDQILLLKSGCLEVVLVRMCRAFNPLNNTVL- 112
Query: 183 LNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKE 242
G+ + + L++ FDFA+ L L L++ EI LFSS V+ISP R+ L
Sbjct: 113 FEGKYGGMQMFKALGSDDLVNEAFDFAKNLCSLQLTEEEIALFSSAVLISPDRAWLLEPR 172
Query: 243 LVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQ 295
V++++ K+ L HV+ +NH + L A+LI+ +P + + LH EKL F+
Sbjct: 173 KVQKLQEKIYFALQHVIQKNHLDDETL-AKLIAKIPTITAVCNLHGEKLQVFK 224
>pdb|1N83|A Chain A, Crystal Structure Of The Complex Between The Orphan
Nuclear Hormone Receptor Ror(Alpha)-Lbd And Cholesterol
pdb|1S0X|A Chain A, Crystal Structure Of The Human Roralpha Ligand Binding
Domain In Complex With Cholesterol Sulfate At 2.2a
Length = 270
Score = 125 bits (315), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 76/230 (33%), Positives = 125/230 (54%), Gaps = 19/230 (8%)
Query: 68 VVRAHLDTCAFTADKIEPMLRRAREHPTYTACPSTLACPLNPNSHPLQGQQE--LLQDFS 125
+ ++HL+TC + ++++ + T L Q +Q + Q +
Sbjct: 27 ISKSHLETCQYLREELQQI---------------TWQTFLQEEIENYQNKQREVMWQLCA 71
Query: 126 ERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNG 185
+ + I+ VVEFAKRI GF LC +DQ+ LLKAG EV+ +R+ FDSQ N+ + +G
Sbjct: 72 IKITEAIQYVVEFAKRIDGFMELCQNDQIVLLKAGSLEVVFIRMCRAFDSQNNT-VYFDG 130
Query: 186 EVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVE 245
+ D S + +F+F + L +HL++ EI LFS+ V++S RS L+ K +E
Sbjct: 131 KYASPDVFKSLGCEDFISFVFEFGKSLCSMHLTEDEIALFSAFVLMSADRSWLQEKVKIE 190
Query: 246 RMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQ 295
+++ K++ L HVL +NH E + +LI + LR L H+EKL+AF+
Sbjct: 191 KLQQKIQLALQHVLQKNHRED-GILTKLICKVSTLRALCGRHTEKLMAFK 239
>pdb|3L0L|A Chain A, Crystal Structure Of Orphan Nuclear Receptor Rorgamma In
Com Natural Ligand
pdb|3L0L|B Chain B, Crystal Structure Of Orphan Nuclear Receptor Rorgamma In
Com Natural Ligand
Length = 248
Score = 106 bits (265), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 72/243 (29%), Positives = 125/243 (51%), Gaps = 23/243 (9%)
Query: 56 AELDDEQRMLSTVVRAHLDTCAFTADKIEPMLRRAREHPTYTACPSTLACPLNPNSHPLQ 115
A L + + ++ +V +++ +TC ++E +LR+ S + + +
Sbjct: 6 ASLTEIEHLVQSVCKSYRETCQL---RLEDLLRQR----------SNIFSREEVTGYQRK 52
Query: 116 GQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDS 175
E+ + + + I+ VVEFAKR+ GF LC +DQ+ LLKAG EV+LVR+ C +
Sbjct: 53 SMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRM-CRAYN 111
Query: 176 QTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSR 235
N + G+ + + L+ S+FDF+ L+ LH S+ EI L++++V+I+ R
Sbjct: 112 ADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHR 171
Query: 236 SGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLP---DLRTLNQLHSEKLV 292
GL+ K VE+++ LE H L + H + +++ LP LR+L H E+L
Sbjct: 172 PGLQEKRKVEQLQYNLELAFHHHLCKTHRQ------SILAKLPPKGKLRSLCSQHVERLQ 225
Query: 293 AFQ 295
FQ
Sbjct: 226 IFQ 228
>pdb|3KYT|A Chain A, Crystal Structure Of Orphan Nuclear Receptor Rorgamma In
Com Natural Ligand
pdb|3L0J|A Chain A, Crystal Structure Of Orphan Nuclear Receptor Rorgamma In
Com Natural Ligand
pdb|3B0W|A Chain A, Crystal Structure Of The Orphan Nuclear Receptor
Ror(Gamma)t Ligand- Binding Domain In Complex With
Digoxin
pdb|3B0W|B Chain B, Crystal Structure Of The Orphan Nuclear Receptor
Ror(Gamma)t Ligand- Binding Domain In Complex With
Digoxin
Length = 243
Score = 106 bits (264), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 72/243 (29%), Positives = 125/243 (51%), Gaps = 23/243 (9%)
Query: 56 AELDDEQRMLSTVVRAHLDTCAFTADKIEPMLRRAREHPTYTACPSTLACPLNPNSHPLQ 115
A L + + ++ +V +++ +TC ++E +LR+ S + + +
Sbjct: 1 ASLTEIEHLVQSVCKSYRETCQL---RLEDLLRQ----------RSNIFSREEVTGYQRK 47
Query: 116 GQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDS 175
E+ + + + I+ VVEFAKR+ GF LC +DQ+ LLKAG EV+LVR+ C +
Sbjct: 48 SMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRM-CRAYN 106
Query: 176 QTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSR 235
N + G+ + + L+ S+FDF+ L+ LH S+ EI L++++V+I+ R
Sbjct: 107 ADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHR 166
Query: 236 SGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLP---DLRTLNQLHSEKLV 292
GL+ K VE+++ LE H L + H + +++ LP LR+L H E+L
Sbjct: 167 PGLQEKRKVEQLQYNLELAFHHHLCKTHRQ------SILAKLPPKGKLRSLCSQHVERLQ 220
Query: 293 AFQ 295
FQ
Sbjct: 221 IFQ 223
>pdb|3DZU|D Chain D, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Bvt.13, 9-Cis Retinoic Acid And Ncoa2
Peptide
pdb|3DZY|D Chain D, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Rosiglitazone, 9-Cis Retinoic Acid And
Ncoa2 Peptide
pdb|3E00|D Chain D, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Gw9662, 9-Cis Retinoic Acid And Ncoa2
Peptide
Length = 419
Score = 102 bits (254), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 85/296 (28%), Positives = 142/296 (47%), Gaps = 29/296 (9%)
Query: 20 HNAPVRFGRVPKREKARILAAMQQSTNTKCTE----KALAAELDDEQRMLSTVVRAHLDT 75
HNA +RFGR+P+ EK ++LA + + E +ALA L D +++ +
Sbjct: 119 HNA-IRFGRMPQAEKEKLLAEISSDIDQLNPESADLRALAKHLYD----------SYIKS 167
Query: 76 CAFTADKIEPML--RRAREHPTYTACPSTLACPLNPNSH----PLQGQQE-----LLQDF 124
T K +L + + P ++L + PLQ Q + + Q
Sbjct: 168 FPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGC 227
Query: 125 SERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLN 184
R ++++ E+AK IPGF L +DQVTLLK GV E++ LA + + + +I
Sbjct: 228 QFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMN-KDGVLISEG 286
Query: 185 GEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKE 242
+ R+ + S F M+ F+FA + N L L D+++ +F +++++S R GL N +
Sbjct: 287 QGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVK 346
Query: 243 LVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+E ++ L L L NHPE L A+L+ + DLR + H + L + TE
Sbjct: 347 PIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTE 402
>pdb|1XDK|B Chain B, Crystal Structure Of The RarbetaRXRALPHA LIGAND BINDING
Domain Heterodimer In Complex With 9-Cis Retinoic Acid
And A Fragment Of The Trap220 Coactivator
pdb|1XDK|F Chain F, Crystal Structure Of The RarbetaRXRALPHA LIGAND BINDING
Domain Heterodimer In Complex With 9-Cis Retinoic Acid
And A Fragment Of The Trap220 Coactivator
Length = 303
Score = 101 bits (251), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 70/256 (27%), Positives = 130/256 (50%), Gaps = 23/256 (8%)
Query: 42 QQSTNTKCTEK-ALAAELDDEQRMLSTVVRAHLDTCAFTADKIEPMLRRAREHPTYTACP 100
++ + +CTE + AELDD + + +AH +T P L + ++ T ++
Sbjct: 15 KEPSKQECTESYEMTAELDD---LTEKIRKAHQETF--------PSLCQLGKYTTNSSA- 62
Query: 101 STLACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAG 160
H ++ L FSE + I +VEFAKR+PGF+ L DQ+TLLKA
Sbjct: 63 ----------DHRVRLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLTIADQITLLKAA 112
Query: 161 VFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDT 220
++L++R+ + + ++M +G L R +H++ L D +F FA +L L + DT
Sbjct: 113 CLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFTFANQLLPLEMDDT 172
Query: 221 EIGLFSSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDL 280
E GL S+I +I R L V++++ L L + + P + ++ +++ + DL
Sbjct: 173 ETGLLSAICLICGDRQDLEEPTKVDKLQEPLLEALKIYIRKRRPSKPHMFPKILMKITDL 232
Query: 281 RTLNQLHSEKLVAFQM 296
R+++ +E+++ +M
Sbjct: 233 RSISAKGAERVITLKM 248
>pdb|1XAP|A Chain A, Structure Of The Ligand Binding Domain Of The Retinoic
Acid Receptor Beta
pdb|4DM6|A Chain A, Crystal Structure Of Rarb Lbd Homodimer In Complex With
Ttnpb
pdb|4DM6|B Chain B, Crystal Structure Of Rarb Lbd Homodimer In Complex With
Ttnpb
pdb|4DM8|A Chain A, Crystal Structure Of Rarb Lbd In Complex With 9cis
Retinoic Acid
pdb|4DM8|B Chain B, Crystal Structure Of Rarb Lbd In Complex With 9cis
Retinoic Acid
Length = 267
Score = 100 bits (249), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 119/228 (52%), Gaps = 2/228 (0%)
Query: 71 AHLDTCAFTA--DKIEPMLRRAREHPTYTACPSTLACPLNPNSHPLQGQQELLQDFSERF 128
+H+++ TA D + +R+A + + C + H ++ L FSE
Sbjct: 19 SHMESYEMTAELDDLTEKIRKAHQETFPSLCQLGKYTTNSSADHRVRLDLGLWDKFSELA 78
Query: 129 SPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVL 188
+ I +VEFAKR+PGF+ L DQ+TLLKA ++L++R+ + + ++M +G L
Sbjct: 79 TKCIIKIVEFAKRLPGFTGLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTL 138
Query: 189 VRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMR 248
R +H++ L D +F FA +L L + DTE GL S+I +I R L V++++
Sbjct: 139 NRTQMHNAGFGPLTDLVFTFANQLLPLEMDDTETGLLSAICLICGDRQDLEEPTKVDKLQ 198
Query: 249 GKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
L L + + P + ++ +++ + DLR+++ +E+++ +M
Sbjct: 199 EPLLEALKIYIRKRRPSKPHMFPKILMKITDLRSISAKGAERVITLKM 246
>pdb|1FCX|A Chain A, Isotype Selectivity Of The Human Retinoic Acid Nuclear
Receptor Hrar: The Complex With The Rargamma-Selective
Retinoid Bms184394
pdb|1FCZ|A Chain A, Isotype Selectivity Of The Human Retinoic Acid Nuclear
Receptor Hrar: The Complex With The Panagonist Retinoid
Bms181156
pdb|1FD0|A Chain A, Isotype Selectivity Of The Human Retinoic Acid Nuclear
Receptor Hrar: The Complex With The Rargamma-Selective
Retinoid Sr11254
Length = 235
Score = 96.7 bits (239), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 98/185 (52%)
Query: 112 HPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLAC 171
H +Q L FSE + I +VEFAKR+PGF+ L DQ+TLLKA ++L++R+
Sbjct: 36 HRVQLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICT 95
Query: 172 MFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVI 231
+ + ++M +G L R +H++ L D +F FA +L L + DTE GL S+I +I
Sbjct: 96 RYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTETGLLSAICLI 155
Query: 232 SPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKL 291
R L E V++++ L L + P Q + ++ + DLR ++ +E+
Sbjct: 156 CGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMKITDLRGISTKGAERA 215
Query: 292 VAFQM 296
+ +M
Sbjct: 216 ITLKM 220
>pdb|1FCY|A Chain A, Isotype Selectivity Of The Human Retinoic Acid Nuclear
Receptor Hrar: The Complex With The RarbetaGAMMA-
Selective Retinoid Cd564
Length = 236
Score = 96.7 bits (239), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 98/185 (52%)
Query: 112 HPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLAC 171
H +Q L FSE + I +VEFAKR+PGF+ L DQ+TLLKA ++L++R+
Sbjct: 37 HRVQLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICT 96
Query: 172 MFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVI 231
+ + ++M +G L R +H++ L D +F FA +L L + DTE GL S+I +I
Sbjct: 97 RYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTETGLLSAICLI 156
Query: 232 SPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKL 291
R L E V++++ L L + P Q + ++ + DLR ++ +E+
Sbjct: 157 CGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMKITDLRGISTKGAERA 216
Query: 292 VAFQM 296
+ +M
Sbjct: 217 ITLKM 221
>pdb|2LBD|A Chain A, Ligand-Binding Domain Of The Human Retinoic Acid Receptor
Gamma Bound To All-Trans Retinoic Acid
pdb|3LBD|A Chain A, Ligand-binding Domain Of The Human Retinoic Acid Receptor
Gamma Bound To 9-cis Retinoic Acid
pdb|4LBD|A Chain A, Ligand-binding Domain Of The Human Retinoic Acid Receptor
Gamma Bound To The Synthetic Agonist Bms961
Length = 267
Score = 96.7 bits (239), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 98/185 (52%)
Query: 112 HPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLAC 171
H +Q L FSE + I +VEFAKR+PGF+ L DQ+TLLKA ++L++R+
Sbjct: 62 HRVQLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICT 121
Query: 172 MFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVI 231
+ + ++M +G L R +H++ L D +F FA +L L + DTE GL S+I +I
Sbjct: 122 RYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTETGLLSAICLI 181
Query: 232 SPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKL 291
R L E V++++ L L + P Q + ++ + DLR ++ +E+
Sbjct: 182 CGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMKITDLRGISTKGAERA 241
Query: 292 VAFQM 296
+ +M
Sbjct: 242 ITLKM 246
>pdb|1EXA|A Chain A, Enantiomer Discrimination Illustrated By Crystal
Structures Of The Human Retinoic Acid Receptor Hrargamma
Ligand Binding Domain: The Complex With The Active
R-Enantiomer Bms270394.
pdb|1EXX|A Chain A, Enantiomer Discrimination Illustrated By Crystal
Structures Of The Human Retinoic Acid Receptor Hrargamma
Ligand Binding Domain: The Complex With The Inactive
S-Enantiomer Bms270395
Length = 246
Score = 96.7 bits (239), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 98/185 (52%)
Query: 112 HPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLAC 171
H +Q L FSE + I +VEFAKR+PGF+ L DQ+TLLKA ++L++R+
Sbjct: 41 HRVQLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICT 100
Query: 172 MFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVI 231
+ + ++M +G L R +H++ L D +F FA +L L + DTE GL S+I +I
Sbjct: 101 RYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTETGLLSAICLI 160
Query: 232 SPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKL 291
R L E V++++ L L + P Q + ++ + DLR ++ +E+
Sbjct: 161 CGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMKITDLRGISTKGAERA 220
Query: 292 VAFQM 296
+ +M
Sbjct: 221 ITLKM 225
>pdb|2Q59|A Chain A, Crystal Structure Of Ppargamma Lbd Bound To Full Agonist
Mrl20
Length = 274
Score = 95.5 bits (236), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 66 PLQEQSKEVAIRIFQGXQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 125
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 126 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 184
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 185 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 244
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 245 EHVQLLQVIKKTE 257
>pdb|3ET0|A Chain A, Structure Of Ppargamma With 3-(5-Methoxy-1h-Indol-3-Yl)-
Propionic Acid
pdb|3ET0|B Chain B, Structure Of Ppargamma With 3-(5-Methoxy-1h-Indol-3-Yl)-
Propionic Acid
Length = 292
Score = 95.1 bits (235), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 84 PLQEQSKEVAIRIFQGXQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 143
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 144 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 202
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 203 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 262
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 263 EHVQLLQVIKKTE 275
>pdb|1I7G|A Chain A, Crystal Structure Of The Ligand Binding Domain From Human
Ppar-Alpha In Complex With The Agonist Az 242
Length = 287
Score = 95.1 bits (235), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 3/170 (1%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVR 190
T+ ++ EFAK IPGF+ L +DQVTLLK GV+E + L+ + + + ++ + R
Sbjct: 102 TVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMN-KDGMLVAYGNGFITR 160
Query: 191 DSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMR 248
+ + S F +M+ FDFA + N L L D++I LF + ++ R GL N +E+M+
Sbjct: 161 EFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQ 220
Query: 249 GKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ ++L L NHP+ + L +L+ + DLR L H++ + + TE
Sbjct: 221 EGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTE 270
>pdb|2ZVT|A Chain A, Cys285ser Mutant Ppargamma Ligand-Binding Domain Complexed
With 15-Deoxy-Delta12,14-Prostaglandin J2
pdb|2ZVT|B Chain B, Cys285ser Mutant Ppargamma Ligand-Binding Domain Complexed
With 15-Deoxy-Delta12,14-Prostaglandin J2
Length = 286
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 79 PLQEQSKEVAIRIFQGSQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 138
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 139 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 197
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 198 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 257
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 258 EHVQLLQVIKKTE 270
>pdb|3LMP|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
pdb|3B1M|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator Cerco-A
pdb|3V9T|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
pdb|3V9V|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
pdb|3V9Y|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
pdb|4F9M|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
Length = 283
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 75 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 134
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 135 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 193
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 194 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 253
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 254 EHVQLLQVIKKTE 266
>pdb|3CS8|A Chain A, Structural And Biochemical Basis For The Binding
Selectivity Of Pparg To Pgc-1a
Length = 275
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 68 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 127
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 128 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 186
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 187 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 246
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 247 EHVQLLQVIKKTE 259
>pdb|1K74|D Chain D, The 2.3 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Ppargamma And Rxralpha Ligand
Binding Domains Respectively Bound With Gw409544 And
9-Cis Retinoic Acid And Co-Activator Peptides
Length = 283
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 75 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 134
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 135 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 193
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 194 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 253
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 254 EHVQLLQVIKKTE 266
>pdb|3S9S|A Chain A, Ligand Binding Domain Of Ppargamma Complexed With A
Benzimidazole Partial Agonist
Length = 284
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 76 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 135
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 136 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 194
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 195 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 254
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 255 EHVQLLQVIKKTE 267
>pdb|2Q59|B Chain B, Crystal Structure Of Ppargamma Lbd Bound To Full Agonist
Mrl20
pdb|2Q5P|A Chain A, Crystal Structure Of Ppargamma Bound To Partial Agonist
Mrl24
pdb|2Q5P|B Chain B, Crystal Structure Of Ppargamma Bound To Partial Agonist
Mrl24
pdb|2Q5S|A Chain A, Crystal Structure Of Ppargamma Bound To Partial Agonist
Ntzdpa
pdb|2Q5S|B Chain B, Crystal Structure Of Ppargamma Bound To Partial Agonist
Ntzdpa
pdb|2Q61|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain Bound
To Partial Agonist Sr145
pdb|2Q61|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain Bound
To Partial Agonist Sr145
pdb|2Q6R|A Chain A, Crystal Structure Of Ppar Gamma Complexed With Partial
Agonist Sf147
pdb|2Q6R|B Chain B, Crystal Structure Of Ppar Gamma Complexed With Partial
Agonist Sf147
pdb|2Q6S|A Chain A, 2.4 Angstrom Crystal Structure Of Ppar Gamma Complexed To
Bvt.13 Without Co-Activator Peptides
pdb|2Q6S|B Chain B, 2.4 Angstrom Crystal Structure Of Ppar Gamma Complexed To
Bvt.13 Without Co-Activator Peptides
Length = 274
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 66 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 125
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 126 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 184
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 185 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 244
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 245 EHVQLLQVIKKTE 257
>pdb|3ADS|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
Indomethacin
pdb|3ADS|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
Indomethacin
pdb|3ADT|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
5-Hydroxy-Indole Acetate
pdb|3ADT|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
5-Hydroxy-Indole Acetate
pdb|3ADU|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
5-Methoxy-Indole Acetate
pdb|3ADU|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
5-Methoxy-Indole Acetate
pdb|3ADV|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
Serotonin
pdb|3ADV|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
Serotonin
pdb|3ADW|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
5-Methoxy-Indole Acetate And 15-Oxo-Eicosatetraenoic
Acid
pdb|3ADW|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
5-Methoxy-Indole Acetate And 15-Oxo-Eicosatetraenoic
Acid
pdb|3ADX|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
Indomethacin And Nitro-233
pdb|3ADX|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
Indomethacin And Nitro-233
pdb|3R8I|A Chain A, Crystal Structure Of Ppargamma With An Achiral
Ureidofibrate Derivative (Rt86)
pdb|3R8I|B Chain B, Crystal Structure Of Ppargamma With An Achiral
Ureidofibrate Derivative (Rt86)
pdb|2YFE|A Chain A, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 1
pdb|2YFE|B Chain B, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 1
pdb|4A4V|A Chain A, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 2
pdb|4A4V|B Chain B, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 2
pdb|4A4W|A Chain A, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 2
pdb|4A4W|B Chain B, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 2
pdb|4E4K|A Chain A, Crystal Structure Of Ppargamma With The Ligand Jo21
pdb|4E4K|B Chain B, Crystal Structure Of Ppargamma With The Ligand Jo21
pdb|4E4Q|A Chain A, Crystal Structure Of Ppargamma With The Ligand Fs214
pdb|4E4Q|B Chain B, Crystal Structure Of Ppargamma With The Ligand Fs214
Length = 287
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 79 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 138
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 139 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 197
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 198 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 257
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 258 EHVQLLQVIKKTE 270
>pdb|3SP6|A Chain A, Structural Basis For Iloprost As A Dual PparalphaDELTA
AGONIST
Length = 285
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 3/170 (1%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVR 190
T+ ++ EFAK IPGF+ L +DQVTLLK GV+E + L+ + + + ++ + R
Sbjct: 100 TVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMN-KDGMLVAYGNGFITR 158
Query: 191 DSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMR 248
+ + S F +M+ FDFA + N L L D++I LF + ++ R GL N +E+M+
Sbjct: 159 EFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQ 218
Query: 249 GKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ ++L L NHP+ + L +L+ + DLR L H++ + + TE
Sbjct: 219 EGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTE 268
>pdb|2VV4|B Chain B, Hppargamma Ligand Binding Domain In Complex With 6-Oxoote
Length = 276
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 68 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 127
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 128 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 186
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 187 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 246
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 247 EHVQLLQVIKKTE 259
>pdb|1I7I|A Chain A, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma In Complex With The Agonist Az 242
pdb|1I7I|B Chain B, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma In Complex With The Agonist Az 242
Length = 292
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 84 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 143
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 144 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 202
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 203 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 262
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 263 EHVQLLQVIKKTE 275
>pdb|1FM6|D Chain D, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Rosiglitazone And Co-Activator Peptides.
pdb|1FM6|X Chain X, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Rosiglitazone And Co-Activator Peptides.
pdb|1FM9|D Chain D, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Gi262570 And Co-Activator Peptides.
pdb|1ZGY|A Chain A, Structural And Biochemical Basis For Selective Repression
Of The Orphan Nuclear Receptor Lrh-1 By Shp
pdb|2POB|A Chain A, Ppargamma Ligand Binding Domain Complexed With A
Farglitazar Analogue Gw4709
pdb|2POB|B Chain B, Ppargamma Ligand Binding Domain Complexed With A
Farglitazar Analogue Gw4709
pdb|3FUR|A Chain A, Crystal Structure Of Pparg In Complex With Int131
pdb|3H0A|D Chain D, Crystal Structure Of Peroxisome Proliferator-Activated
Receptor Gamma (Pparg) And Retinoic Acid Receptor Alpha
(Rxra) In Complex With 9-Cis Retinoic Acid, Co-Activator
Peptide, And A Partial Agonist
pdb|3K8S|A Chain A, Crystal Structure Of Pparg In Complex With T2384
pdb|3K8S|B Chain B, Crystal Structure Of Pparg In Complex With T2384
pdb|3KMG|A Chain A, The X-Ray Crystal Structure Of Ppar-Gamma In Complex With
An Indole Derivative Modulator, Gsk538, And An Src-1
Peptide
pdb|3KMG|D Chain D, The X-Ray Crystal Structure Of Ppar-Gamma In Complex With
An Indole Derivative Modulator, Gsk538, And An Src-1
Peptide
Length = 272
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 64 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 123
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 124 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 182
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 183 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 242
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 243 EHVQLLQVIKKTE 255
>pdb|3VN2|A Chain A, Crystal Structure Of Ppargamma Complexed With Telmisartan
Length = 285
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 77 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 136
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 137 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 195
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 196 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 255
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 256 EHVQLLQVIKKTE 268
>pdb|2I4J|A Chain A, Crystal Structure Of The Complex Between Ppargamma And The
Agonist Lt160 (Ureidofibrate Derivative)
pdb|2I4J|B Chain B, Crystal Structure Of The Complex Between Ppargamma And The
Agonist Lt160 (Ureidofibrate Derivative)
pdb|2I4P|A Chain A, Crystal Structure Of The Complex Between Ppargamma And The
Partial Agonist Lt127 (Ureidofibrate Derivative).
Structure Obtained From Crystals Of The Apo-Form Soaked
For 30 Days.
pdb|2I4P|B Chain B, Crystal Structure Of The Complex Between Ppargamma And The
Partial Agonist Lt127 (Ureidofibrate Derivative).
Structure Obtained From Crystals Of The Apo-Form Soaked
For 30 Days.
pdb|2I4Z|A Chain A, Crystal Structure Of The Complex Between Ppargamma And The
Partial Agonist Lt127 (Ureidofibrate Derivative). This
Structure Has Been Obtained From Crystals Soaked For 6
Hours.
pdb|2I4Z|B Chain B, Crystal Structure Of The Complex Between Ppargamma And The
Partial Agonist Lt127 (Ureidofibrate Derivative). This
Structure Has Been Obtained From Crystals Soaked For 6
Hours.
pdb|3B3K|A Chain A, Crystal Structure Of The Complex Between Ppargamma And The
Full Agonist Lt175
pdb|3B3K|B Chain B, Crystal Structure Of The Complex Between Ppargamma And The
Full Agonist Lt175
pdb|3CDS|A Chain A, Crystal Structure Of The Complex Between Ppar-Gamma And
The Agonist Lt248 (Clofibric Acid Analogue)
pdb|3CDS|B Chain B, Crystal Structure Of The Complex Between Ppar-Gamma And
The Agonist Lt248 (Clofibric Acid Analogue)
pdb|3D6D|A Chain A, Crystal Structure Of The Complex Between Ppargamma Lbd And
The Lt175(R-Enantiomer)
pdb|3D6D|B Chain B, Crystal Structure Of The Complex Between Ppargamma Lbd And
The Lt175(R-Enantiomer)
pdb|3CDP|A Chain A, Crystal Structure Of Ppar-Gamma Lbd Complexed With A
Partial Agonist, Analogue Of Clofibric Acid
pdb|3CDP|B Chain B, Crystal Structure Of Ppar-Gamma Lbd Complexed With A
Partial Agonist, Analogue Of Clofibric Acid
pdb|2ZK0|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain
pdb|2ZK0|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain
pdb|2ZK1|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With
15-Deoxy-Delta12,14- Prostaglandin J2
pdb|2ZK1|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With
15-Deoxy-Delta12,14- Prostaglandin J2
pdb|2ZK2|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With Glutathion
Conjugated 15-Deoxy-Delta12,14-Prostaglandin J2
pdb|2ZK2|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With Glutathion
Conjugated 15-Deoxy-Delta12,14-Prostaglandin J2
pdb|2ZK3|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With 8-Oxo-
Eicosatetraenoic Acid
pdb|2ZK3|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With 8-Oxo-
Eicosatetraenoic Acid
pdb|2ZK4|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With 15-Oxo-
Eicosatetraenoic Acid
pdb|2ZK4|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With 15-Oxo-
Eicosatetraenoic Acid
pdb|2ZK5|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With Nitro-233
pdb|2ZK5|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With Nitro-233
pdb|2ZK6|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With C8-Bodipy
pdb|2ZK6|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With C8-Bodipy
pdb|2ZNO|A Chain A, Human Pprr Gamma Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp703
pdb|2ZNO|B Chain B, Human Pprr Gamma Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp703
pdb|3HO0|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
New Aryloxy-3phenylpropanoic Acid
pdb|3HO0|B Chain B, Crystal Structure Of The Ppargamma-Lbd Complexed With A
New Aryloxy-3phenylpropanoic Acid
pdb|3HOD|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
New Aryloxy-3phenylpropanoic Acid
pdb|3HOD|B Chain B, Crystal Structure Of The Ppargamma-Lbd Complexed With A
New Aryloxy-3phenylpropanoic Acid
pdb|3AN3|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With A
Gamma Selective Agonist Mo3s
pdb|3AN3|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With A
Gamma Selective Agonist Mo3s
pdb|3AN4|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With A
Gamma Selective Agonist Mo4r
pdb|3AN4|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With A
Gamma Selective Agonist Mo4r
pdb|3VJH|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With
Jkpl35
pdb|3VJH|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With
Jkpl35
pdb|3VJI|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With
Jkpl53
pdb|3VJI|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With
Jkpl53
Length = 286
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 79 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 138
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 139 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 197
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 198 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 257
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 258 EHVQLLQVIKKTE 270
>pdb|1ZEO|A Chain A, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complexed With An Alpha-Aryloxyphenylacetic Acid
Agonist
pdb|1ZEO|B Chain B, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complexed With An Alpha-Aryloxyphenylacetic Acid
Agonist
pdb|2P4Y|A Chain A, Crystal Structure Of Human Ppar-Gamma-Ligand Binding
Domain Complexed With An Indole-Based Modulator
pdb|2P4Y|B Chain B, Crystal Structure Of Human Ppar-Gamma-Ligand Binding
Domain Complexed With An Indole-Based Modulator
pdb|3TY0|A Chain A, Structure Of Ppargamma Ligand Binding Domain In Complex
With (R)-5-(3-
((3-(6-Methoxybenzo[d]isoxazol-3-Yl)-2-Oxo-2,
3-Dihydro-1h-
Benzo[d]imidazol-1-Yl)methyl)phenyl)-5-
Methyloxazolidine-2,4-Dione
pdb|3TY0|B Chain B, Structure Of Ppargamma Ligand Binding Domain In Complex
With (R)-5-(3-
((3-(6-Methoxybenzo[d]isoxazol-3-Yl)-2-Oxo-2,
3-Dihydro-1h-
Benzo[d]imidazol-1-Yl)methyl)phenyl)-5-
Methyloxazolidine-2,4-Dione
Length = 277
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 69 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 128
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 129 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 187
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 188 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 247
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 248 EHVQLLQVIKKTE 260
>pdb|3OSI|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tetrachloro-Bisphenol A (Tcbpa)
pdb|3OSI|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tetrachloro-Bisphenol A (Tcbpa)
pdb|3OSW|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tetrabromo-Bisphenol A (Tbbpa)
pdb|3OSW|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tetrabromo-Bisphenol A (Tbbpa)
Length = 285
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 78 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 137
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 138 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 196
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 197 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 256
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 257 EHVQLLQVIKKTE 269
>pdb|3BC5|A Chain A, X-Ray Crystal Structure Of Human Ppar Gamma With
2-(5-(3-(2-
(5-Methyl-2-Phenyloxazol-4-Yl)ethoxy)benzyl)-2-Phenyl-
2h-1, 2,3-Triazol-4-Yl)acetic Acid
Length = 296
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 88 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 147
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 148 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 206
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 207 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 266
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 267 EHVQLLQVIKKTE 279
>pdb|1RDT|D Chain D, Crystal Structure Of A New Rexinoid Bound To The Rxralpha
Ligand Binding Doamin In The RxralphaPPARGAMMA
HETERODIMER
Length = 284
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 76 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 135
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 136 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 194
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 195 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 254
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 255 EHVQLLQVIKKTE 267
>pdb|3PBA|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Monosulfate Tetrabromo-Bisphenol A
(Monotbbpa)
pdb|3PBA|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Monosulfate Tetrabromo-Bisphenol A
(Monotbbpa)
pdb|3PO9|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tripropyltin
pdb|3PO9|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tripropyltin
Length = 286
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 78 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 137
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 138 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 196
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 197 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 256
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 257 EHVQLLQVIKKTE 269
>pdb|3PRG|A Chain A, Ligand Binding Domain Of Human Peroxisome Proliferator
Activated Receptor
Length = 278
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 70 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 129
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 130 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 188
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 189 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 248
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 249 EHVQLLQVIKKTE 261
>pdb|2VV1|B Chain B, Hppargamma Ligand Binding Domain In Complex With 4-Hdha
Length = 276
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 68 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 127
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 128 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 186
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 187 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 246
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 247 EHVQLLQVIKKTE 259
>pdb|2VSR|A Chain A, Hppargamma Ligand Binding Domain In Complex With
9-(S)-Hode
pdb|2VSR|B Chain B, Hppargamma Ligand Binding Domain In Complex With
9-(S)-Hode
pdb|2VST|A Chain A, Hppargamma Ligand Binding Domain In Complex With 13-(S)-
Hode
pdb|2VST|B Chain B, Hppargamma Ligand Binding Domain In Complex With 13-(S)-
Hode
pdb|2VV0|A Chain A, Hppargamma Ligand Binding Domain In Complex With Dha
pdb|2VV0|B Chain B, Hppargamma Ligand Binding Domain In Complex With Dha
pdb|2VV1|A Chain A, Hppargamma Ligand Binding Domain In Complex With 4-Hdha
pdb|2VV2|A Chain A, Hppargamma Ligand Binding Domain In Complex With 5-Hepa
pdb|2VV2|B Chain B, Hppargamma Ligand Binding Domain In Complex With 5-Hepa
pdb|2VV3|A Chain A, Hppargamma Ligand Binding Domain In Complex With 4-Oxodha
pdb|2VV3|B Chain B, Hppargamma Ligand Binding Domain In Complex With 4-Oxodha
pdb|2VV4|A Chain A, Hppargamma Ligand Binding Domain In Complex With 6-Oxoote
Length = 276
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 68 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 127
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 128 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 186
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 187 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 246
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 247 EHVQLLQVIKKTE 259
>pdb|2HFP|A Chain A, Crystal Structure Of Ppar Gamma With N-Sulfonyl-2-Indole
Carboxamide Ligands
Length = 282
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 74 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 133
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 134 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 192
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 193 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 252
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 253 EHVQLLQVIKKTE 265
>pdb|2OM9|A Chain A, Ajulemic Acid, A Synthetic Cannabinoid Bound To Ppar Gamma
pdb|2OM9|B Chain B, Ajulemic Acid, A Synthetic Cannabinoid Bound To Ppar Gamma
pdb|2OM9|C Chain C, Ajulemic Acid, A Synthetic Cannabinoid Bound To Ppar Gamma
pdb|2OM9|D Chain D, Ajulemic Acid, A Synthetic Cannabinoid Bound To Ppar Gamma
pdb|3SZ1|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With
Luteolin And Myristic Acid
pdb|3SZ1|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With
Luteolin And Myristic Acid
Length = 278
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 70 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 129
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 130 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 188
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 189 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 248
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 249 EHVQLLQVIKKTE 261
>pdb|1NYX|A Chain A, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma In Complex With An Agonist
pdb|1NYX|B Chain B, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma In Complex With An Agonist
Length = 276
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 68 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 127
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 128 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 186
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 187 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 246
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 247 EHVQLLQVIKKTE 259
>pdb|2REW|A Chain A, Crystal Structure Of Pparalpha Ligand Binding Domain With
Bms-631707
pdb|3KDT|A Chain A, Crystal Structure Of Peroxisome
Proliferator-Activatedecepto (Pparalpha) Complex With
N-3-((2-(4-Chlorophenyl)-5-Methyl-
Oxazol-4-Yl)methoxy)benzyl)-N-(Methoxycarbonyl)glycine
pdb|3KDT|B Chain B, Crystal Structure Of Peroxisome
Proliferator-Activatedecepto (Pparalpha) Complex With
N-3-((2-(4-Chlorophenyl)-5-Methyl-
Oxazol-4-Yl)methoxy)benzyl)-N-(Methoxycarbonyl)glycine
pdb|3KDU|A Chain A, Crystal Structure Of Peroxisome
Proliferator-Activatedecepto (Pparalpha) Complex With
N-3-((2-(4-Chlorophenyl)-5-Methyl-
Oxazol-4-Yl)methoxy)benzyl)-N-((4-
Methylphenoxy)carbonyl)gl
pdb|3KDU|B Chain B, Crystal Structure Of Peroxisome
Proliferator-Activatedecepto (Pparalpha) Complex With
N-3-((2-(4-Chlorophenyl)-5-Methyl-
Oxazol-4-Yl)methoxy)benzyl)-N-((4-
Methylphenoxy)carbonyl)gl
Length = 277
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 3/170 (1%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVR 190
T+ ++ EFAK IPGF+ L +DQVTLLK GV+E + L+ + + + ++ + R
Sbjct: 92 TVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMN-KDGMLVAYGNGFITR 150
Query: 191 DSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMR 248
+ + S F +M+ FDFA + N L L D++I LF + ++ R GL N +E+M+
Sbjct: 151 EFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQ 210
Query: 249 GKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ ++L L NHP+ + L +L+ + DLR L H++ + + TE
Sbjct: 211 EGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTE 260
>pdb|1WM0|X Chain X, Ppargamma In Complex With A 2-Baba Compound
Length = 292
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 84 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 143
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 144 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 202
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 203 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 262
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 263 EHVQLLQVIKKTE 275
>pdb|3T03|A Chain A, Crystal Structure Of Ppar Gamma Ligand Binding Domain In
Complex With A Novel Partial Agonist Gq-16
pdb|3T03|B Chain B, Crystal Structure Of Ppar Gamma Ligand Binding Domain In
Complex With A Novel Partial Agonist Gq-16
Length = 284
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 76 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 135
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 136 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 194
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 195 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 254
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 255 EHVQLLQVIKKTE 267
>pdb|3B0Q|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With
Mcc555
pdb|3B0Q|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With
Mcc555
pdb|3B0R|A Chain A, Human Ppar Gamma Ligand Binding Dmain Complexed With
Gw9662 In A Covalent Bonded Form
pdb|3B0R|B Chain B, Human Ppar Gamma Ligand Binding Dmain Complexed With
Gw9662 In A Covalent Bonded Form
Length = 274
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 67 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 126
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 127 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 185
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 186 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 245
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 246 EHVQLLQVIKKTE 258
>pdb|1KNU|A Chain A, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma In Complex With A Synthetic
Agonist
pdb|1KNU|B Chain B, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma In Complex With A Synthetic
Agonist
pdb|2XKW|A Chain A, Ligand Binding Domain Of Human Ppar-Gamma In Complex With
The Agonist Pioglitazone
pdb|2XKW|B Chain B, Ligand Binding Domain Of Human Ppar-Gamma In Complex With
The Agonist Pioglitazone
pdb|3R5N|A Chain A, Crystal Structure Of Ppargammalbd Complexed With The
Agonist Magnolol
Length = 274
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 66 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 125
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 126 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 184
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 185 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 244
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 245 EHVQLLQVIKKTE 257
>pdb|1K7L|A Chain A, The 2.5 Angstrom Resolution Crystal Structure Of The Human
Pparalpha Ligand Binding Domain Bound With Gw409544 And
A Co-Activator Peptide.
pdb|1K7L|C Chain C, The 2.5 Angstrom Resolution Crystal Structure Of The Human
Pparalpha Ligand Binding Domain Bound With Gw409544 And
A Co-Activator Peptide.
pdb|1K7L|E Chain E, The 2.5 Angstrom Resolution Crystal Structure Of The Human
Pparalpha Ligand Binding Domain Bound With Gw409544 And
A Co-Activator Peptide.
pdb|1K7L|G Chain G, The 2.5 Angstrom Resolution Crystal Structure Of The Human
Pparalpha Ligand Binding Domain Bound With Gw409544 And
A Co-Activator Peptide
Length = 288
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 3/170 (1%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVR 190
T+ ++ EFAK IPGF+ L +DQVTLLK GV+E + L+ + + + ++ + R
Sbjct: 103 TVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMN-KDGMLVAYGNGFITR 161
Query: 191 DSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMR 248
+ + S F +M+ FDFA + N L L D++I LF + ++ R GL N +E+M+
Sbjct: 162 EFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQ 221
Query: 249 GKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ ++L L NHP+ + L +L+ + DLR L H++ + + TE
Sbjct: 222 EGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTE 271
>pdb|3ET1|A Chain A, Structure Of Pparalpha With 3-[5-Methoxy-1-(4-Methoxy-
Benzenesulfonyl)-1h-Indol-3-Yl]-Propionic Acid
pdb|3ET1|B Chain B, Structure Of Pparalpha With 3-[5-Methoxy-1-(4-Methoxy-
Benzenesulfonyl)-1h-Indol-3-Yl]-Propionic Acid
Length = 291
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 3/170 (1%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVR 190
T+ ++ EFAK IPGF+ L +DQVTLLK GV+E + L+ + + + ++ + R
Sbjct: 106 TVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMN-KDGMLVAYGNGFITR 164
Query: 191 DSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMR 248
+ + S F +M+ FDFA + N L L D++I LF + ++ R GL N +E+M+
Sbjct: 165 EFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQ 224
Query: 249 GKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ ++L L NHP+ + L +L+ + DLR L H++ + + TE
Sbjct: 225 EGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTE 274
>pdb|3R8A|A Chain A, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Compound With Dual Ppar
Gamma Agonism And Angiotensin Ii Type I Receptor
Antagonism Activity
pdb|3R8A|B Chain B, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Compound With Dual Ppar
Gamma Agonism And Angiotensin Ii Type I Receptor
Antagonism Activity
Length = 282
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 74 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 133
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 134 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 192
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 193 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 252
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 253 EHVQLLQVIKKTE 265
>pdb|3ET3|A Chain A, Structure Of Ppargamma With 3-[5-Methoxy-1-(4-Methoxy-
Benzenesulfonyl)-1h-Indol-3-Yl]-Propionic Acid
Length = 292
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 84 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 143
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 144 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 202
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 203 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 262
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 263 EHVQLLQVIKKTE 275
>pdb|2ZNN|A Chain A, Human Pprr Alpha Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp703
pdb|3VI8|A Chain A, Human Pprr Alpha Ligand Binding Domain In Complex With A
Synthetic Agonist Aphm13
Length = 273
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 3/170 (1%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVR 190
T+ ++ EFAK IPGF+ L +DQVTLLK GV+E + L+ + + + ++ + R
Sbjct: 88 TVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMN-KDGMLVAYGNGFITR 146
Query: 191 DSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMR 248
+ + S F +M+ FDFA + N L L D++I LF + ++ R GL N +E+M+
Sbjct: 147 EFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQ 206
Query: 249 GKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ ++L L NHP+ + L +L+ + DLR L H++ + + TE
Sbjct: 207 EGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTE 256
>pdb|2PRG|A Chain A, Ligand-Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma
pdb|2PRG|B Chain B, Ligand-Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma
pdb|2F4B|A Chain A, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma In Complex With An Agonist
pdb|2F4B|B Chain B, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma In Complex With An Agonist
pdb|2FVJ|A Chain A, A Novel Anti-adipogenic Partial Agonist Of Peroxisome
Proliferator- Activated Receptor-gamma (pparg) Recruits
Pparg-coactivator-1 Alpha (pgc1a) But Potentiates
Insulin Signaling In Vitro
pdb|2G0G|A Chain A, Structure-based Drug Design Of A Novel Family Of Ppar
Partial Agonists: Virtual Screening, X-ray
Crystallography And In Vitro/in Vivo Biological
Activities
pdb|2G0G|B Chain B, Structure-based Drug Design Of A Novel Family Of Ppar
Partial Agonists: Virtual Screening, X-ray
Crystallography And In Vitro/in Vivo Biological
Activities
pdb|2G0H|A Chain A, Structure-Based Drug Design Of A Novel Family Of Ppar
Partial Agonists: Virtual Screening, X-Ray
Crystallography And In VitroIN VIVO BIOLOGICAL
ACTIVITIES
pdb|2G0H|B Chain B, Structure-Based Drug Design Of A Novel Family Of Ppar
Partial Agonists: Virtual Screening, X-Ray
Crystallography And In VitroIN VIVO BIOLOGICAL
ACTIVITIES
pdb|2ATH|A Chain A, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma Im Complex With An Agonist
pdb|2ATH|B Chain B, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma Im Complex With An Agonist
pdb|2GTK|A Chain A, Structure-Based Design Of Indole Propionic Acids As Novel
Pparag Co-Agonists
pdb|2HWQ|A Chain A, Structural Basis For The Structure-Activity Relationships
Of Peroxisome Proliferator-Activated Receptor Agonists
pdb|2HWQ|B Chain B, Structural Basis For The Structure-Activity Relationships
Of Peroxisome Proliferator-Activated Receptor Agonists
pdb|2HWR|A Chain A, Structural Basis For The Structure-Activity Relationships
Of Peroxisome Proliferator-Activated Receptor Agonists
pdb|2HWR|B Chain B, Structural Basis For The Structure-Activity Relationships
Of Peroxisome Proliferator-Activated Receptor Agonists
pdb|2Q8S|A Chain A, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Ppar GammaALPHA DUAL
AGONIST
pdb|2Q8S|B Chain B, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Ppar GammaALPHA DUAL
AGONIST
pdb|3G9E|A Chain A, Aleglitaar. A New. Potent, And Balanced Dual PparaG
AGONIST For The Treatment Of Type Ii Diabetes
pdb|3IA6|A Chain A, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Ppar GammaALPHA DUAL
Agonist
pdb|3IA6|B Chain B, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Ppar GammaALPHA DUAL
Agonist
pdb|3FEJ|A Chain A, Design And Biological Evaluation Of Novel, Balanced Dual
PparaG AGONISTS
pdb|3GBK|A Chain A, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complexed With A Potent And Selective Agonist
pdb|3GBK|B Chain B, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complexed With A Potent And Selective Agonist
pdb|3NOA|A Chain A, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complex With A Potency Improved Agonist
pdb|3NOA|B Chain B, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complex With A Potency Improved Agonist
pdb|3QT0|A Chain A, Revealing A Steroid Receptor Ligand As A Unique Ppargamma
Agonist
Length = 271
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 63 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 122
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 123 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 181
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 182 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 241
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 242 EHVQLLQVIKKTE 254
>pdb|3G8I|A Chain A, Aleglitazar, A New, Potent, And Balanced Ppar AlphaGAMMA
Agonist For The Treatment Of Type Ii Diabetes
Length = 270
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 3/170 (1%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVR 190
T+ ++ EFAK IPGF+ L +DQVTLLK GV+E + L+ + + + ++ + R
Sbjct: 85 TVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMN-KDGMLVAYGNGFITR 143
Query: 191 DSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMR 248
+ + S F +M+ FDFA + N L L D++I LF + ++ R GL N +E+M+
Sbjct: 144 EFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQ 203
Query: 249 GKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ ++L L NHP+ + L +L+ + DLR L H++ + + TE
Sbjct: 204 EGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTE 253
>pdb|2NPA|A Chain A, The Crystal Structure Of The Human Pparaplpha Ligand
Binding Domain In Complex With A A-Hydroxyimino
Phenylpropanoic Acid
pdb|2NPA|C Chain C, The Crystal Structure Of The Human Pparaplpha Ligand
Binding Domain In Complex With A A-Hydroxyimino
Phenylpropanoic Acid
Length = 270
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 3/170 (1%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVR 190
T+ ++ EFAK IPGF+ L +DQVTLLK GV+E + L+ + + + ++ + R
Sbjct: 85 TVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMN-KDGMLVAYGNGFITR 143
Query: 191 DSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMR 248
+ + S F +M+ FDFA + N L L D++I LF + ++ R GL N +E+M+
Sbjct: 144 EFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQ 203
Query: 249 GKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ ++L L NHP+ + L +L+ + DLR L H++ + + TE
Sbjct: 204 EGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTE 253
>pdb|4PRG|A Chain A, 0072 Partial Agonist Ppar Gamma Cocrystal
pdb|4PRG|B Chain B, 0072 Partial Agonist Ppar Gamma Cocrystal
pdb|4PRG|C Chain C, 0072 Partial Agonist Ppar Gamma Cocrystal
pdb|4PRG|D Chain D, 0072 Partial Agonist Ppar Gamma Cocrystal
pdb|1PRG|A Chain A, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma
pdb|1PRG|B Chain B, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma
pdb|2QMV|A Chain A, High Resolution Structure Of Peroxisone
Proliferation-Activated Receptor Gamma And
Characterisation Of Its Interaction With The Co-
Activator Transcriptional Intermediary Factor 2
Length = 270
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 63 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 122
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 123 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 181
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 182 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 241
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 242 EHVQLLQVIKKTE 254
>pdb|3U9Q|A Chain A, Ligand Binding Domain Of Ppargamma Complexed With Decanoic
Acid And Pgc-1a Peptide
Length = 269
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 62 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 121
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 122 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 180
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 181 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 240
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 241 EHVQLLQVIKKTE 253
>pdb|3CWD|A Chain A, Molecular Recognition Of Nitro-Fatty Acids By Ppar Gamma
pdb|3CWD|B Chain B, Molecular Recognition Of Nitro-Fatty Acids By Ppar Gamma
Length = 270
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 113 PLQGQQE-----LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
PLQ Q + + Q R ++++ E+AK IPGF L +DQVTLLK GV E++
Sbjct: 62 PLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYT 121
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLF 225
LA + + + +I + R+ + S F M+ F+FA + N L L D+++ +F
Sbjct: 122 MLASLMN-KDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIF 180
Query: 226 SSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
+++++S R GL N + +E ++ L L L NHPE L A+L+ + DLR +
Sbjct: 181 IAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVT 240
Query: 286 LHSEKLVAFQMTE 298
H + L + TE
Sbjct: 241 EHVQLLQVIKKTE 253
>pdb|1KKQ|A Chain A, Crystal Structure Of The Human Ppar-Alpha Ligand-Binding
Domain In Complex With An Antagonist Gw6471 And A Smrt
Corepressor Motif
pdb|1KKQ|B Chain B, Crystal Structure Of The Human Ppar-Alpha Ligand-Binding
Domain In Complex With An Antagonist Gw6471 And A Smrt
Corepressor Motif
pdb|1KKQ|C Chain C, Crystal Structure Of The Human Ppar-Alpha Ligand-Binding
Domain In Complex With An Antagonist Gw6471 And A Smrt
Corepressor Motif
pdb|1KKQ|D Chain D, Crystal Structure Of The Human Ppar-Alpha Ligand-Binding
Domain In Complex With An Antagonist Gw6471 And A Smrt
Corepressor Motif
Length = 269
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 3/170 (1%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVR 190
T+ ++ EFAK IPGF+ L +DQVTLLK GV+E + L+ + + + ++ + R
Sbjct: 84 TVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMN-KDGMLVAYGNGFITR 142
Query: 191 DSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMR 248
+ + S F +M+ FDFA + N L L D++I LF + ++ R GL N +E+M+
Sbjct: 143 EFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQ 202
Query: 249 GKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ ++L L NHP+ + L +L+ + DLR L H++ + + TE
Sbjct: 203 EGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTE 252
>pdb|2P54|A Chain A, A Crystal Structure Of Ppar Alpha Bound With Src1 Peptide
And Gw735
pdb|3FEI|A Chain A, Design And Biological Evaluation Of Novel, Balanced Dual
PparaG AGONISTS
Length = 267
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 3/170 (1%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVR 190
T+ ++ EFAK IPGF+ L +DQVTLLK GV+E + L+ + + + ++ + R
Sbjct: 82 TVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMN-KDGMLVAYGNGFITR 140
Query: 191 DSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMR 248
+ + S F +M+ FDFA + N L L D++I LF + ++ R GL N +E+M+
Sbjct: 141 EFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQ 200
Query: 249 GKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ ++L L NHP+ + L +L+ + DLR L H++ + + TE
Sbjct: 201 EGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTE 250
>pdb|3A9E|B Chain B, Crystal Structure Of A Mixed Agonist-Bound Rar-Alpha And
Antagonist- Bound Rxr-Alpha Heterodimer Ligand Binding
Domains
Length = 269
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 98/178 (55%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
+L FSE + I VEFAK++PGF+ L DQ+TLLKA ++L++R+ + + +
Sbjct: 71 DLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQD 130
Query: 179 SMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGL 238
+M +G L R +H++ L D +F FA +L L + D E GL S+I +I R L
Sbjct: 131 TMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDL 190
Query: 239 RNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
+ V+ ++ L L + + P + ++ +++ + DLR+++ +E+++ +M
Sbjct: 191 EQPDRVDMLQEPLLEALKVYVRKRRPSRPHMFPKMLMKITDLRSISAKGAERVITLKM 248
>pdb|3KMR|A Chain A, Crystal Structure Of Raralpha Ligand Binding Domain In
Complex With An Agonist Ligand (Am580) And A Coactivator
Fragment
pdb|3KMZ|B Chain B, Crystal Structure Of Raralpha Ligand Binding Domain In
Complex With The Inverse Agonist Bms493 And A
Corepressor Fragment
pdb|3KMZ|A Chain A, Crystal Structure Of Raralpha Ligand Binding Domain In
Complex With The Inverse Agonist Bms493 And A
Corepressor Fragment
Length = 266
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 98/178 (55%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
+L FSE + I VEFAK++PGF+ L DQ+TLLKA ++L++R+ + + +
Sbjct: 68 DLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQD 127
Query: 179 SMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGL 238
+M +G L R +H++ L D +F FA +L L + D E GL S+I +I R L
Sbjct: 128 TMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDL 187
Query: 239 RNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
+ V+ ++ L L + + P + ++ +++ + DLR+++ +E+++ +M
Sbjct: 188 EQPDRVDMLQEPLLEALKVYVRKRRPSRPHMFPKMLMKITDLRSISAKGAERVITLKM 245
>pdb|4DQM|A Chain A, Revealing A Marine Natural Product As A Novel Agonist For
Retinoic Acid Receptors With A Unique Binding Mode And
Antitumor Activity
pdb|4DQM|C Chain C, Revealing A Marine Natural Product As A Novel Agonist For
Retinoic Acid Receptors With A Unique Binding Mode And
Antitumor Activity
Length = 234
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 98/178 (55%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
+L FSE + I VEFAK++PGF+ L DQ+TLLKA ++L++R+ + + +
Sbjct: 42 DLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQD 101
Query: 179 SMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGL 238
+M +G L R +H++ L D +F FA +L L + D E GL S+I +I R L
Sbjct: 102 TMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDL 161
Query: 239 RNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
+ V+ ++ L L + + P + ++ +++ + DLR+++ +E+++ +M
Sbjct: 162 EQPDRVDMLQEPLLEALKVYVRKRRPSRPHMFPKMLMKITDLRSISAKGAERVITLKM 219
>pdb|1DKF|B Chain B, Crystal Structure Of A Heterodimeric Complex Of Rar And
Rxr Ligand-Binding Domains
Length = 235
Score = 93.6 bits (231), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 98/178 (55%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
+L FSE + I VEFAK++PGF+ L DQ+TLLKA ++L++R+ + + +
Sbjct: 42 DLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQD 101
Query: 179 SMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGL 238
+M +G L R +H++ L D +F FA +L L + D E GL S+I +I R L
Sbjct: 102 TMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDL 161
Query: 239 RNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
+ V+ ++ L L + + P + ++ +++ + DLR+++ +E+++ +M
Sbjct: 162 EQPDRVDMLQEPLLEALKVYVRKRRPSRPHMFPKMLMKITDLRSISAKGAERVITLKM 219
>pdb|3IPQ|A Chain A, X-Ray Structure Of Gw3965 Synthetic Agonist Bound To The
Lxr
pdb|3IPS|A Chain A, X-Ray Structure Of Benzisoxazole Synthetic Agonist Bound
To Alpha
pdb|3IPS|B Chain B, X-Ray Structure Of Benzisoxazole Synthetic Agonist Bound
To Alpha
pdb|3IPU|A Chain A, X-Ray Structure Of Benzisoxazole Urea Synthetic Agonist
Boun Lxr-Alpha
pdb|3IPU|B Chain B, X-Ray Structure Of Benzisoxazole Urea Synthetic Agonist
Boun Lxr-Alpha
Length = 283
Score = 93.6 bits (231), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 51/195 (26%), Positives = 105/195 (53%), Gaps = 1/195 (0%)
Query: 105 CPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEV 164
P+ P+ H + +Q+ F+E +++++V+FAK++PGF L +DQ+ LLK EV
Sbjct: 74 WPMAPDPHSREARQQRFAHFTELAIVSVQEIVDFAKQLPGFLQLSREDQIALLKTSAIEV 133
Query: 165 LLVRLACMFDSQTNSMICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLNGLHLSDTEIG 223
+L+ + ++ + S+ L R+ + + ++ +F+F+ +N L L+D E
Sbjct: 134 MLLETSRRYNPGSESITFLKDFSYNREDFAKAGLQVEFINPIFEFSRAMNELQLNDAEFA 193
Query: 224 LFSSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTL 283
L +I + S R ++++ VER++ L ++ +HP + ++ L LRTL
Sbjct: 194 LLIAISIFSADRPNVQDQLQVERLQHTYVEALHAYVSIHHPHDRLMFPRMLMKLVSLRTL 253
Query: 284 NQLHSEKLVAFQMTE 298
+ +HSE++ A ++ +
Sbjct: 254 SSVHSEQVFALRLQD 268
>pdb|1R20|D Chain D, Crystal Structure Of The Ligand-Binding Domains Of The
Heterodimer EcrUSP BOUND TO THE SYNTHETIC AGONIST
BYI06830
pdb|3IXP|D Chain D, Crystal Structure Of The Ecdysone Receptor Bound To
Byi08346
Length = 265
Score = 93.6 bits (231), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 50/169 (29%), Positives = 97/169 (57%), Gaps = 4/169 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVR 190
T++ +VEFAK +PGFS + DQ+TLLKA EV+++R+A +D+ T+S++ N + R
Sbjct: 79 TVQLIVEFAKGLPGFSKISQSDQITLLKACSSEVMMLRVARRYDAATDSVLFANNQAYTR 138
Query: 191 DSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM-RG 249
D+ + ++++ + F + + + + L ++IV+ S R GL LVE + R
Sbjct: 139 DNYRKAGMAYVIEDLLHFCRCMYSMMMDNVHYALLTAIVIFS-DRPGLEQPSLVEEIQRY 197
Query: 250 KLENMLMHVLNQN--HPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
L + +++LNQN P + +++ +L ++RTL +S ++ ++
Sbjct: 198 YLNTLRVYILNQNSASPRSAVIFGKILGILTEIRTLGMQNSNMCISLKL 246
>pdb|2B50|A Chain A, Human Nuclear Receptor-Ligand Complex 2
pdb|2B50|B Chain B, Human Nuclear Receptor-Ligand Complex 2
Length = 272
Score = 93.6 bits (231), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 58/171 (33%), Positives = 93/171 (54%), Gaps = 5/171 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV- 189
T+R++ EFAK IP FS L +DQVTLLK GV E + LA + + + ++ NG V
Sbjct: 88 TVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK--DGLLVANGSGFVT 145
Query: 190 RDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
R+ + S F +++ F+FA + N L L D+++ LF + +++ R GL N VE +
Sbjct: 146 REFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAI 205
Query: 248 RGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ + L L NHP+ L +L+ + DLR L H++ + + TE
Sbjct: 206 QDTILRALEFHLQANHPDAQQLFPKLLQKMADLRQLVTEHAQMMQRIKKTE 256
>pdb|3ET2|A Chain A, Structure Of Ppardelta With 3-[5-Methoxy-1-(4-Methoxy-
Benzenesulfonyl)-1h-Indol-3-Yl]-Propionic Acid
pdb|3ET2|B Chain B, Structure Of Ppardelta With 3-[5-Methoxy-1-(4-Methoxy-
Benzenesulfonyl)-1h-Indol-3-Yl]-Propionic Acid
Length = 287
Score = 93.2 bits (230), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 58/171 (33%), Positives = 93/171 (54%), Gaps = 5/171 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV- 189
T+R++ EFAK IP FS L +DQVTLLK GV E + LA + + + ++ NG V
Sbjct: 102 TVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK--DGLLVANGSGFVT 159
Query: 190 RDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
R+ + S F +++ F+FA + N L L D+++ LF + +++ R GL N VE +
Sbjct: 160 REFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAI 219
Query: 248 RGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ + L L NHP+ L +L+ + DLR L H++ + + TE
Sbjct: 220 QDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTE 270
>pdb|2Q5G|A Chain A, Ligand Binding Domain Of Ppar Delta Receptor In Complex
With A Partial Agonist
pdb|2Q5G|B Chain B, Ligand Binding Domain Of Ppar Delta Receptor In Complex
With A Partial Agonist
Length = 283
Score = 93.2 bits (230), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 58/171 (33%), Positives = 93/171 (54%), Gaps = 5/171 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV- 189
T+R++ EFAK IP FS L +DQVTLLK GV E + LA + + + ++ NG V
Sbjct: 98 TVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK--DGLLVANGSGFVT 155
Query: 190 RDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
R+ + S F +++ F+FA + N L L D+++ LF + +++ R GL N VE +
Sbjct: 156 REFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAI 215
Query: 248 RGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ + L L NHP+ L +L+ + DLR L H++ + + TE
Sbjct: 216 QDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTE 266
>pdb|2XYJ|A Chain A, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYJ|B Chain B, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYW|A Chain A, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYW|B Chain B, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYX|A Chain A, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYX|B Chain B, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
Length = 288
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 58/171 (33%), Positives = 93/171 (54%), Gaps = 5/171 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV- 189
T+R++ EFAK IP FS L +DQVTLLK GV E + LA + + + ++ NG V
Sbjct: 103 TVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK--DGLLVANGSGFVT 160
Query: 190 RDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
R+ + S F +++ F+FA + N L L D+++ LF + +++ R GL N VE +
Sbjct: 161 REFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAI 220
Query: 248 RGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ + L L NHP+ L +L+ + DLR L H++ + + TE
Sbjct: 221 QDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTE 271
>pdb|2ZNP|A Chain A, Human Pprr Delta Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp204
pdb|2ZNP|B Chain B, Human Pprr Delta Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp204
pdb|2ZNQ|A Chain A, Human Pprr Delta Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp401
pdb|2ZNQ|B Chain B, Human Pprr Delta Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp401
Length = 276
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 58/171 (33%), Positives = 93/171 (54%), Gaps = 5/171 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV- 189
T+R++ EFAK IP FS L +DQVTLLK GV E + LA + + + ++ NG V
Sbjct: 91 TVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK--DGLLVANGSGFVT 148
Query: 190 RDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
R+ + S F +++ F+FA + N L L D+++ LF + +++ R GL N VE +
Sbjct: 149 REFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAI 208
Query: 248 RGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ + L L NHP+ L +L+ + DLR L H++ + + TE
Sbjct: 209 QDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTE 259
>pdb|1Y0S|A Chain A, Crystal Structure Of Ppar Delta Complexed With Gw2331
pdb|1Y0S|B Chain B, Crystal Structure Of Ppar Delta Complexed With Gw2331
Length = 272
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 58/171 (33%), Positives = 93/171 (54%), Gaps = 5/171 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV- 189
T+R++ EFAK IP FS L +DQVTLLK GV E + LA + + + ++ NG V
Sbjct: 87 TVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK--DGLLVANGSGFVT 144
Query: 190 RDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
R+ + S F +++ F+FA + N L L D+++ LF + +++ R GL N VE +
Sbjct: 145 REFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAI 204
Query: 248 RGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ + L L NHP+ L +L+ + DLR L H++ + + TE
Sbjct: 205 QDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTE 255
>pdb|2AWH|A Chain A, Human Nuclear Receptor-Ligand Complex 1
pdb|2AWH|B Chain B, Human Nuclear Receptor-Ligand Complex 1
Length = 268
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 58/171 (33%), Positives = 93/171 (54%), Gaps = 5/171 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV- 189
T+R++ EFAK IP FS L +DQVTLLK GV E + LA + + + ++ NG V
Sbjct: 83 TVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK--DGLLVANGSGFVT 140
Query: 190 RDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
R+ + S F +++ F+FA + N L L D+++ LF + +++ R GL N VE +
Sbjct: 141 REFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAI 200
Query: 248 RGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ + L L NHP+ L +L+ + DLR L H++ + + TE
Sbjct: 201 QDTILRALEFHLQANHPDAQQLFPKLLQKMADLRQLVTEHAQMMQRIKKTE 251
>pdb|2J14|A Chain A, 3,4,5-Trisubstituted Isoxazoles As Novel Ppardelta
Agonists: Part2
pdb|2J14|B Chain B, 3,4,5-Trisubstituted Isoxazoles As Novel Ppardelta
Agonists: Part2
pdb|3OZ0|A Chain A, Ppar Delta In Complex With Azppard02
Length = 285
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 58/171 (33%), Positives = 93/171 (54%), Gaps = 5/171 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV- 189
T+R++ EFAK IP FS L +DQVTLLK GV E + LA + + + ++ NG V
Sbjct: 100 TVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK--DGLLVANGSGFVT 157
Query: 190 RDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
R+ + S F +++ F+FA + N L L D+++ LF + +++ R GL N VE +
Sbjct: 158 REFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAI 217
Query: 248 RGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ + L L NHP+ L +L+ + DLR L H++ + + TE
Sbjct: 218 QDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTE 268
>pdb|3SP9|A Chain A, Structural Basis For Iloprost As A Dual PparalphaDELTA
AGONIST
pdb|3SP9|B Chain B, Structural Basis For Iloprost As A Dual PparalphaDELTA
AGONIST
Length = 281
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 58/171 (33%), Positives = 93/171 (54%), Gaps = 5/171 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV- 189
T+R++ EFAK IP FS L +DQVTLLK GV E + LA + + + ++ NG V
Sbjct: 96 TVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK--DGLLVANGSGFVT 153
Query: 190 RDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
R+ + S F +++ F+FA + N L L D+++ LF + +++ R GL N VE +
Sbjct: 154 REFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAI 213
Query: 248 RGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ + L L NHP+ L +L+ + DLR L H++ + + TE
Sbjct: 214 QDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTE 264
>pdb|2GWX|A Chain A, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-Activated Receptors
pdb|2GWX|B Chain B, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-Activated Receptors
pdb|2BAW|A Chain A, Human Nuclear Receptor-Ligand Complex 1
pdb|2BAW|B Chain B, Human Nuclear Receptor-Ligand Complex 1
pdb|3D5F|A Chain A, Crystal Structure Of Ppar-Delta Complex
pdb|3D5F|B Chain B, Crystal Structure Of Ppar-Delta Complex
Length = 267
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 58/171 (33%), Positives = 93/171 (54%), Gaps = 5/171 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV- 189
T+R++ EFAK IP FS L +DQVTLLK GV E + LA + + + ++ NG V
Sbjct: 82 TVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK--DGLLVANGSGFVT 139
Query: 190 RDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
R+ + S F +++ F+FA + N L L D+++ LF + +++ R GL N VE +
Sbjct: 140 REFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAI 199
Query: 248 RGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ + L L NHP+ L +L+ + DLR L H++ + + TE
Sbjct: 200 QDTILRALEFHLQANHPDAQQLFPKLLQKMADLRQLVTEHAQMMQRIKKTE 250
>pdb|3TKM|A Chain A, Crystal Structure Ppar Delta Binding Gw0742
Length = 275
Score = 92.8 bits (229), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 58/171 (33%), Positives = 93/171 (54%), Gaps = 5/171 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV- 189
T+R++ EFAK IP FS L +DQVTLLK GV E + LA + + + ++ NG V
Sbjct: 90 TVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK--DGLLVANGSGFVT 147
Query: 190 RDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
R+ + S F +++ F+FA + N L L D+++ LF + +++ R GL N VE +
Sbjct: 148 REFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAI 207
Query: 248 RGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ + L L NHP+ L +L+ + DLR L H++ + + TE
Sbjct: 208 QDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTE 258
>pdb|1GWX|A Chain A, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-Activated Receptors
pdb|1GWX|B Chain B, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-Activated Receptors
pdb|3GWX|A Chain A, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-activated Receptors
pdb|3GWX|B Chain B, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-activated Receptors
pdb|3DY6|A Chain A, Ppardelta Complexed With An Anthranilic Acid Partial
Agonist
pdb|3DY6|B Chain B, Ppardelta Complexed With An Anthranilic Acid Partial
Agonist
pdb|3PEQ|A Chain A, Ppard Complexed With A Phenoxyacetic Acid Partial Agonist
pdb|3PEQ|B Chain B, Ppard Complexed With A Phenoxyacetic Acid Partial Agonist
Length = 271
Score = 92.8 bits (229), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 58/171 (33%), Positives = 93/171 (54%), Gaps = 5/171 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV- 189
T+R++ EFAK IP FS L +DQVTLLK GV E + LA + + + ++ NG V
Sbjct: 86 TVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK--DGLLVANGSGFVT 143
Query: 190 RDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
R+ + S F +++ F+FA + N L L D+++ LF + +++ R GL N VE +
Sbjct: 144 REFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAI 203
Query: 248 RGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ + L L NHP+ L +L+ + DLR L H++ + + TE
Sbjct: 204 QDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTE 254
>pdb|1UHL|B Chain B, Crystal Structure Of The Lxralfa-Rxrbeta Lbd Heterodimer
Length = 242
Score = 91.7 bits (226), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 51/195 (26%), Positives = 105/195 (53%), Gaps = 1/195 (0%)
Query: 105 CPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEV 164
P+ P+ H + +Q+ F+E +++++V+FAK++PGF L +DQ+ LLK EV
Sbjct: 33 WPMAPDPHSREARQQRFAHFTELAIVSVQEIVDFAKQLPGFLQLSREDQIALLKTSAIEV 92
Query: 165 LLVRLACMFDSQTNSMICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLNGLHLSDTEIG 223
+L+ + ++ + S+ L R+ + + ++ +F+F+ +N L L+D E
Sbjct: 93 MLLETSRRYNPGSESITFLKDFSYNREDFAKAGLQVEFINPIFEFSRAMNELQLNDAEFA 152
Query: 224 LFSSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTL 283
L +I + S R ++++ VER++ L ++ +HP + ++ L LRTL
Sbjct: 153 LLIAISIFSADRPNVQDQLQVERLQHTYVEALHAYVSIHHPHDRLMFPRMLMKLVSLRTL 212
Query: 284 NQLHSEKLVAFQMTE 298
+ +HSE++ A ++ +
Sbjct: 213 SSVHSEQVFALRLQD 227
>pdb|3GZ9|A Chain A, Crystal Structure Of Peroxisome Proliferator-Activated
Receptor Delta (Ppard) In Complex With A Full Agonist
Length = 269
Score = 91.7 bits (226), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 57/171 (33%), Positives = 92/171 (53%), Gaps = 5/171 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV- 189
T+R++ EFAK IP F L +DQVTLLK GV E + LA + + + ++ NG V
Sbjct: 86 TVRELTEFAKSIPSFGSLFLNDQVTLLKYGVHEAIFAMLASLVNK--DGLLVANGSGFVT 143
Query: 190 RDSIHSSNARF--LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
R+ + S F +++ F+FA + N L L D+++ LF + +++ R GL N VE +
Sbjct: 144 REFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAI 203
Query: 248 RGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
+ + L L NHP+ L +L+ + DLR L H++ + + TE
Sbjct: 204 QDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTE 254
>pdb|3FC6|B Chain B, Hrxralpha & Mlxralpha With An Indole Pharmacophore,
Sb786875
pdb|3FC6|D Chain D, Hrxralpha & Mlxralpha With An Indole Pharmacophore,
Sb786875
pdb|3FAL|B Chain B, Humanrxr Alpha & Mouse Lxr Alpha Complexed With Retenoic
Acid And Gsk2186
pdb|3FAL|D Chain D, Humanrxr Alpha & Mouse Lxr Alpha Complexed With Retenoic
Acid And Gsk2186
Length = 266
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 51/195 (26%), Positives = 104/195 (53%), Gaps = 1/195 (0%)
Query: 105 CPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEV 164
P+ P+ + +Q+ F+E +++++V+FAK++PGF L +DQ+ LLK EV
Sbjct: 57 WPIAPDPQSREARQQRFAHFTELAIVSVQEIVDFAKQLPGFLQLSREDQIALLKTSAIEV 116
Query: 165 LLVRLACMFDSQTNSMICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLNGLHLSDTEIG 223
+L+ + ++ + S+ L R+ + + ++ +F+F+ +N L L+D E
Sbjct: 117 MLLETSRRYNPGSESITFLKDFSYNREDFAKAGLQVEFINPIFEFSRAMNELQLNDAEFA 176
Query: 224 LFSSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTL 283
L +I + S R ++++ VER++ L ++ NHP + ++ L LRTL
Sbjct: 177 LLIAISIFSADRPNVQDQLQVERLQHTYVEALHAYVSINHPHDPLMFPRMLMKLVSLRTL 236
Query: 284 NQLHSEKLVAFQMTE 298
+ +HSE++ A ++ +
Sbjct: 237 SSVHSEQVFALRLQD 251
>pdb|2ACL|B Chain B, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
pdb|2ACL|D Chain D, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
pdb|2ACL|F Chain F, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
pdb|2ACL|H Chain H, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
Length = 244
Score = 90.5 bits (223), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 51/195 (26%), Positives = 104/195 (53%), Gaps = 1/195 (0%)
Query: 105 CPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEV 164
P+ P+ + +Q+ F+E +++++V+FAK++PGF L +DQ+ LLK EV
Sbjct: 35 WPIAPDPQSREARQQRFAHFTELAIVSVQEIVDFAKQLPGFLQLSREDQIALLKTSAIEV 94
Query: 165 LLVRLACMFDSQTNSMICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLNGLHLSDTEIG 223
+L+ + ++ + S+ L R+ + + ++ +F+F+ +N L L+D E
Sbjct: 95 MLLETSRRYNPGSESITFLKDFSYNREDFAKAGLQVEFINPIFEFSRAMNELQLNDAEFA 154
Query: 224 LFSSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTL 283
L +I + S R ++++ VER++ L ++ NHP + ++ L LRTL
Sbjct: 155 LLIAISIFSADRPNVQDQLQVERLQHTYVEALHAYVSINHPHDPLMFPRMLMKLVSLRTL 214
Query: 284 NQLHSEKLVAFQMTE 298
+ +HSE++ A ++ +
Sbjct: 215 SSVHSEQVFALRLQD 229
>pdb|1R1K|D Chain D, Crystal Structure Of The Ligand-Binding Domains Of The
Heterodimer EcrUSP BOUND TO PONASTERONE A
pdb|2R40|D Chain D, Crystal Structure Of 20e Bound Ecr/usp
Length = 266
Score = 90.1 bits (222), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 49/169 (28%), Positives = 97/169 (57%), Gaps = 4/169 (2%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVR 190
T++ +VEFAK +PGF+ + DQ+TLLKA EV+++R+A +D+ T+S++ N + R
Sbjct: 80 TVQLIVEFAKGLPGFAKISQSDQITLLKACSSEVMMLRVARRYDAATDSVLFANNQAYTR 139
Query: 191 DSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM-RG 249
D+ + ++++ + F + + + + L ++IV+ S R GL LVE + R
Sbjct: 140 DNYRKAGMAYVIEDLLHFCRCMYSMMMDNVHYALLTAIVIFS-DRPGLEQPLLVEEIQRY 198
Query: 250 KLENMLMHVLNQN--HPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
L + +++LNQN P + +++ +L ++RTL +S ++ ++
Sbjct: 199 YLNTLRVYILNQNSASPRCAVIFGKILGILTEIRTLGMQNSNMCISLKL 247
>pdb|3P88|A Chain A, Fxr Bound To Isoquinolinecarboxylic Acid
Length = 229
Score = 90.1 bits (222), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 52/167 (31%), Positives = 95/167 (56%), Gaps = 3/167 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
++ +VEF K++PGF L H+DQ+ LLK E + +R A +F+ + S E +R+
Sbjct: 52 VQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRN 111
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S S + MF F + + L ++ E L ++IV++SP R ++++E VE+++ L
Sbjct: 112 SGISDEY---ITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPL 168
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
++L + + PE AEL+ L +LRT N H+E L+++++ +
Sbjct: 169 LDVLQKLCKIHQPENPQHFAELLGRLTELRTFNHHHAEMLMSWRVND 215
>pdb|3HC6|A Chain A, Fxr With Src1 And Gsk088
Length = 232
Score = 90.1 bits (222), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 52/167 (31%), Positives = 95/167 (56%), Gaps = 3/167 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
++ +VEF K++PGF L H+DQ+ LLK E + +R A +F+ + S E +R+
Sbjct: 55 VQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRN 114
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S S + MF F + + L ++ E L ++IV++SP R ++++E VE+++ L
Sbjct: 115 SGISDEY---ITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPL 171
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
++L + + PE AEL+ L +LRT N H+E L+++++ +
Sbjct: 172 LDVLQKLCKIHQPENPQHFAELLGRLTELRTFNHHHAEMLMSWRVND 218
>pdb|3GD2|A Chain A, Isoxazole Ligand Bound To Farnesoid X Receptor (Fxr)
Length = 229
Score = 89.7 bits (221), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 52/167 (31%), Positives = 95/167 (56%), Gaps = 3/167 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
++ +VEF K++PGF L H+DQ+ LLK E + +R A +F+ + S E +R+
Sbjct: 52 VQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRN 111
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S S + MF F + + L ++ E L ++IV++SP R ++++E VE+++ L
Sbjct: 112 SGISDEY---ITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPL 168
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
++L + + PE AEL+ L +LRT N H+E L+++++ +
Sbjct: 169 LDVLQKLCKIHQPENPQHFAELLGRLTELRTFNHHHAEMLMSWRVND 215
>pdb|3P89|A Chain A, Fxr Bound To A Quinolinecarboxylic Acid
Length = 229
Score = 89.7 bits (221), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 52/167 (31%), Positives = 95/167 (56%), Gaps = 3/167 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
++ +VEF K++PGF L H+DQ+ LLK E + +R A +F+ + S E +R+
Sbjct: 52 VQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRN 111
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S S + MF F + + L ++ E L ++IV++SP R ++++E VE+++ L
Sbjct: 112 SGISDEY---ITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPL 168
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
++L + + PE AEL+ L +LRT N H+E L+++++ +
Sbjct: 169 LDVLQKLCKIHQPENPQHFAELLGRLTELRTFNHHHAEMLMSWRVND 215
>pdb|2NXX|E Chain E, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
pdb|2NXX|F Chain F, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
pdb|2NXX|G Chain G, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
pdb|2NXX|H Chain H, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
Length = 248
Score = 89.7 bits (221), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 54/167 (32%), Positives = 97/167 (58%), Gaps = 2/167 (1%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVR 190
T++ +VEFAKR+PGF L +DQ+ LLKA EV++ R+A +D QT+S++ +N + R
Sbjct: 64 TVQLIVEFAKRLPGFDKLLREDQIALLKACSSEVMMFRMARRYDVQTDSILFVNNQPYSR 123
Query: 191 DSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRG- 249
DS + + ++ + F + + + + E L ++IV+ S R L VE+++
Sbjct: 124 DSYNLAGMGETIEDLLHFCRTMYSMRVDNAEYALLTAIVIFS-ERPALIEGWKVEKIQEI 182
Query: 250 KLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
LE + +V N+ P+ + A+L+S+L +LRTL +SE + ++
Sbjct: 183 YLEALRAYVDNRRKPKPGTIFAKLLSVLTELRTLGNQNSEMCFSLKL 229
>pdb|3L0E|A Chain A, X-Ray Crystal Structure Of A Potent Liver X Receptor
Modulator
Length = 253
Score = 89.4 bits (220), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 1/205 (0%)
Query: 95 TYTACPSTLACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQV 154
+++ P PL + +Q+ F+E +++++V+FAK++PGF L +DQ+
Sbjct: 34 SFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQI 93
Query: 155 TLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLN 213
LLKA E++L+ A ++ +T S+ L +D H + + ++ +F+F+ ++
Sbjct: 94 ALLKASTIEIMLLETARRYNHETESITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMS 153
Query: 214 GLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAEL 273
L L D E L +I + S R ++ VE ++ L+ P+ +
Sbjct: 154 SLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRM 213
Query: 274 ISMLPDLRTLNQLHSEKLVAFQMTE 298
+ L LRTL+ +HSE++ A ++ +
Sbjct: 214 LMKLVSLRTLSSVHSEQVFALRLAD 238
>pdb|3JZC|A Chain A, Crystal Structure Of Tr-Beta Bound To The Selective
Thyromimetic Triac
Length = 263
Score = 89.0 bits (219), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 63/238 (26%), Positives = 112/238 (47%), Gaps = 17/238 (7%)
Query: 59 DDEQRMLSTVVRAHLDTCA---FTADKIEPMLRRAREHPTYTACPSTLACPLNPNSHPLQ 115
D+E ++ TV AH+ T A K + + + P A P L SH
Sbjct: 18 DEEWELIKTVTEAHVATNAQGSHWKQKRKFLPEDIGQAPIVNA-PEGGKVDLEAFSH--- 73
Query: 116 GQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDS 175
F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A +D
Sbjct: 74 --------FTKIITPAITRVVDFAKKLPMFXELPXEDQIILLKGCCMEIMSLRAAVRYDP 125
Query: 176 QTNSMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS 234
++ ++ LNGE+ V R + + + D++FD L+ +L DTE+ L +++++S
Sbjct: 126 ESETL-TLNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSD 184
Query: 235 RSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
R GL E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 185 RPGLAXVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGAXHASRFL 242
>pdb|1Z5X|E Chain E, Hemipteran Ecdysone Receptor Ligand-Binding Domain
Complexed With Ponasterone A
Length = 310
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 108/206 (52%), Gaps = 6/206 (2%)
Query: 92 EHPTYTACPSTLACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHD 151
EHP+ P + +N +E + +E T++ +VEF+KR+PGF L +
Sbjct: 93 EHPS----PEDIKRIVNAAPEEENVAEERFRHITEITILTVQLIVEFSKRLPGFDKLIRE 148
Query: 152 DQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAER 211
DQ+ LLKA EV++ R+A +D++T+S++ + R+S + ++ + F
Sbjct: 149 DQIALLKACSSEVMMFRMARRYDAETDSILFATNQPYTRESYTVAGMGDTVEDLLRFCRH 208
Query: 212 LNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRG-KLENMLMHVLNQNHPEQMNLC 270
+ + + + E L ++IV+ S R L VE+++ +E + +V N+ P +
Sbjct: 209 MCAMKVDNAEYALLTAIVIFS-ERPSLSEGWKVEKIQEIYIEALKAYVENRRKPYATTIF 267
Query: 271 AELISMLPDLRTLNQLHSEKLVAFQM 296
A+L+S+L +LRTL ++SE + ++
Sbjct: 268 AKLLSVLTELRTLGNMNSETCFSLKL 293
>pdb|2H79|A Chain A, Crystal Structure Of Human Tr Alpha Bound T3 In
Orthorhombic Space Group
Length = 269
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 48/175 (27%), Positives = 97/175 (55%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E +F++ +P I VV+FAK++P FS L +DQ+ LLK E++ +R A +D +++
Sbjct: 72 EAFSEFTKIITPAITRVVDFAKKLPMFSELPXEDQIILLKGCCMEIMSLRAAVRYDPESD 131
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ L+GE+ V R+ + + + D++F+ + L+ +L DTE+ L +++++S RSG
Sbjct: 132 TL-TLSGEMAVKREQLKNGGLGVVSDAIFELGKSLSAFNLDDTEVALLQAVLLMSTDRSG 190
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L + +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 191 LLXVDKIEKSQEAYLLAFEHYVNHRKHNIPHFWPKLLMKVTDLRMIGAXHASRFL 245
>pdb|3GWS|X Chain X, Crystal Structure Of T3-Bound Thyroid Hormone Receptor
Length = 259
Score = 87.8 bits (216), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A +D ++
Sbjct: 66 EAFSHFTKIITPAITRVVDFAKKLPMFXELPCEDQIILLKGCCMEIMSLRAAVRYDPESE 125
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ LNGE+ V R + + + D++FD L+ +L DTE+ L +++++S R G
Sbjct: 126 TL-TLNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 184
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 185 LAXVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGAXHASRFL 239
>pdb|3HZF|A Chain A, Structure Of Tr-alfa Bound To Selective Thyromimetic Gc-1
In C2 Space Group
Length = 269
Score = 87.8 bits (216), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 48/175 (27%), Positives = 97/175 (55%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E +F++ +P I VV+FAK++P FS L +DQ+ LLK E++ +R A +D +++
Sbjct: 72 EAFSEFTKIITPAITRVVDFAKKLPMFSELPXEDQIILLKGCCMEIMSLRAAVRYDPESD 131
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ L+GE+ V R+ + + + D++F+ + L+ +L DTE+ L +++++S RSG
Sbjct: 132 TL-TLSGEMAVKREQLKNGGLGVVSDAIFELGKSLSAFNLDDTEVALLQAVLLMSTDRSG 190
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L + +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 191 LLXVDKIEKSQEAYLLAFEHYVNHRKHNIPHFWPKLLMKVTDLRMIGAXHASRFL 245
>pdb|3JZB|A Chain A, Crystal Structure Of Tr-Alfa Bound To The Selective
Thyromimetic Triac
pdb|3ILZ|A Chain A, Structure Of Tr-Alfa Bound To Selective Thyromimetic Gc-1
In Space Group
Length = 267
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 48/175 (27%), Positives = 97/175 (55%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E +F++ +P I VV+FAK++P FS L +DQ+ LLK E++ +R A +D +++
Sbjct: 70 EAFSEFTKIITPAITRVVDFAKKLPMFSELPXEDQIILLKGCCMEIMSLRAAVRYDPESD 129
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ L+GE+ V R+ + + + D++F+ + L+ +L DTE+ L +++++S RSG
Sbjct: 130 TL-TLSGEMAVKREQLKNGGLGVVSDAIFELGKSLSAFNLDDTEVALLQAVLLMSTDRSG 188
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L + +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 189 LLXVDKIEKSQEAYLLAFEHYVNHRKHNIPHFWPKLLMKVTDLRMIGAXHASRFL 243
>pdb|3IMY|A Chain A, Structure Of Tr-Beta Bound To Selective Thyromimetic Gc-1
Length = 261
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A +D ++
Sbjct: 67 EAFSHFTKIITPAITRVVDFAKKLPMFXELPCEDQIILLKGCCMEIMSLRAAVRYDPESE 126
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ LNGE+ V R + + + D++FD L+ +L DTE+ L +++++S R G
Sbjct: 127 TL-TLNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 185
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 186 LAXVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGAXHASRFL 240
>pdb|3P8X|A Chain A, Synthesis, Structure, And Biological Activity Of Des-Side
Chain Analogues Of 1alpha,25-Dihydroxyvitamin D3 With
Substituents At C-18
Length = 280
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 100/185 (54%), Gaps = 6/185 (3%)
Query: 117 QQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQ 176
Q +L ++ S +I+ V+ FAK IPGF L +DQ+ LLK+ EV+++R F
Sbjct: 76 QLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMD 135
Query: 177 TNSMICLNGEVLVR--DSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS 234
S C N + R D + ++ L++ + F L L+L + E L +I ++SP
Sbjct: 136 DMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPD 195
Query: 235 RSGLRNKELVERMRGKLENMLMHVLNQNHPEQMN--LCAELISMLPDLRTLNQLHSE--K 290
R G+++ L+E ++ +L N L + HP + L A++I L DLR+LN+ HS+ +
Sbjct: 196 RPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYR 255
Query: 291 LVAFQ 295
++FQ
Sbjct: 256 CLSFQ 260
>pdb|1DB1|A Chain A, Crystal Structure Of The Nuclear Receptor For Vitamin D
Complexed To Vitamin D
pdb|1IE8|A Chain A, Crystal Structure Of The Nuclear Receptor For Vitamin D
Ligand Binding Domain Bound To Kh1060
pdb|1IE9|A Chain A, Crystal Structure Of The Nuclear Receptor For Vitamin D
Ligand Binding Domain Bound To Mc1288
pdb|3OGT|A Chain A, Design, Chemical Synthesis, Functional Characterization
And Crystal Structure Of The Sidechain Analogue Of
1,25-Dihydroxyvitamin D3.
pdb|3KPZ|A Chain A, Crystal Structure Of A Novel Vitamin D3 Analogue, Zk203278
Showing Dissociated Profile
pdb|3TKC|A Chain A, Design, Synthesis, Evaluation And Structure Of Vitamin D
Analogues With Furan Side Chains
pdb|4G2I|A Chain A, Structural Basis For The Accommodation Of Bis- And
Tris-Aromatic Derivatives In Vitamin D Nuclear Receptor
Length = 259
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 100/185 (54%), Gaps = 6/185 (3%)
Query: 117 QQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQ 176
Q +L ++ S +I+ V+ FAK IPGF L +DQ+ LLK+ EV+++R F
Sbjct: 55 QLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMD 114
Query: 177 TNSMICLNGEVLVR--DSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS 234
S C N + R D + ++ L++ + F L L+L + E L +I ++SP
Sbjct: 115 DMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPD 174
Query: 235 RSGLRNKELVERMRGKLENMLMHVLNQNHPEQMN--LCAELISMLPDLRTLNQLHSE--K 290
R G+++ L+E ++ +L N L + HP + L A++I L DLR+LN+ HS+ +
Sbjct: 175 RPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYR 234
Query: 291 LVAFQ 295
++FQ
Sbjct: 235 CLSFQ 239
>pdb|1NQ0|A Chain A, Tr Receptor Mutations Conferring Hormone Resistance And
Reduced Corepressor Release Exhibit Decreased Stability
In The Nterminal Lbd
Length = 263
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A +D ++
Sbjct: 69 EAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESE 128
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ LNGE+ V R + + + D++FD L+ +L DTE+ L +++++S R G
Sbjct: 129 TLT-LNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 187
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 188 LACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFL 242
>pdb|1NQ1|A Chain A, Tr Receptor Mutations Conferring Hormone Resistance And
Reduced Corepressor Release Exhibit Decreased Stability
In The Nterminal Lbd
Length = 263
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A +D ++
Sbjct: 69 EAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESE 128
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ LNGE+ V R + + + D++FD L+ +L DTE+ L +++++S R G
Sbjct: 129 TLT-LNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 187
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 188 LACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFL 242
>pdb|3B0T|A Chain A, Human Vdr Ligand Binding Domain In Complex With
Maxacalcitol
Length = 254
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 100/185 (54%), Gaps = 6/185 (3%)
Query: 117 QQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQ 176
Q +L ++ S +I+ V+ FAK IPGF L +DQ+ LLK+ EV+++R F
Sbjct: 54 QLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMD 113
Query: 177 TNSMICLNGEVLVR--DSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS 234
S C N + R D + ++ L++ + F L L+L + E L +I ++SP
Sbjct: 114 DMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPD 173
Query: 235 RSGLRNKELVERMRGKLENMLMHVLNQNHPEQMN--LCAELISMLPDLRTLNQLHSE--K 290
R G+++ L+E ++ +L N L + HP + L A++I L DLR+LN+ HS+ +
Sbjct: 174 RPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYR 233
Query: 291 LVAFQ 295
++FQ
Sbjct: 234 CLSFQ 238
>pdb|1R6G|A Chain A, Crystal Structure Of The Thyroid Hormone Receptor Beta
Ligand Binding Domain In Complex With A Beta Selective
Compound
Length = 259
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A +D ++
Sbjct: 65 EAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESE 124
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ LNGE+ V R + + + D++FD L+ +L DTE+ L +++++S R G
Sbjct: 125 TLT-LNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 183
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 184 LACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFL 238
>pdb|3AZ1|A Chain A, Crystal Structure Analysis Of Vitamin D Receptor
pdb|3AZ2|A Chain A, Crystal Structure Analysis Of Vitamin D Receptor
pdb|3AZ3|A Chain A, Crystal Structure Analysis Of Vitamin D Receptor
Length = 253
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 100/185 (54%), Gaps = 6/185 (3%)
Query: 117 QQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQ 176
Q +L ++ S +I+ V+ FAK IPGF L +DQ+ LLK+ EV+++R F
Sbjct: 53 QLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMD 112
Query: 177 TNSMICLNGEVLVR--DSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS 234
S C N + R D + ++ L++ + F L L+L + E L +I ++SP
Sbjct: 113 DMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPD 172
Query: 235 RSGLRNKELVERMRGKLENMLMHVLNQNHPEQMN--LCAELISMLPDLRTLNQLHSE--K 290
R G+++ L+E ++ +L N L + HP + L A++I L DLR+LN+ HS+ +
Sbjct: 173 RPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYR 232
Query: 291 LVAFQ 295
++FQ
Sbjct: 233 CLSFQ 237
>pdb|1S0Z|A Chain A, Crystal Structure Of The Vdr Lbd Complexed To Seocalcitol.
pdb|1S19|A Chain A, Crystal Structure Of Vdr Ligand Binding Domain Complexed
To Calcipotriol.
pdb|1TXI|A Chain A, Crystal Structure Of The Vdr Ligand Binding Domain
Complexed To Tx522
pdb|2HAM|A Chain A, Crystal Structure Of Vdr Lbd Complexed To 2alpha-Propyl-
Calcitriol
pdb|2HAR|A Chain A, Crystal Structure Of Vdr Lbd In Complex With 2 Alpha-(3-
Hydroxy-1-Propoxy) Calcitriol
pdb|2HAS|A Chain A, Crystal Structure Of Vdr Lbd In Complex With 2alpha-(1-
Propoxy) Calcitriol
pdb|2HB7|A Chain A, Crystal Structure Of Vdr Lbd In Complex With 2alpha(3-
Hydroxy-1-Propyl) Calcitriol
pdb|2HB8|A Chain A, Crystal Structure Of Vdr Lbd In Complex With 2alpha-Methyl
Calcitriol
pdb|3CS4|A Chain A, Structure-Based Design Of A Superagonist Ligand For The
Vitamin D Nuclear Receptor
pdb|3CS6|A Chain A, Structure-Based Design Of A Superagonist Ligand For The
Vitamin D Nuclear Receptor
pdb|3A3Z|X Chain X, Crystal Structure Of The Human Vdr Ligand Binding Domain
Bound To The Synthetic Agonist Compound 2alpha-Methyl-
Amcr277a(C23s)
pdb|3A40|X Chain X, Crystal Structure Of The Human Vdr Ligand Binding Domain
Bound To The Synthetic Agonist Compound 2alpha-Methyl-
Amcr277b(C23r)
pdb|3A78|A Chain A, Crystal Structure Of The Human Vdr Ligand Binding Domain
Bound To The Natural Metabolite
1alpha,25-Dihydroxy-3-Epi-Vitamin D3
pdb|3AUQ|A Chain A, Crystal Structure Of The Human Vitamin D Receptor Ligand
Binding Domain Complexed With Yne-Diene Type Analog Of
Active 14-Epi-2alpha- Methyl-19-Norvitamin D3
pdb|3AUR|A Chain A, Crystal Structure Of The Human Vitamin D Receptor Ligand
Binding Domain Complexed With Yne-Diene Type Analog Of
Active 14-Epi-2beta- Methyl-19-Norvitamin D3
pdb|3AX8|A Chain A, Crystal Structure Of The Human Vitamin D Receptor Ligand
Binding Domain Complexed With
15alpha-Methoxy-1alpha,25-Dihydroxyvitamin D3
Length = 263
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 100/185 (54%), Gaps = 6/185 (3%)
Query: 117 QQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQ 176
Q +L ++ S +I+ V+ FAK IPGF L +DQ+ LLK+ EV+++R F
Sbjct: 59 QLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMD 118
Query: 177 TNSMICLNGEVLVR--DSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS 234
S C N + R D + ++ L++ + F L L+L + E L +I ++SP
Sbjct: 119 DMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPD 178
Query: 235 RSGLRNKELVERMRGKLENMLMHVLNQNHPEQMN--LCAELISMLPDLRTLNQLHSE--K 290
R G+++ L+E ++ +L N L + HP + L A++I L DLR+LN+ HS+ +
Sbjct: 179 RPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYR 238
Query: 291 LVAFQ 295
++FQ
Sbjct: 239 CLSFQ 243
>pdb|1NAX|A Chain A, Thyroid Receptor Beta1 In Complex With A Beta-Selective
Ligand
Length = 252
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A +D ++
Sbjct: 59 EAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESE 118
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ LNGE+ V R + + + D++FD L+ +L DTE+ L +++++S R G
Sbjct: 119 TLT-LNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 177
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 178 LACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFL 232
>pdb|1N46|A Chain A, Crystal Structure Of Human Tr Beta Ligand-Binding Domain
Complexed With A Potent Subtype-Selective Thyromimetic
pdb|1N46|B Chain B, Crystal Structure Of Human Tr Beta Ligand-Binding Domain
Complexed With A Potent Subtype-Selective Thyromimetic
Length = 258
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A +D ++
Sbjct: 64 EAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESE 123
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ LNGE+ V R + + + D++FD L+ +L DTE+ L +++++S R G
Sbjct: 124 TLT-LNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 182
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 183 LACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFL 237
>pdb|1BSX|A Chain A, Structure And Specificity Of Nuclear Receptor-Coactivator
Interactions
pdb|1BSX|B Chain B, Structure And Specificity Of Nuclear Receptor-Coactivator
Interactions
Length = 260
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A +D ++
Sbjct: 66 EAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESE 125
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ LNGE+ V R + + + D++FD L+ +L DTE+ L +++++S R G
Sbjct: 126 TLT-LNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 184
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 185 LACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFL 239
>pdb|1Q4X|A Chain A, Crystal Structure Of Human Thyroid Hormone Receptor Beta
Lbd In Complex With Specific Agonist Gc-24
Length = 253
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A +D ++
Sbjct: 59 EAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESE 118
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ LNGE+ V R + + + D++FD L+ +L DTE+ L +++++S R G
Sbjct: 119 TLT-LNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 177
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 178 LACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFL 232
>pdb|1RJK|A Chain A, Crystal Structure Of The Rat Vitamin D Receptor Ligand
Binding Domain Complexed With 2md And A Synthetic
Peptide Containing The Nr2 Box Of Drip 205
pdb|1RK3|A Chain A, Crystal Structure Of The Rat Vitamin D Receptor Ligand
Binding Domain Complexed With 1,25-Dihydroxyvitamin D3
And A Synthetic Peptide Containing The Nr2 Box Of Drip
205
pdb|1RKG|A Chain A, Crystal Structure Of The Rat Vitamin D Receptor Ligand
Binding Domain Complexed With 2mbisp And A Synthetic
Peptide Containing The Nr2 Box Of Drip 205
pdb|1RKH|A Chain A, Crystal Structure Of The Rat Vitamin D Receptor Ligand
Binding Domain Complexed With 2am20r And A Synthetic
Peptide Containing The Nr2 Box Of Drip 205
pdb|2O4J|A Chain A, Crystal Structure Of Rat Vitamin D Receptor Ligand Binding
Domain Complexed With Vitiii 17-20z And The Nr2 Box Of
Drip 205
pdb|2O4R|A Chain A, Crystal Structure Of Rat Vitamin D Receptor Ligand Binding
Domain Complexed With Vitiii 17-20e And The Nr2 Box Of
Drip 205
Length = 292
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/182 (32%), Positives = 98/182 (53%), Gaps = 6/182 (3%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
+L ++ S +I+ V+ FAK IPGF L DDQ+ LLK+ EV+++R F S
Sbjct: 60 MLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIMLRSNQSFTMDDMS 119
Query: 180 MICLNGEVL--VRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
C + + V D + + L++ + F L L+L + E L +I ++SP R G
Sbjct: 120 WDCGSQDYKYDVTDVSKAGHTLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPG 179
Query: 238 LRNKELVERMRGKLENMLMHVLNQNH--PEQMNLCAELISMLPDLRTLNQLHSEKL--VA 293
+++ +LVE ++ +L N L + H P L A++I L DLR+LN+ HS++ ++
Sbjct: 180 VQDAKLVEAIQDRLSNTLQTYIRCRHPPPGSHQLYAKMIQKLADLRSLNEEHSKQYRSLS 239
Query: 294 FQ 295
FQ
Sbjct: 240 FQ 241
>pdb|1XZX|X Chain X, Thyroxine-Thyroid Hormone Receptor Interactions
pdb|1Y0X|X Chain X, Thyroxine-Thyroid Hormone Receptor Interactions
Length = 281
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A +D ++
Sbjct: 87 EAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESE 146
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ LNGE+ V R + + + D++FD L+ +L DTE+ L +++++S R G
Sbjct: 147 TLT-LNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 205
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 206 LACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFL 260
>pdb|2ZL9|A Chain A, 2-Substituted-16-Ene-22-Thia-1alpha,25-Dihydroxy-26,27-
Dimethyl-19-Norvitamin D3 Analogs: Synthesis, Biological
Evaluation And Crystal Structure
pdb|2ZLA|A Chain A, 2-Substituted-16-Ene-22-Thia-1alpha,25-Dihydroxy-26,27-
Dimethyl-19-Norvitamin D3 Analogs: Synthesis, Biological
Evaluation And Crystal Structure
pdb|2ZLC|A Chain A, 2-Substituted-16-Ene-22-Thia-1alpha,25-Dihydroxy-26,27-
Dimethyl-19-Norvitamin D3 Analogs: Synthesis, Biological
Evaluation And Crystal Structure
pdb|2ZMH|A Chain A, Crystal Structure Of Rat Vitamin D Receptor Bound To
Adamantyl Vitamin D Analogs: Structural Basis For
Vitamin D Receptor Antagonism AndOR PARTIAL AGONISM
pdb|2ZMI|A Chain A, Crystal Structure Of Rat Vitamin D Receptor Bound To
Adamantyl Vitamin D Analogs: Structural Basis For
Vitamin D Receptor Antagonism AndOR PARTIAL AGONISM
pdb|2ZMJ|A Chain A, Crystal Structure Of Rat Vitamin D Receptor Bound To
Adamantyl Vitamin D Analogs: Structural Basis For
Vitamin D Receptor Antagonism AndOR PARTIAL AGONISM
pdb|2ZXM|A Chain A, A New Class Of Vitamin D Receptor Ligands That Induce
Structural Rearrangement Of The Ligand-Binding Pocket
pdb|2ZXN|A Chain A, A New Class Of Vitamin D Receptor Ligands That Induce
Structural Rearrangement Of The Ligand-Binding Pocket
pdb|3AFR|A Chain A, Crystal Structure Of
Vdr-Lbd22S-Butyl-1a,24r-Dihydroxyvitamin D3 Complex
pdb|3VJS|A Chain A, Vitamin D Receptor Complex With A Carborane Compound
pdb|3VJT|A Chain A, Vitamin D Receptor Complex With A Carborane Compound
pdb|3VRT|A Chain A, Vdr Ligand Binding Domain In Complex With
2-Mehylidene-19,25,26,27-
Tetranor-1alpha,24-Dihydroxyvitamind3
pdb|3VRU|A Chain A, Vdr Ligand Binding Domain In Complex With
2-Methylidene-19,24-Dinor- 1alpha,25-Dihydroxy Vitamind3
pdb|3VRV|A Chain A, Vdr Ligand Binding Domain In Complex With
2-Methylidene-26,27-
Dimethyl-19,24-Dinor-1alpha,25-Dihydroxyvitamin D3
pdb|3VRW|A Chain A, Vdr Ligand Binding Domain In Complex With
22s-Butyl-2-Methylidene-26,
27-Dimethyl-19,24-Dinor-1alpha,25-Dihydroxyvitamin D3
Length = 271
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/182 (32%), Positives = 98/182 (53%), Gaps = 6/182 (3%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
+L ++ S +I+ V+ FAK IPGF L DDQ+ LLK+ EV+++R F S
Sbjct: 70 MLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIMLRSNQSFTMDDMS 129
Query: 180 MICLNGEVL--VRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
C + + V D + + L++ + F L L+L + E L +I ++SP R G
Sbjct: 130 WDCGSQDYKYDVTDVSKAGHTLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPG 189
Query: 238 LRNKELVERMRGKLENMLMHVLNQNH--PEQMNLCAELISMLPDLRTLNQLHSEKL--VA 293
+++ +LVE ++ +L N L + H P L A++I L DLR+LN+ HS++ ++
Sbjct: 190 VQDAKLVEAIQDRLSNTLQTYIRCRHPPPGSHQLYAKMIQKLADLRSLNEEHSKQYRSLS 249
Query: 294 FQ 295
FQ
Sbjct: 250 FQ 251
>pdb|3M7R|A Chain A, Crystal Structure Of Vdr H305q Mutant
Length = 253
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 99/185 (53%), Gaps = 6/185 (3%)
Query: 117 QQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQ 176
Q +L ++ S +I+ V+ FAK IPGF L +DQ+ LLK+ EV+++R F
Sbjct: 53 QLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMD 112
Query: 177 TNSMICLNGEVLVR--DSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS 234
S C N + R D + + L++ + F L L+L + E L +I ++SP
Sbjct: 113 DMSWTCGNQDYKYRVSDVTKAGQSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPD 172
Query: 235 RSGLRNKELVERMRGKLENMLMHVLNQNHPEQMN--LCAELISMLPDLRTLNQLHSE--K 290
R G+++ L+E ++ +L N L + HP + L A++I L DLR+LN+ HS+ +
Sbjct: 173 RPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYR 232
Query: 291 LVAFQ 295
++FQ
Sbjct: 233 CLSFQ 237
>pdb|2H77|A Chain A, Crystal Structure Of Human Tr Alpha Bound T3 In Monoclinic
Space Group
Length = 269
Score = 87.0 bits (214), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 48/175 (27%), Positives = 97/175 (55%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E +F++ +P I VV+FAK++P FS L +DQ+ LLK E++ +R A +D +++
Sbjct: 72 EAFSEFTKIITPAITRVVDFAKKLPMFSELPCEDQIILLKGCCMEIMSLRAAVRYDPESD 131
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ L+GE+ V R+ + + + D++F+ + L+ +L DTE+ L +++++S RSG
Sbjct: 132 TL-TLSGEMAVKREQLKNGGLGVVSDAIFELGKSLSAFNLDDTEVALLQAVLLMSTDRSG 190
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L + +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 191 LLXVDKIEKSQEAYLLAFEHYVNHRKHNIPHFWPKLLMKVTDLRMIGAXHASRFL 245
>pdb|3UVV|A Chain A, Crystal Structure Of The Ligand Binding Domains Of The
Thyroid Receptor:retinoid X Receptor Complexed With
3,3',5 Triiodo-L- Thyronine And 9-Cis Retinoic Acid
Length = 265
Score = 87.0 bits (214), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 48/175 (27%), Positives = 96/175 (54%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E +F++ +P I VV+FAK++P FS L +DQ+ LLK E++ +R A +D ++
Sbjct: 68 EAFSEFTKIITPAITRVVDFAKKLPMFSELPCEDQIILLKGCCMEIMSLRAAVRYDPESE 127
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ L+GE+ V R+ + + + D++FD + L+ +L DTE+ L +++++S R+G
Sbjct: 128 TLT-LSGEMAVKREQLKNGGLGVVSDAIFDLGKSLSAFNLDDTEVALLQAVLLMSSDRTG 186
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L + +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 187 LICVDKIEKCQETYLLAFEHYINYRKHNIPHFWPKLLMKVTDLRMIGACHASRFL 241
>pdb|3FXV|A Chain A, Identification Of An N-Oxide Pyridine Gw4064 Analogue As A
Potent Fxr Agonist
pdb|3OKH|A Chain A, Crystal Structure Of Human Fxr In Complex With
2-(4-Chlorophenyl)-1-
[(1s)-1-Cyclohexyl-2-(Cyclohexylamino)-2-Oxoethyl]-1h-
Benzimidazole- 6-Carboxylic Acid
pdb|3OKI|A Chain A, Crystal Structure Of Human Fxr In Complex With
(2s)-2-[2-(4-
Chlorophenyl)-1h-Benzimidazol-1-Yl]-N,
2-Dicyclohexylethanamide
pdb|3OKI|C Chain C, Crystal Structure Of Human Fxr In Complex With
(2s)-2-[2-(4-
Chlorophenyl)-1h-Benzimidazol-1-Yl]-N,
2-Dicyclohexylethanamide
pdb|3OLF|A Chain A, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)-3-Methylbenzoic Acid
pdb|3OLF|C Chain C, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)-3-Methylbenzoic Acid
pdb|3OMK|A Chain A, Crystal Structure Of Human Fxr In Complex With
(2s)-2-[2-(4-
Chlorophenyl)-5,
6-Difluoro-1h-Benzimidazol-1-Yl]-2-Cyclohexyl-N-(2-
Methylphenyl)ethanamide
pdb|3OMK|C Chain C, Crystal Structure Of Human Fxr In Complex With
(2s)-2-[2-(4-
Chlorophenyl)-5,
6-Difluoro-1h-Benzimidazol-1-Yl]-2-Cyclohexyl-N-(2-
Methylphenyl)ethanamide
pdb|3OMM|A Chain A, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)-3-Fluorobenzoic Acid
pdb|3OMM|C Chain C, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)-3-Fluorobenzoic Acid
pdb|3OOF|A Chain A, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)benzoic Acid
pdb|3OOF|C Chain C, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)benzoic Acid
pdb|3OOK|A Chain A, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)-3,5-Difluorobenzoic Acid
pdb|3OOK|C Chain C, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)-3,5-Difluorobenzoic Acid
Length = 233
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 94/167 (56%), Gaps = 3/167 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
++ +VEF K++PGF L H+DQ+ LLK E + +R A +F+ + S E +R+
Sbjct: 56 VQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEARIRN 115
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S S + MF F + + L ++ E L ++IV++SP R ++++E VE+++ L
Sbjct: 116 SGISDEY---ITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPL 172
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
++L + + PE A L+ L +LRT N H+E L+++++ +
Sbjct: 173 LDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVND 219
>pdb|2ZFX|A Chain A, Crystal Structure Of The Rat Vitamin D Receptor Ligand
Binding Domain Complexed With Yr301 And A Synthetic
Peptide Containing The Nr2 Box Of Drip 205
pdb|3A2H|A Chain A, Crystal Structure Of The Rat Vitamin D Receptor Ligand
Binding Domain Complexed With Tei-9647 And A Synthetic
Peptide Containing The Nr2 Box Of Drip 205
pdb|3AUN|A Chain A, Crystal Structure Of The Rat Vitamin D Receptor Ligand
Binding Domain Complexed With Yr335 And A Synthetic
Peptide Containing The Nr2 Box Of Drip 205
Length = 265
Score = 86.3 bits (212), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 59/182 (32%), Positives = 98/182 (53%), Gaps = 6/182 (3%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
+L ++ S +I+ V+ FAK IPGF L DDQ+ LLK+ EV+++R F S
Sbjct: 64 MLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIMLRSNQSFTMDDMS 123
Query: 180 MICLNGEVL--VRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
C + + V D + + L++ + F L L+L + E L +I ++SP R G
Sbjct: 124 WDCGSQDYKYDVTDVSKAGHTLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPG 183
Query: 238 LRNKELVERMRGKLENMLMHVLNQNH--PEQMNLCAELISMLPDLRTLNQLHSEKL--VA 293
+++ +LVE ++ +L N L + H P L A++I L DLR+LN+ HS++ ++
Sbjct: 184 VQDAKLVEAIQDRLSNTLQTYIRCRHPPPGSHQLYAKMIQKLADLRSLNEEHSKQYRSLS 243
Query: 294 FQ 295
FQ
Sbjct: 244 FQ 245
>pdb|3BEJ|A Chain A, Structure Of Human Fxr In Complex With Mfa-1 And Co-
Activator Peptide
pdb|3BEJ|B Chain B, Structure Of Human Fxr In Complex With Mfa-1 And Co-
Activator Peptide
Length = 238
Score = 86.3 bits (212), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 94/167 (56%), Gaps = 3/167 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
++ +VEF K++PGF L H+DQ+ LLK E + +R A +F+ + S E +R+
Sbjct: 61 VQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRN 120
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S S + MF F + + L ++ E L ++IV++SP R ++++E VE+++ L
Sbjct: 121 SGISDEY---ITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPL 177
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
++L + + PE A L+ L +LRT N H+E L+++++ +
Sbjct: 178 LDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVND 224
>pdb|1NAV|A Chain A, Thyroid Receptor Alpha In Complex With An Agonist
Selective For Thyroid Receptor Beta1
Length = 263
Score = 86.3 bits (212), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 48/175 (27%), Positives = 97/175 (55%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E +F++ +P I VV+FAK++P FS L +DQ+ LLK E++ +R A +D +++
Sbjct: 68 EAFSEFTKIITPAITRVVDFAKKLPMFSELPCEDQIILLKGCCMEIMSLRAAVRYDPESD 127
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ L+GE+ V R+ + + + D++F+ + L+ +L DTE+ L +++++S RSG
Sbjct: 128 TLT-LSGEMAVKREQLKNGGLGVVSDAIFELGKSLSAFNLDDTEVALLQAVLLMSTDRSG 186
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L + +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 187 LLCVDKIEKSQEAYLLAFEHYVNHRKHNIPHFWPKLLMKVTDLRMIGACHASRFL 241
>pdb|3DCT|A Chain A, Fxr With Src1 And Gw4064
pdb|3DCU|A Chain A, Fxr With Src1 And Gsk8062
Length = 235
Score = 85.9 bits (211), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 94/167 (56%), Gaps = 3/167 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
++ +VEF K++PGF L H+DQ+ LLK E + +R A +F+ + S E +R+
Sbjct: 58 VQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRN 117
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S S + MF F + + L ++ E L ++IV++SP R ++++E VE+++ L
Sbjct: 118 SGISDEY---ITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPL 174
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
++L + + PE A L+ L +LRT N H+E L+++++ +
Sbjct: 175 LDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVND 221
>pdb|3A2I|A Chain A, Crystal Structure Of The Human Vitamin D Receptor (H305f)
Ligand Binding Domain Complexed With Tei-9647
Length = 263
Score = 85.9 bits (211), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 99/185 (53%), Gaps = 6/185 (3%)
Query: 117 QQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQ 176
Q +L ++ S +I+ V+ FAK IPGF L +DQ+ LLK+ EV+++R F
Sbjct: 59 QLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMD 118
Query: 177 TNSMICLNGEVLVR--DSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS 234
S C N + R D + + L++ + F L L+L + E L +I ++SP
Sbjct: 119 DMSWTCGNQDYKYRVSDVTKAGFSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPD 178
Query: 235 RSGLRNKELVERMRGKLENMLMHVLNQNHPEQMN--LCAELISMLPDLRTLNQLHSE--K 290
R G+++ L+E ++ +L N L + HP + L A++I L DLR+LN+ HS+ +
Sbjct: 179 RPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYR 238
Query: 291 LVAFQ 295
++FQ
Sbjct: 239 CLSFQ 243
>pdb|1NQ2|A Chain A, Two Rth Mutants With Impaired Hormone Binding
Length = 264
Score = 85.9 bits (211), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 48/175 (27%), Positives = 91/175 (52%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A ++ ++
Sbjct: 70 EAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRTAVRYEPESE 129
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ LNGE+ V R + + + D++FD L+ +L DTE+ L +++++S R G
Sbjct: 130 TLT-LNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 188
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 189 LACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFL 243
>pdb|3HC5|A Chain A, Fxr With Src1 And Gsk826
pdb|3RVF|A Chain A, Fxr With Src1 And Gsk2034
Length = 232
Score = 85.9 bits (211), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 94/167 (56%), Gaps = 3/167 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
++ +VEF K++PGF L H+DQ+ LLK E + +R A +F+ + S E +R+
Sbjct: 55 VQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRN 114
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S S + MF F + + L ++ E L ++IV++SP R ++++E VE+++ L
Sbjct: 115 SGISDEY---ITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPL 171
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
++L + + PE A L+ L +LRT N H+E L+++++ +
Sbjct: 172 LDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVND 218
>pdb|3L1B|A Chain A, Complex Structure Of Fxr Ligand-Binding Domain With A
Tetrahydroazepinoindole Compound
Length = 233
Score = 85.9 bits (211), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 94/167 (56%), Gaps = 3/167 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
++ +VEF K++PGF L H+DQ+ LLK E + +R A +F+ + S E +R+
Sbjct: 56 VQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRN 115
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S S + MF F + + L ++ E L ++IV++SP R ++++E VE+++ L
Sbjct: 116 SGISDEY---ITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPL 172
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
++L + + PE A L+ L +LRT N H+E L+++++ +
Sbjct: 173 LDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVND 219
>pdb|1OSH|A Chain A, A Chemical, Genetic, And Structural Analysis Of The
Nuclear Bile Acid Receptor Fxr
Length = 232
Score = 85.9 bits (211), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 94/167 (56%), Gaps = 3/167 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
++ +VEF K++PGF L H+DQ+ LLK E + +R A +F+ + S E +R+
Sbjct: 55 VQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRN 114
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S S + MF F + + L ++ E L ++IV++SP R ++++E VE+++ L
Sbjct: 115 SGISDEY---ITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPL 171
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
++L + + PE A L+ L +LRT N H+E L+++++ +
Sbjct: 172 LDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVND 218
>pdb|3FLI|A Chain A, Discovery Of Xl335, A Highly Potent, Selective And Orally-
Active Agonist Of The Farnesoid X Receptor (Fxr)
Length = 231
Score = 85.9 bits (211), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 94/167 (56%), Gaps = 3/167 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
++ +VEF K++PGF L H+DQ+ LLK E + +R A +F+ + S E +R+
Sbjct: 54 VQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRN 113
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S S + MF F + + L ++ E L ++IV++SP R ++++E VE+++ L
Sbjct: 114 SGISDEY---ITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPL 170
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
++L + + PE A L+ L +LRT N H+E L+++++ +
Sbjct: 171 LDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVND 217
>pdb|3RUT|A Chain A, Fxr With Src1 And Gsk359
pdb|3RUU|A Chain A, Fxr With Src1 And Gsk237
Length = 229
Score = 85.9 bits (211), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 94/167 (56%), Gaps = 3/167 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
++ +VEF K++PGF L H+DQ+ LLK E + +R A +F+ + S E +R+
Sbjct: 52 VQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRN 111
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S S + MF F + + L ++ E L ++IV++SP R ++++E VE+++ L
Sbjct: 112 SGISDEY---ITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPL 168
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
++L + + PE A L+ L +LRT N H+E L+++++ +
Sbjct: 169 LDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVND 215
>pdb|1UPV|A Chain A, Crystal Structure Of The Human Liver X Receptor Beta
Ligand Binding Domain In Complex With A Synthetic
Agonist
pdb|1UPW|A Chain A, Crystal Structure Of The Human Liver X Receptor Beta
Ligand Binding Domain In Complex With A Synthetic
Agonist
Length = 257
Score = 85.5 bits (210), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 50/205 (24%), Positives = 100/205 (48%), Gaps = 1/205 (0%)
Query: 95 TYTACPSTLACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQV 154
+++ P PL + +Q+ F+E +++++V+FAK++PGF L +DQ+
Sbjct: 38 SFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQI 97
Query: 155 TLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLN 213
LLKA E++L+ A ++ +T + L +D H + + ++ +F+F+ +
Sbjct: 98 ALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMR 157
Query: 214 GLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAEL 273
L L D E L +I + S R ++ VE ++ L+ P+ +
Sbjct: 158 RLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRM 217
Query: 274 ISMLPDLRTLNQLHSEKLVAFQMTE 298
+ L LRTL+ +HSE++ A ++ +
Sbjct: 218 LMKLVSLRTLSSVHSEQVFALRLQD 242
>pdb|1P8D|A Chain A, X-Ray Crystal Structure Of Lxr Ligand Binding Domain With
24(S),25- Epoxycholesterol
pdb|1P8D|B Chain B, X-Ray Crystal Structure Of Lxr Ligand Binding Domain With
24(S),25- Epoxycholesterol
Length = 250
Score = 85.5 bits (210), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 50/205 (24%), Positives = 100/205 (48%), Gaps = 1/205 (0%)
Query: 95 TYTACPSTLACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQV 154
+++ P PL + +Q+ F+E +++++V+FAK++PGF L +DQ+
Sbjct: 31 SFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQI 90
Query: 155 TLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLN 213
LLKA E++L+ A ++ +T + L +D H + + ++ +F+F+ +
Sbjct: 91 ALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMR 150
Query: 214 GLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAEL 273
L L D E L +I + S R ++ VE ++ L+ P+ +
Sbjct: 151 RLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRM 210
Query: 274 ISMLPDLRTLNQLHSEKLVAFQMTE 298
+ L LRTL+ +HSE++ A ++ +
Sbjct: 211 LMKLVSLRTLSSVHSEQVFALRLQD 235
>pdb|1PQ6|A Chain A, Human Lxr Beta Hormone Receptor / Gw3965 Complex
pdb|1PQ6|B Chain B, Human Lxr Beta Hormone Receptor / Gw3965 Complex
pdb|1PQ6|C Chain C, Human Lxr Beta Hormone Receptor / Gw3965 Complex
pdb|1PQ6|D Chain D, Human Lxr Beta Hormone Receptor / Gw3965 Complex
pdb|1PQ9|A Chain A, Human Lxr Beta Hormone Receptor Complexed With T0901317
Complex
pdb|1PQ9|B Chain B, Human Lxr Beta Hormone Receptor Complexed With T0901317
Complex
pdb|1PQ9|C Chain C, Human Lxr Beta Hormone Receptor Complexed With T0901317
Complex
pdb|1PQ9|D Chain D, Human Lxr Beta Hormone Receptor Complexed With T0901317
Complex
pdb|1PQC|A Chain A, Human Lxr Beta Hormone Receptor Complexed With T0901317
pdb|1PQC|B Chain B, Human Lxr Beta Hormone Receptor Complexed With T0901317
pdb|1PQC|C Chain C, Human Lxr Beta Hormone Receptor Complexed With T0901317
pdb|1PQC|D Chain D, Human Lxr Beta Hormone Receptor Complexed With T0901317
pdb|3KFC|A Chain A, Complex Structure Of Lxr With An Agonist
pdb|3KFC|B Chain B, Complex Structure Of Lxr With An Agonist
pdb|3KFC|C Chain C, Complex Structure Of Lxr With An Agonist
pdb|3KFC|D Chain D, Complex Structure Of Lxr With An Agonist
Length = 253
Score = 85.1 bits (209), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 50/205 (24%), Positives = 100/205 (48%), Gaps = 1/205 (0%)
Query: 95 TYTACPSTLACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQV 154
+++ P PL + +Q+ F+E +++++V+FAK++PGF L +DQ+
Sbjct: 34 SFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQI 93
Query: 155 TLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLN 213
LLKA E++L+ A ++ +T + L +D H + + ++ +F+F+ +
Sbjct: 94 ALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMR 153
Query: 214 GLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAEL 273
L L D E L +I + S R ++ VE ++ L+ P+ +
Sbjct: 154 RLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRM 213
Query: 274 ISMLPDLRTLNQLHSEKLVAFQMTE 298
+ L LRTL+ +HSE++ A ++ +
Sbjct: 214 LMKLVSLRTLSSVHSEQVFALRLQD 238
>pdb|2J4A|A Chain A, Human Thyroid Hormone Receptor Beta Ligand Binding Domain
In Complex With Kb131084
Length = 253
Score = 85.1 bits (209), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 48/175 (27%), Positives = 91/175 (52%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A +D ++
Sbjct: 59 EAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESE 118
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ L+GE+ V R + + + D++FD L+ +L DTE+ L +++++S R G
Sbjct: 119 TLT-LSGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 177
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 178 LACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFL 232
>pdb|4DK8|A Chain A, Crystal Structure Of Lxr Ligand Binding Domain In Complex
With Partial Agonist 5
pdb|4DK8|C Chain C, Crystal Structure Of Lxr Ligand Binding Domain In Complex
With Partial Agonist 5
Length = 247
Score = 85.1 bits (209), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 50/205 (24%), Positives = 100/205 (48%), Gaps = 1/205 (0%)
Query: 95 TYTACPSTLACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQV 154
+++ P PL + +Q+ F+E +++++V+FAK++PGF L +DQ+
Sbjct: 28 SFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQI 87
Query: 155 TLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLN 213
LLKA E++L+ A ++ +T + L +D H + + ++ +F+F+ +
Sbjct: 88 ALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMR 147
Query: 214 GLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAEL 273
L L D E L +I + S R ++ VE ++ L+ P+ +
Sbjct: 148 RLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRM 207
Query: 274 ISMLPDLRTLNQLHSEKLVAFQMTE 298
+ L LRTL+ +HSE++ A ++ +
Sbjct: 208 LMKLVSLRTLSSVHSEQVFALRLQD 232
>pdb|1NUO|A Chain A, Two Rth Mutants With Impaired Hormone Binding
Length = 261
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 48/175 (27%), Positives = 90/175 (51%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ + A +D ++
Sbjct: 67 EAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLHAAVRYDPESE 126
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ LNGE+ V R + + + D++FD L+ +L DTE+ L +++++S R G
Sbjct: 127 TLT-LNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 185
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 186 LACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFL 240
>pdb|1OSV|A Chain A, Structural Basis For Bile Acid Binding And Activation Of
The Nuclear Receptor Fxr
pdb|1OSV|B Chain B, Structural Basis For Bile Acid Binding And Activation Of
The Nuclear Receptor Fxr
Length = 230
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 92/167 (55%), Gaps = 3/167 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
++ +VEF KR+PGF L H+DQ+ LLK E + +R A +F+ + + E +R
Sbjct: 53 VQILVEFTKRLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPAGHADLLEERIRK 112
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S S + MF F + + L ++ E L ++IV++SP R ++++E VE+++ L
Sbjct: 113 SGISDEY---ITPMFSFYKSVGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPL 169
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
++L + PE A L+ L +LRT N H+E L+++++ +
Sbjct: 170 LDVLQKLCKIYQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVND 216
>pdb|1OT7|A Chain A, Structural Basis For 3-Deoxy-Cdca Binding And Activation
Of Fxr
pdb|1OT7|B Chain B, Structural Basis For 3-Deoxy-Cdca Binding And Activation
Of Fxr
Length = 229
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 92/167 (55%), Gaps = 3/167 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
++ +VEF KR+PGF L H+DQ+ LLK E + +R A +F+ + + E +R
Sbjct: 53 VQILVEFTKRLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPAGHADLLEERIRK 112
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S S + MF F + + L ++ E L ++IV++SP R ++++E VE+++ L
Sbjct: 113 SGISDEY---ITPMFSFYKSVGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPL 169
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
++L + PE A L+ L +LRT N H+E L+++++ +
Sbjct: 170 LDVLQKLCKIYQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVND 216
>pdb|3D57|A Chain A, Tr Variant D355r
pdb|3D57|B Chain B, Tr Variant D355r
Length = 266
Score = 84.3 bits (207), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 48/175 (27%), Positives = 90/175 (51%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A +D ++
Sbjct: 73 EAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESE 132
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ LNGE+ V R + + + D++F L+ +L DTE+ L +++++S R G
Sbjct: 133 TLT-LNGEMAVTRGQLKNGGLGVVSDAIFRLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 191
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 192 LACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFL 246
>pdb|2PIN|A Chain A, Thyroid Receptor Beta In Complex With Inhibitor
pdb|2PIN|B Chain B, Thyroid Receptor Beta In Complex With Inhibitor
Length = 253
Score = 84.3 bits (207), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 48/175 (27%), Positives = 90/175 (51%), Gaps = 2/175 (1%)
Query: 119 ELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN 178
E F++ +P I VV+FAK++P F L +DQ+ LLK E++ +R A +D ++
Sbjct: 59 EAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESE 118
Query: 179 SMICLNGEVLV-RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSG 237
++ LNGE+ V R + + + D++F L+ +L DTE+ L +++++S R G
Sbjct: 119 TLT-LNGEMAVTRGQLKNGGLGVVSDAIFRLGMSLSSFNLDDTEVALLQAVLLMSSDRPG 177
Query: 238 LRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLV 292
L E +E+ + H +N + +L+ + DLR + H+ + +
Sbjct: 178 LACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFL 232
>pdb|3DZU|A Chain A, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Bvt.13, 9-Cis Retinoic Acid And Ncoa2
Peptide
pdb|3DZY|A Chain A, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Rosiglitazone, 9-Cis Retinoic Acid And
Ncoa2 Peptide
pdb|3E00|A Chain A, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Gw9662, 9-Cis Retinoic Acid And Ncoa2
Peptide
Length = 467
Score = 83.6 bits (205), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 1/163 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 284 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 343
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 344 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 403
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 404 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKL 446
>pdb|4DK7|A Chain A, Crystal Structure Of Lxr Ligand Binding Domain In Complex
With Full Agonist 1
pdb|4DK7|C Chain C, Crystal Structure Of Lxr Ligand Binding Domain In Complex
With Full Agonist 1
Length = 247
Score = 83.2 bits (204), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 1/205 (0%)
Query: 95 TYTACPSTLACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQV 154
+++ P PL + +Q+ F+E +++++V+FAK++PGF L +DQ+
Sbjct: 28 SFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQI 87
Query: 155 TLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLN 213
LLKA E+ L+ A ++ +T + L +D H + + ++ +F+F+
Sbjct: 88 ALLKASTIEIXLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAXR 147
Query: 214 GLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAEL 273
L L D E L +I + S R ++ VE ++ L+ P+
Sbjct: 148 RLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRX 207
Query: 274 ISMLPDLRTLNQLHSEKLVAFQMTE 298
+ L LRTL+ +HSE++ A ++ +
Sbjct: 208 LXKLVSLRTLSSVHSEQVFALRLQD 232
>pdb|1XNX|A Chain A, Crystal Structure Of Constitutive Androstane Receptor
pdb|1XNX|B Chain B, Crystal Structure Of Constitutive Androstane Receptor
Length = 256
Score = 82.8 bits (203), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 50/174 (28%), Positives = 96/174 (55%), Gaps = 2/174 (1%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
LL F++ + ++ +++F K +P F L +DQ++LLK E+L + L F QT +
Sbjct: 65 LLTHFADINTFMVQQIIKFTKDLPLFRSLTMEDQISLLKGAAVEILHISLNTTFCLQTEN 124
Query: 180 MICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLR 239
C + D++H+ ++S+ F + L GLHL + E L ++ + SP R G+
Sbjct: 125 FFCGPLCYKMEDAVHAGFQYEFLESILHFHKNLKGLHLQEPEYVLMAATALFSPDRPGVT 184
Query: 240 NKELVERMRGKLENML-MHVLNQNHPEQMN-LCAELISMLPDLRTLNQLHSEKL 291
+E +++++ ++ +L H++ Q Q L A+L+ +L DLR++N +S +L
Sbjct: 185 QREEIDQLQEEMALILNNHIMEQQSRLQSRFLYAKLMGLLADLRSINNAYSYEL 238
>pdb|3A2J|A Chain A, Crystal Structure Of The Human Vitamin D Receptor
(H305fH397F) LIGAND Binding Domain Complexed With
Tei-9647
Length = 263
Score = 82.4 bits (202), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 98/185 (52%), Gaps = 6/185 (3%)
Query: 117 QQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQ 176
Q +L ++ S +I+ V+ FAK IPGF L +DQ+ LLK+ EV+++R F
Sbjct: 59 QLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMD 118
Query: 177 TNSMICLNGEVLVR--DSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS 234
S C N + R D + + L++ + F L L+L + E L +I ++SP
Sbjct: 119 DMSWTCGNQDYKYRVSDVTKAGFSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPD 178
Query: 235 RSGLRNKELVERMRGKLENMLMHVLNQNHPEQMN--LCAELISMLPDLRTLNQLHSE--K 290
R G+++ L+E ++ +L N L + HP + L A++I L DLR+LN+ S+ +
Sbjct: 179 RPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEFSKQYR 238
Query: 291 LVAFQ 295
++FQ
Sbjct: 239 CLSFQ 243
>pdb|1XLS|E Chain E, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
pdb|1XLS|F Chain F, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
pdb|1XLS|G Chain G, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
pdb|1XLS|H Chain H, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
Length = 242
Score = 82.4 bits (202), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 50/174 (28%), Positives = 96/174 (55%), Gaps = 2/174 (1%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
LL F++ + ++ +++F K +P F L +DQ++LLK E+L + L F QT +
Sbjct: 51 LLTHFADINTFMVQQIIKFTKDLPLFRSLTMEDQISLLKGAAVEILHISLNTTFCLQTEN 110
Query: 180 MICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLR 239
C + D++H+ ++S+ F + L GLHL + E L ++ + SP R G+
Sbjct: 111 FFCGPLCYKMEDAVHAGFQYEFLESILHFHKNLKGLHLQEPEYVLMAATALFSPDRPGVT 170
Query: 240 NKELVERMRGKLENML-MHVLNQNHPEQMN-LCAELISMLPDLRTLNQLHSEKL 291
+E +++++ ++ +L H++ Q Q L A+L+ +L DLR++N +S +L
Sbjct: 171 QREEIDQLQEEMALILNNHIMEQQSRLQSRFLYAKLMGLLADLRSINNAYSYEL 224
>pdb|2HBH|A Chain A, Crystal Structure Of Vitamin D Nuclear Receptor Ligand
Binding Domain Bound To A Locked Side-Chain Analog Of
Calcitriol And Src-1 Peptide
pdb|2HC4|A Chain A, Crystal Structure Of The Lbd Of Vdr Of Danio Rerio In
Complex With Calcitriol
pdb|2HCD|A Chain A, Crystal Structure Of The Ligand Binding Domain Of The
Vitamin D Nuclear Receptor In Complex With Gemini And A
Coactivator Peptide
pdb|3DR1|A Chain A, Side-Chain Fluorine Atoms Of Non-Steroidal Vitamin D3
Analogs Stabilize Helix 12 Of Vitamin D Receptor
pdb|3O1D|A Chain A, Structure-Function Study Of Gemini Derivatives With Two
Different Side Chains At C-20, Gemini-0072 And
Gemini-0097.
pdb|3O1E|A Chain A, Structure-Function Of Gemini Derivatives With Two
Different Side Chains At C-20, Gemini-0072 And
Gemini-0097
Length = 302
Score = 81.6 bits (200), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 54/185 (29%), Positives = 99/185 (53%), Gaps = 4/185 (2%)
Query: 115 QGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFD 174
Q + +L ++ S +I+ V+ FAK IPGF L +DQ+ LLK+ E++++R F
Sbjct: 98 QSRLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTAEDQIALLKSSAIEIIMLRSNQSFS 157
Query: 175 SQTNSMICL--NGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVIS 232
+ S C + + + D + + L++ + F L L L + E L +I ++S
Sbjct: 158 LEDMSWSCGGPDFKYCINDVTKAGHTLELLEPLVKFQVGLKKLKLHEEEHVLLMAICLLS 217
Query: 233 PSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKL- 291
P R G+++ +E ++ +L ++L + HP L A++I L DLR+LN+ HS++
Sbjct: 218 PDRPGVQDHVRIEALQDRLCDVLQAYIRIQHPGGRLLYAKMIQKLADLRSLNEEHSKQYR 277
Query: 292 -VAFQ 295
++FQ
Sbjct: 278 SLSFQ 282
>pdb|4FHH|A Chain A, Development Of Synthetically Accessible Non-Secosteroidal
Hybrid Molecules Combining Vitamin D Receptor Agonism
And Histone Deacetylase Inhibition
pdb|4FHI|A Chain A, Development Of Synthetically Accessible Non-Secosteroidal
Hybrid Molecules Combining Vitamin D Receptor Agonism
And Histone Deacetylase Inhibition
pdb|4G1D|A Chain A, Structural Basis For The Accommodation Of Bis- And
Tris-Aromatic Derivatives In Vitamin D Nuclear Receptor
pdb|4G1Y|A Chain A, Structural Basis For The Accommodation Of Bis- And
Tris-Aromatic Derivatives In Vitamin D Nuclear Receptor
pdb|4G1Z|A Chain A, Structural Basis For The Accommodation Of Bis- And
Tris-Aromatic Derivatives In Vitamin D Nuclear Receptor
pdb|4G20|A Chain A, Structural Basis For The Accommodation Of Bis- And
Tris-Aromatic Derivatives In Vitamin D Nuclear Receptor
pdb|4G21|A Chain A, Structural Basis For The Accommodation Of Bis- And
Tris-Aromatic Derivatives In Vitamin D Nuclear Receptor
pdb|4G2H|A Chain A, Structural Basis For The Accommodation Of Bis- And
Tris-Aromatic Derivatives In Vitamin D Nuclear Receptor
Length = 300
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 54/185 (29%), Positives = 99/185 (53%), Gaps = 4/185 (2%)
Query: 115 QGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFD 174
Q + +L ++ S +I+ V+ FAK IPGF L +DQ+ LLK+ E++++R F
Sbjct: 96 QSRLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTAEDQIALLKSSAIEIIMLRSNQSFS 155
Query: 175 SQTNSMICL--NGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVIS 232
+ S C + + + D + + L++ + F L L L + E L +I ++S
Sbjct: 156 LEDMSWSCGGPDFKYCINDVTKAGHTLELLEPLVKFQVGLKKLKLHEEEHVLLMAICLLS 215
Query: 233 PSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKL- 291
P R G+++ +E ++ +L ++L + HP L A++I L DLR+LN+ HS++
Sbjct: 216 PDRPGVQDHVRIEALQDRLCDVLQAYIRIQHPGGRLLYAKMIQKLADLRSLNEEHSKQYR 275
Query: 292 -VAFQ 295
++FQ
Sbjct: 276 SLSFQ 280
>pdb|1LBD|A Chain A, Ligand-Binding Domain Of The Human Nuclear Receptor
Rxr-Alpha
Length = 282
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 1/163 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 99 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 158
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 159 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 218
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 219 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKL 261
>pdb|3A9E|A Chain A, Crystal Structure Of A Mixed Agonist-Bound Rar-Alpha And
Antagonist- Bound Rxr-Alpha Heterodimer Ligand Binding
Domains
Length = 240
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 1/163 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 57 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 116
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 117 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 176
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 177 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKL 219
>pdb|1MV9|A Chain A, Crystal Structure Of The Human Rxr Alpha Ligand Binding
Domain Bound To The Eicosanoid Dha (Docosa Hexaenoic
Acid) And A Coactivator Peptide
pdb|1MVC|A Chain A, Crystal Structure Of The Human Rxr Alpha Ligand Binding
Domain Bound To The Synthetic Agonist Compound Bms 649
And A Coactivator Peptide
pdb|1MZN|A Chain A, Crystal Structure At 1.9 Angstroems Resolution Of The
Homodimer Of Human Rxr Alpha Ligand Binding Domain Bound
To The Synthetic Agonist Compound Bms 649 And A
Coactivator Peptide
pdb|1MZN|C Chain C, Crystal Structure At 1.9 Angstroems Resolution Of The
Homodimer Of Human Rxr Alpha Ligand Binding Domain Bound
To The Synthetic Agonist Compound Bms 649 And A
Coactivator Peptide
pdb|1MZN|E Chain E, Crystal Structure At 1.9 Angstroems Resolution Of The
Homodimer Of Human Rxr Alpha Ligand Binding Domain Bound
To The Synthetic Agonist Compound Bms 649 And A
Coactivator Peptide
pdb|1MZN|G Chain G, Crystal Structure At 1.9 Angstroems Resolution Of The
Homodimer Of Human Rxr Alpha Ligand Binding Domain Bound
To The Synthetic Agonist Compound Bms 649 And A
Coactivator Peptide
pdb|2P1T|A Chain A, Crystal Structure Of The Ligand Binding Domain Of The
Retinoid X Receptor Alpha In Complex With
3-(2'-Methoxy)- Tetrahydronaphtyl Cinnamic Acid And A
Fragment Of The Coactivator Tif-2
pdb|2P1U|A Chain A, Crystal Structure Of The Ligand Binding Domain Of The
Retinoid X Receptor Alpha In Complex With 3-(2'-Ethoxy)-
Tetrahydronaphtyl Cinnamic Acid And A Fragment Of The
Coactivator Tif-2
pdb|2P1V|A Chain A, Crystal Structure Of The Ligand Binding Domain Of The
Retinoid X Receptor Alpha In Complex With
3-(2'-Propoxy)- Tetrahydronaphtyl Cinnamic Acid And A
Fragment Of The Coactivator Tif-2
pdb|3FUG|A Chain A, Crystal Structure Of The Retinoid X Receptor Ligand
Binding Domain Bound To The Synthetic Agonist
3-[4-Hydroxy-3-(3,5,
5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)-
Phenyl]acrylic Acid
pdb|2ZXZ|A Chain A, Crystal Structure Of The Human Rxr Alpha Ligand Binding
Domain Bound To A Synthetic Agonist Compound And A
Coactivator Peptide
pdb|2ZY0|A Chain A, Crystal Structure Of The Human Rxr Alpha Ligand Binding
Domain Bound To A Synthetic Agonist Compound And A
Coactivator Peptide
pdb|2ZY0|C Chain C, Crystal Structure Of The Human Rxr Alpha Ligand Binding
Domain Bound To A Synthetic Agonist Compound And A
Coactivator Peptide
pdb|3NSP|A Chain A, Crystal Structure Of Tetrameric Rxralpha-Lbd
pdb|3NSP|B Chain B, Crystal Structure Of Tetrameric Rxralpha-Lbd
pdb|3NSQ|A Chain A, Crystal Structure Of Tetrameric Rxralpha-Lbd Complexed
With Antagonist Danthron
pdb|3NSQ|B Chain B, Crystal Structure Of Tetrameric Rxralpha-Lbd Complexed
With Antagonist Danthron
pdb|3R29|A Chain A, Crystal Structure Of Rxralpha Ligand-Binding Domain
Complexed With Corepressor Smrt2
pdb|3R29|B Chain B, Crystal Structure Of Rxralpha Ligand-Binding Domain
Complexed With Corepressor Smrt2
pdb|3R2A|A Chain A, Crystal Structure Of Rxralpha Ligand-Binding Domain
Complexed With Corepressor Smrt2 And Antagonist Rhein
pdb|3R2A|B Chain B, Crystal Structure Of Rxralpha Ligand-Binding Domain
Complexed With Corepressor Smrt2 And Antagonist Rhein
pdb|3R2A|C Chain C, Crystal Structure Of Rxralpha Ligand-Binding Domain
Complexed With Corepressor Smrt2 And Antagonist Rhein
pdb|3R2A|D Chain D, Crystal Structure Of Rxralpha Ligand-Binding Domain
Complexed With Corepressor Smrt2 And Antagonist Rhein
pdb|3R5M|A Chain A, Crystal Structure Of Rxralphalbd Complexed With The
Agonist Magnolol
pdb|3R5M|C Chain C, Crystal Structure Of Rxralphalbd Complexed With The
Agonist Magnolol
Length = 240
Score = 80.9 bits (198), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 1/163 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 57 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 116
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 117 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 176
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 177 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKL 219
>pdb|3E94|A Chain A, Crystal Structure Of Rxralpha Ligand Binding Domain In
Complex With Tributyltin And A Coactivator Fragment
pdb|3KWY|A Chain A, Crystal Structure Of Rxralpha Ligand Binding Domain In
Complex With Triphenyltin And A Coactivator Fragment
Length = 244
Score = 80.9 bits (198), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 1/163 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 61 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 120
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 121 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 180
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 181 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKL 223
>pdb|1XDK|A Chain A, Crystal Structure Of The RarbetaRXRALPHA LIGAND BINDING
Domain Heterodimer In Complex With 9-Cis Retinoic Acid
And A Fragment Of The Trap220 Coactivator
pdb|1XDK|E Chain E, Crystal Structure Of The RarbetaRXRALPHA LIGAND BINDING
Domain Heterodimer In Complex With 9-Cis Retinoic Acid
And A Fragment Of The Trap220 Coactivator
Length = 238
Score = 80.9 bits (198), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 1/163 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 55 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 114
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 115 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 174
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 175 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKL 217
>pdb|1RDT|A Chain A, Crystal Structure Of A New Rexinoid Bound To The Rxralpha
Ligand Binding Doamin In The RxralphaPPARGAMMA
HETERODIMER
pdb|3FC6|A Chain A, Hrxralpha & Mlxralpha With An Indole Pharmacophore,
Sb786875
pdb|3FC6|C Chain C, Hrxralpha & Mlxralpha With An Indole Pharmacophore,
Sb786875
pdb|3FAL|A Chain A, Humanrxr Alpha & Mouse Lxr Alpha Complexed With Retenoic
Acid And Gsk2186
pdb|3FAL|C Chain C, Humanrxr Alpha & Mouse Lxr Alpha Complexed With Retenoic
Acid And Gsk2186
Length = 242
Score = 80.9 bits (198), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 1/164 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 59 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 118
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 119 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 178
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMT 297
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 179 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLI 222
>pdb|1FBY|A Chain A, Crystal Structure Of The Human Rxr Alpha Ligand Binding
Domain Bound To 9-Cis Retinoic Acid
pdb|1FBY|B Chain B, Crystal Structure Of The Human Rxr Alpha Ligand Binding
Domain Bound To 9-Cis Retinoic Acid
Length = 239
Score = 80.9 bits (198), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 1/164 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 56 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 115
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 116 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 175
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMT 297
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 176 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLI 219
>pdb|1FM6|A Chain A, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Rosiglitazone And Co-Activator Peptides.
pdb|1FM6|U Chain U, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Rosiglitazone And Co-Activator Peptides.
pdb|1FM9|A Chain A, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Gi262570 And Co-Activator Peptides.
pdb|1G5Y|A Chain A, The 2.0 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain Tetramer In The Presence
Of A Non-Activating Retinoic Acid Isomer.
pdb|1G5Y|B Chain B, The 2.0 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain Tetramer In The Presence
Of A Non-Activating Retinoic Acid Isomer.
pdb|1G5Y|C Chain C, The 2.0 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain Tetramer In The Presence
Of A Non-Activating Retinoic Acid Isomer.
pdb|1G5Y|D Chain D, The 2.0 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain Tetramer In The Presence
Of A Non-Activating Retinoic Acid Isomer.
pdb|1G1U|A Chain A, The 2.5 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain In Tetramer In The
Absence Of Ligand
pdb|1G1U|B Chain B, The 2.5 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain In Tetramer In The
Absence Of Ligand
pdb|1G1U|C Chain C, The 2.5 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain In Tetramer In The
Absence Of Ligand
pdb|1G1U|D Chain D, The 2.5 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain In Tetramer In The
Absence Of Ligand
pdb|1K74|A Chain A, The 2.3 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Ppargamma And Rxralpha Ligand
Binding Domains Respectively Bound With Gw409544 And
9-Cis Retinoic Acid And Co-Activator Peptides.
pdb|2ACL|A Chain A, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
pdb|2ACL|C Chain C, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
pdb|2ACL|E Chain E, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
pdb|2ACL|G Chain G, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
pdb|3OZJ|A Chain A, Crystal Structure Of Human Retinoic X Receptor Alpha
Complexed With Bigelovin And Coactivator Src-1
pdb|3OZJ|C Chain C, Crystal Structure Of Human Retinoic X Receptor Alpha
Complexed With Bigelovin And Coactivator Src-1
Length = 238
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 1/164 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 55 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 114
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 115 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 174
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMT 297
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 175 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLI 218
>pdb|3UVV|B Chain B, Crystal Structure Of The Ligand Binding Domains Of The
Thyroid Receptor:retinoid X Receptor Complexed With
3,3',5 Triiodo-L- Thyronine And 9-Cis Retinoic Acid
Length = 244
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 1/163 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 59 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 118
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 119 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 178
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 179 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKL 221
>pdb|3OAP|A Chain A, Crystal Structure Of Human Retinoid X Receptor
Alpha-Ligand Binding Domain Complex With 9-Cis Retinoic
Acid And The Coactivator Peptide Grip-1
Length = 231
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 1/164 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 52 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 111
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 112 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 171
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMT 297
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 172 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLI 215
>pdb|1XLS|A Chain A, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
pdb|1XLS|B Chain B, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
pdb|1XLS|C Chain C, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
pdb|1XLS|D Chain D, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
Length = 232
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 1/164 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 53 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 112
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 113 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 172
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMT 297
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 173 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLI 216
>pdb|3PCU|A Chain A, Crystal Structure Of Human Retinoic X Receptor Alpha
Ligand-Binding Domain Complexed With Lx0278 And Src1
Peptide
Length = 230
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 1/164 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 51 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 110
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 111 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 170
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMT 297
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 171 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLI 214
>pdb|1XV9|A Chain A, Crystal Structure Of CarRXR HETERODIMER BOUND WITH SRC1
Peptide, Fatty Acid, And 5b-Pregnane-3,20-Dione.
pdb|1XV9|C Chain C, Crystal Structure Of CarRXR HETERODIMER BOUND WITH SRC1
Peptide, Fatty Acid, And 5b-Pregnane-3,20-Dione.
pdb|1XVP|A Chain A, Crystal Structure Of CarRXR HETERODIMER BOUND WITH SRC1
Peptide, Fatty Acid And Citco
pdb|1XVP|C Chain C, Crystal Structure Of CarRXR HETERODIMER BOUND WITH SRC1
Peptide, Fatty Acid And Citco
Length = 236
Score = 80.5 bits (197), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 1/164 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 53 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 112
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 113 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 172
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMT 297
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 173 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLI 216
>pdb|2GL8|A Chain A, Human Retinoic Acid Receptor Rxr-Gamma Ligand-Binding
Domain
pdb|2GL8|B Chain B, Human Retinoic Acid Receptor Rxr-Gamma Ligand-Binding
Domain
pdb|2GL8|C Chain C, Human Retinoic Acid Receptor Rxr-Gamma Ligand-Binding
Domain
pdb|2GL8|D Chain D, Human Retinoic Acid Receptor Rxr-Gamma Ligand-Binding
Domain
Length = 241
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 1/163 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L +DQV LL+AG E+L+ + S + ++ G + R S H
Sbjct: 58 LVEWAKRIPHFSDLTLEDQVILLRAGWNELLIASFSHRSVSVQDGILLATGLHVHRSSAH 117
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + +E+G +IV+ +P GL N VE +R K+
Sbjct: 118 SAGVGSIFDRVLTELVSKMKDMQMDKSELGCLRAIVLFNPDAKGLSNPSEVETLREKVYA 177
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
L Q +PEQ A+L+ LP LR++ E L F++
Sbjct: 178 TLEAYTKQKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKL 220
>pdb|1UHL|A Chain A, Crystal Structure Of The Lxralfa-Rxrbeta Lbd Heterodimer
Length = 236
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 1/164 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + ++ G + R+S H
Sbjct: 53 LVEWAKRIPHFSSLPLDDQVILLRAGWNELLIASFSHRSIDVRDGILLATGLHVHRNSAH 112
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +I++ +P GL N VE +R K+
Sbjct: 113 SAGVGAIFDRVLTELVSKMRDMRMDKTELGCLRAIILFNPDAKGLSNPSEVEVLREKVYA 172
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMT 297
L Q +PEQ A+L+ LP LR++ E L F++
Sbjct: 173 SLETYCKQKYPEQQGRFAKLLLRLPALRSIGLKCLEHLFFFKLI 216
>pdb|3H0A|A Chain A, Crystal Structure Of Peroxisome Proliferator-Activated
Receptor Gamma (Pparg) And Retinoic Acid Receptor Alpha
(Rxra) In Complex With 9-Cis Retinoic Acid, Co-Activator
Peptide, And A Partial Agonist
Length = 228
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 1/164 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 52 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAH 111
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 112 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 171
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMT 297
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 172 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLI 215
>pdb|1H9U|A Chain A, The Structure Of The Human Retinoid-X-Receptor Beta Ligand
Binding Domain In Complex With The Specific Synthetic
Agonist Lg100268
pdb|1H9U|B Chain B, The Structure Of The Human Retinoid-X-Receptor Beta Ligand
Binding Domain In Complex With The Specific Synthetic
Agonist Lg100268
pdb|1H9U|C Chain C, The Structure Of The Human Retinoid-X-Receptor Beta Ligand
Binding Domain In Complex With The Specific Synthetic
Agonist Lg100268
pdb|1H9U|D Chain D, The Structure Of The Human Retinoid-X-Receptor Beta Ligand
Binding Domain In Complex With The Specific Synthetic
Agonist Lg100268
Length = 224
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 1/164 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + ++ G + R+S H
Sbjct: 52 LVEWAKRIPHFSSLPLDDQVILLRAGWNELLIASFSHRSIDVRDGILLATGLHVHRNSAH 111
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +I++ +P GL N VE +R K+
Sbjct: 112 SAGVGAIFDRVLTELVSKMRDMRMDKTELGCLRAIILFNPDAKGLSNPSEVEVLREKVYA 171
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMT 297
L Q +PEQ A+L+ LP LR++ E L F++
Sbjct: 172 SLETYCKQKYPEQQGRFAKLLLRLPALRSIGLKCLEHLFFFKLI 215
>pdb|3EYB|A Chain A, Structural And Functional Insights Into The Ligand Binding
Domain Of A Non-Duplicated Rxr From The Invertebrate
Chordate Amphioxus
pdb|3EYB|B Chain B, Structural And Functional Insights Into The Ligand Binding
Domain Of A Non-Duplicated Rxr From The Invertebrate
Chordate Amphioxus
pdb|3EYB|C Chain C, Structural And Functional Insights Into The Ligand Binding
Domain Of A Non-Duplicated Rxr From The Invertebrate
Chordate Amphioxus
pdb|3EYB|D Chain D, Structural And Functional Insights Into The Ligand Binding
Domain Of A Non-Duplicated Rxr From The Invertebrate
Chordate Amphioxus
Length = 219
Score = 79.7 bits (195), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 1/164 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + ++ +G + R S H
Sbjct: 43 LVEWAKRIPHFSDLPIDDQVILLRAGWNELLIAAFSHRSIDVKDGILLASGLHVHRSSAH 102
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
+ + D + + ++ + + TE+G +IV+ +P GL + LVE +R K+
Sbjct: 103 QAGVGTIFDRVLTELVAKMRDMKMDKTELGCLRAIVLFNPDAKGLTDPSLVESLREKVYA 162
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMT 297
L Q +PEQ A+L+ LP LR++ E L F++
Sbjct: 163 SLEEYCKQQYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLI 206
>pdb|1DKF|A Chain A, Crystal Structure Of A Heterodimeric Complex Of Rar And
Rxr Ligand-Binding Domains
Length = 233
Score = 79.3 bits (194), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 1/164 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L DDQV LL+AG E+L+ + + + ++ G + R+S H
Sbjct: 55 LVEWAKRIPHFSELPLDDQVILLRAGWNELLIASASHRSIAVKDGILLATGLHVHRNSAH 114
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
S+ + D + + ++ + + TE+G +IV+ +P GL N VE +R K+
Sbjct: 115 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 174
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMT 297
L +PEQ A+L+ LP LR++ E L F++
Sbjct: 175 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLI 218
>pdb|1Z5X|U Chain U, Hemipteran Ecdysone Receptor Ligand-Binding Domain
Complexed With Ponasterone A
Length = 262
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 48/164 (29%), Positives = 87/164 (53%), Gaps = 1/164 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
++E+AK IP F+ L +DQV LLK+G E+L+ + S + ++ G V+ R+ H
Sbjct: 80 LIEWAKHIPHFTELPVEDQVILLKSGWNELLIAGFSHRSMSVKDGIMLATGLVVHRNCAH 139
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
+ + D + + ++ + + TE+G SIV+ +P GL++ + VE +R K+
Sbjct: 140 QAGVGAIFDRVLTELVAKMREMKMDKTELGCLRSIVLFNPEAKGLKSTQQVENLREKVYA 199
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMT 297
+L Q +P+Q A+L+ LP LR++ E L F++
Sbjct: 200 ILEEYCRQTYPDQSGRFAKLLLRLPALRSIGLKCLEHLFFFKLV 243
>pdb|3CTB|A Chain A, Tethered Pxr-LbdSRC-1p Apoprotein
pdb|3CTB|B Chain B, Tethered Pxr-LbdSRC-1p Apoprotein
pdb|3HVL|A Chain A, Tethered Pxr-LbdSRC-1p Complexed With Sr-12813
pdb|3HVL|B Chain B, Tethered Pxr-LbdSRC-1p Complexed With Sr-12813
Length = 344
Score = 72.8 bits (177), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 44/166 (26%), Positives = 86/166 (51%), Gaps = 3/166 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
+ ++ FAK I F L +DQ++LLK FE+ +R +F+++T + C + D
Sbjct: 133 FKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLED 192
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
+ + L++ M F L L L + E L +I + SP R G+ +V++++ +
Sbjct: 193 TA-GGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQF 251
Query: 252 ENMLMHVLNQNHPEQMN--LCAELISMLPDLRTLNQLHSEKLVAFQ 295
L + N P+ + L ++++ML +LR++N H+++L+ Q
Sbjct: 252 AITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQ 297
>pdb|1ILG|A Chain A, Crystal Structure Of Apo Human Pregnane X Receptor Ligand
Binding Domain
pdb|1ILH|A Chain A, Crystal Structure Of Human Pregnane X Receptor Ligand
Binding Domain Bound To Sr12813
pdb|1M13|A Chain A, Crystal Structure Of The Human Pregane X Receptor Ligand
Binding Domain In Complex With Hyperforin, A Constituent
Of St. John's Wort
pdb|1NRL|A Chain A, Crystal Structure Of The Human Pxr-Lbd In Complex With An
Src-1 Coactivator Peptide And Sr12813
pdb|1NRL|B Chain B, Crystal Structure Of The Human Pxr-Lbd In Complex With An
Src-1 Coactivator Peptide And Sr12813
pdb|2QNV|A Chain A, Crystal Structure Of The Pregnane X Receptor Bound To
Colupulone
pdb|3R8D|A Chain A, Activation Of The Human Nuclear Xenobiotic Receptor Pxr By
The Reverse Transcriptase-Targeted Anti-Hiv Drug
Pnu-142721
Length = 316
Score = 72.8 bits (177), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 44/166 (26%), Positives = 86/166 (51%), Gaps = 3/166 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
+ ++ FAK I F L +DQ++LLK FE+ +R +F+++T + C + D
Sbjct: 133 FKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLED 192
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
+ + L++ M F L L L + E L +I + SP R G+ +V++++ +
Sbjct: 193 TA-GGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQF 251
Query: 252 ENMLMHVLNQNHPEQMN--LCAELISMLPDLRTLNQLHSEKLVAFQ 295
L + N P+ + L ++++ML +LR++N H+++L+ Q
Sbjct: 252 AITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQ 297
>pdb|1SKX|A Chain A, Structural Disorder In The Complex Of Human Pxr And The
Macrolide Antibiotic Rifampicin
Length = 313
Score = 72.4 bits (176), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 44/166 (26%), Positives = 86/166 (51%), Gaps = 3/166 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
+ ++ FAK I F L +DQ++LLK FE+ +R +F+++T + C + D
Sbjct: 133 FKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLED 192
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
+ + L++ M F L L L + E L +I + SP R G+ +V++++ +
Sbjct: 193 TA-GGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQF 251
Query: 252 ENMLMHVLNQNHPEQMN--LCAELISMLPDLRTLNQLHSEKLVAFQ 295
L + N P+ + L ++++ML +LR++N H+++L+ Q
Sbjct: 252 AITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQ 297
>pdb|2O9I|A Chain A, Crystal Structure Of The Human Pregnane X Receptor Lbd In
Complex With An Src-1 Coactivator Peptide And T0901317
pdb|2O9I|B Chain B, Crystal Structure Of The Human Pregnane X Receptor Lbd In
Complex With An Src-1 Coactivator Peptide And T0901317
Length = 293
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 44/166 (26%), Positives = 86/166 (51%), Gaps = 3/166 (1%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRD 191
+ ++ FAK I F L +DQ++LLK FE+ +R +F+++T + C + D
Sbjct: 110 FKGIISFAKVISYFRDLPIEDQISLLKGAAFELSQLRFNTVFNAETGTWECGRLSYCLED 169
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
+ + L++ M F L L L + E L +I + SP R G+ +V++++ +
Sbjct: 170 TA-GGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQF 228
Query: 252 ENMLMHVLNQNHPEQMN--LCAELISMLPDLRTLNQLHSEKLVAFQ 295
L + N P+ + L ++++ML +LR++N H+++L+ Q
Sbjct: 229 AITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQ 274
>pdb|1XIU|A Chain A, Crystal Structure Of The Agonist-Bound Ligand-Binding
Domain Of Biomphalaria Glabrata Rxr
pdb|1XIU|B Chain B, Crystal Structure Of The Agonist-Bound Ligand-Binding
Domain Of Biomphalaria Glabrata Rxr
Length = 230
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 1/163 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP F+ L +DQV LL+AG E+L+ + + ++ G + R S H
Sbjct: 47 LVEWAKRIPHFTELPLEDQVILLRAGWNELLIAGFSHRSIMAKDGILLATGLHVHRSSAH 106
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
+ + D + + ++ + + TE+G ++V+ +P GL + VE++R K+
Sbjct: 107 QAGVGTIFDRVLTELVAKMRDMKMDKTELGCLRAVVLFNPDAKGLTAVQEVEQLREKVYA 166
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
L +PE+ A+L+ LP LR++ E L F++
Sbjct: 167 SLEEYTKSRYPEEPGRFAKLLLRLPALRSIGLKCLEHLFFFKL 209
>pdb|1XV9|B Chain B, Crystal Structure Of CarRXR HETERODIMER BOUND WITH SRC1
Peptide, Fatty Acid, And 5b-Pregnane-3,20-Dione.
pdb|1XV9|D Chain D, Crystal Structure Of CarRXR HETERODIMER BOUND WITH SRC1
Peptide, Fatty Acid, And 5b-Pregnane-3,20-Dione.
pdb|1XVP|B Chain B, Crystal Structure Of CarRXR HETERODIMER BOUND WITH SRC1
Peptide, Fatty Acid And Citco
pdb|1XVP|D Chain D, Crystal Structure Of CarRXR HETERODIMER BOUND WITH SRC1
Peptide, Fatty Acid And Citco
Length = 246
Score = 64.3 bits (155), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 41/174 (23%), Positives = 86/174 (49%), Gaps = 2/174 (1%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
L+ F++ + + V++F K +P F L +DQ++LLK E+ + L F QT +
Sbjct: 55 LVTHFADINTFMVLQVIKFTKDLPVFRSLPIEDQISLLKGAAVEICHIVLNTTFCLQTQN 114
Query: 180 MICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLR 239
+C + D ++ +F F L L L + E L +++ + SP R G+
Sbjct: 115 FLCGPLRYTIEDGARVGFQVEFLELLFHFHGTLRKLQLQEPEYVLLAAMALFSPDRPGVT 174
Query: 240 NKELVERMRGKLENMLMHVL--NQNHPEQMNLCAELISMLPDLRTLNQLHSEKL 291
++ +++++ ++ L + Q P L A+L+ +L +LR++N+ + ++
Sbjct: 175 QRDEIDQLQEEMALTLQSYIKGQQRRPRDRFLYAKLLGLLAELRSINEAYGYQI 228
>pdb|2Q60|A Chain A, Crystal Structure Of The Ligand Binding Domain Of
Polyandrocarpa Misakiensis Rxr In Tetramer In Absence Of
Ligand
pdb|2Q60|B Chain B, Crystal Structure Of The Ligand Binding Domain Of
Polyandrocarpa Misakiensis Rxr In Tetramer In Absence Of
Ligand
pdb|2Q60|C Chain C, Crystal Structure Of The Ligand Binding Domain Of
Polyandrocarpa Misakiensis Rxr In Tetramer In Absence Of
Ligand
pdb|2Q60|D Chain D, Crystal Structure Of The Ligand Binding Domain Of
Polyandrocarpa Misakiensis Rxr In Tetramer In Absence Of
Ligand
Length = 258
Score = 64.3 bits (155), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 1/164 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+VE+AKRIP FS L +DQV LL+AG E+L+ + +S++ +G + R S H
Sbjct: 74 LVEWAKRIPHFSSLPLEDQVILLRAGWNELLIASFSHRSIDVKDSILLASGLHVHRHSAH 133
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
+ + D + + ++ + + TE+G ++V+ +P + +E +R K+
Sbjct: 134 QAGVGPIFDRVLTELVSKMRDMMMDKTELGCLRAVVLFNPDVKNPSDSAHIESLREKVYA 193
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMT 297
L +P+Q A+L+ LP LR++ E L F++
Sbjct: 194 SLEAYCRSKYPDQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLI 237
>pdb|2NXX|A Chain A, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
pdb|2NXX|B Chain B, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
pdb|2NXX|C Chain C, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
pdb|2NXX|D Chain D, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
Length = 235
Score = 62.4 bits (150), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 40/163 (24%), Positives = 83/163 (50%), Gaps = 1/163 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
+V++AK +P F+ L DQV LL+AG E+L+ + ++++ G + + + H
Sbjct: 53 LVQWAKLVPHFTSLPLTDQVQLLRAGWNELLIAAFSHRSMQAQDAIVLATGLTVNKSTAH 112
Query: 195 SSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLEN 253
+ + D + + ++ + + TE+G +I++ +P G+++ + VE +R K+
Sbjct: 113 AVGVGNIYDRVLSELVNKMKEMKMDKTELGCLRAIILYNPDVRGIKSVQEVEMLREKIYG 172
Query: 254 MLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
+L HP + A+L+ LP LR++ E L F++
Sbjct: 173 VLEEYTRTTHPNEPGRFAKLLLRLPALRSIGLKCLEHLFFFKL 215
>pdb|1PDU|A Chain A, Ligand-Binding Domain Of Drosophila Orphan Nuclear
Receptor Dhr38
pdb|1PDU|B Chain B, Ligand-Binding Domain Of Drosophila Orphan Nuclear
Receptor Dhr38
Length = 244
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 4/166 (2%)
Query: 121 LQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSM 180
+Q F + + ++ + +FA++IPG+ L +DQ L ++ E+ ++RLA +
Sbjct: 49 VQQFYQLLTSSVDVIKQFAEKIPGYFDLLPEDQELLFQSASLELFVLRLAYRARIDDTKL 108
Query: 181 ICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRN 240
I NG VL R S +L D M +F+ L+ L + + ++ +I+ R GLR
Sbjct: 109 IFCNGTVLHRTQCLRSFGEWLNDIM-EFSRSLHNLEIDISAFACLCALTLIT-ERHGLRE 166
Query: 241 KELVERMRGKLENMLM-HV-LNQNHPEQMNLCAELISMLPDLRTLN 284
+ VE+++ K+ L HV N ++ + + L+ LP+LR+L+
Sbjct: 167 PKKVEQLQMKIIGSLRDHVTYNAEAQKKQHYFSRLLGKLPELRSLS 212
>pdb|1OVL|A Chain A, Crystal Structure Of Nurr1 Lbd
pdb|1OVL|D Chain D, Crystal Structure Of Nurr1 Lbd
Length = 271
Score = 60.5 bits (145), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 50/180 (27%), Positives = 89/180 (49%), Gaps = 8/180 (4%)
Query: 108 NPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
NP+ + +Q F + + ++ + +A++IPGF+ L DQ L ++ E+ ++
Sbjct: 63 NPDYQMSGDDTQHIQQFYDLLTGSMEIIRGWAEKIPGFADLPKADQDLLFESAFLELFVL 122
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSS 227
RLA + +I NG VL R ++ DS+ +F+ L ++ +I FS
Sbjct: 123 RLAYRSNPVEGKLIFCNGVVLHRLQCVRGFGEWI-DSIVEFSSNLQNXNI---DISAFSC 178
Query: 228 IVVIS--PSRSGLRNKELVERMRGKLENMLM-HV-LNQNHPEQMNLCAELISMLPDLRTL 283
I ++ R GL+ + VE ++ K+ N L HV N + N ++L+ LP+LRTL
Sbjct: 179 IAALAXVTERHGLKEPKRVEELQNKIVNCLKDHVTFNNGGLNRPNYLSKLLGKLPELRTL 238
>pdb|2QW4|A Chain A, Human Nr4a1 Ligand-Binding Domain
pdb|2QW4|B Chain B, Human Nr4a1 Ligand-Binding Domain
pdb|2QW4|C Chain C, Human Nr4a1 Ligand-Binding Domain
pdb|2QW4|D Chain D, Human Nr4a1 Ligand-Binding Domain
Length = 273
Score = 60.1 bits (144), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 4/165 (2%)
Query: 121 LQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSM 180
+Q F + S ++ + ++A++IPGF+ L DQ LL++ E+ ++RLA +
Sbjct: 78 VQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKL 137
Query: 181 ICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRN 240
I +G VL R + +DS+ F+ L+ L + S++V+I+ R GL+
Sbjct: 138 IFCSGLVLHRLQCARGFGDW-IDSILAFSRSLHSLLVDVPAFACLSALVLIT-DRHGLQE 195
Query: 241 KELVERMRGKLENMLM-HVLN-QNHPEQMNLCAELISMLPDLRTL 283
VE ++ ++ + L HV P+ + + L+ LP+LRTL
Sbjct: 196 PRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTL 240
>pdb|1OVL|B Chain B, Crystal Structure Of Nurr1 Lbd
pdb|1OVL|C Chain C, Crystal Structure Of Nurr1 Lbd
pdb|1OVL|E Chain E, Crystal Structure Of Nurr1 Lbd
pdb|1OVL|F Chain F, Crystal Structure Of Nurr1 Lbd
Length = 271
Score = 59.7 bits (143), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 50/180 (27%), Positives = 88/180 (48%), Gaps = 8/180 (4%)
Query: 108 NPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLV 167
NP+ + +Q F + + + + +A++IPGF+ L DQ L ++ E+ ++
Sbjct: 63 NPDYQMSGDDTQHIQQFYDLLTGSXEIIRGWAEKIPGFADLPKADQDLLFESAFLELFVL 122
Query: 168 RLACMFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSS 227
RLA + +I NG VL R + +DS+ +F+ L ++ +I FS
Sbjct: 123 RLAYRSNPVEGKLIFCNGVVLHRLQCVRGFGEW-IDSIVEFSSNLQNXNI---DISAFSC 178
Query: 228 IVVIS--PSRSGLRNKELVERMRGKLENMLM-HV-LNQNHPEQMNLCAELISMLPDLRTL 283
I ++ R GL+ + VE ++ K+ N L HV N + N ++L+ LP+LRTL
Sbjct: 179 IAALAXVTERHGLKEPKRVEELQNKIVNCLKDHVTFNNGGLNRPNYLSKLLGKLPELRTL 238
>pdb|3V3E|B Chain B, Crystal Structure Of The Human Nur77 Ligand-Binding Domain
pdb|3V3E|A Chain A, Crystal Structure Of The Human Nur77 Ligand-Binding Domain
pdb|3V3Q|A Chain A, Crystal Structure Of Human Nur77 Ligand-Binding Domain In
Complex With Ethyl 2-[2,3,4
Trimethoxy-6(1-Octanoyl)phenyl]acetate
pdb|3V3Q|B Chain B, Crystal Structure Of Human Nur77 Ligand-Binding Domain In
Complex With Ethyl 2-[2,3,4
Trimethoxy-6(1-Octanoyl)phenyl]acetate
Length = 257
Score = 59.7 bits (143), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 4/165 (2%)
Query: 121 LQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSM 180
+Q F + S ++ + ++A++IPGF+ L DQ LL++ E+ ++RLA +
Sbjct: 54 VQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKL 113
Query: 181 ICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRN 240
I +G VL R + +DS+ F+ L+ L + S++V+I+ R GL+
Sbjct: 114 IFCSGLVLHRLQCARGFGDW-IDSILAFSRSLHSLLVDVPAFACLSALVLIT-DRHGLQE 171
Query: 241 KELVERMRGKLENMLM-HVLN-QNHPEQMNLCAELISMLPDLRTL 283
VE ++ ++ + L HV P+ + + L+ LP+LRTL
Sbjct: 172 PRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTL 216
>pdb|1YJE|A Chain A, Crystal Structure Of The Rngfi-B Ligand-Binding Domain
Length = 264
Score = 56.6 bits (135), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 43/180 (23%), Positives = 89/180 (49%), Gaps = 4/180 (2%)
Query: 121 LQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSM 180
+Q F + S ++ + ++A++IPGF L DQ LL++ E+ ++RLA +
Sbjct: 69 VQQFYDLLSGSLDVIRKWAEKIPGFIELSPGDQDLLLESAFLELFILRLAYRSKPGEGKL 128
Query: 181 ICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRN 240
I +G VL R + +D++ F+ L+ L + S++V+I+ R GL++
Sbjct: 129 IFCSGLVLHRLQCARGFGDW-IDNILAFSRSLHSLGVDVPAFACLSALVLIT-DRHGLQD 186
Query: 241 KELVERMRGKLENMLMHVLN--QNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQMTE 298
VE ++ ++ + L + P+ + + L+ LP+LRTL +++ ++ +
Sbjct: 187 PRRVEELQNRIASCLKEHMAAVAGDPQPASCLSRLLGKLPELRTLCTQGLQRIFCLKLED 246
>pdb|1M7W|A Chain A, Hnf4a Ligand Binding Domain With Bound Fatty Acid
pdb|1M7W|B Chain B, Hnf4a Ligand Binding Domain With Bound Fatty Acid
pdb|1M7W|C Chain C, Hnf4a Ligand Binding Domain With Bound Fatty Acid
pdb|1M7W|D Chain D, Hnf4a Ligand Binding Domain With Bound Fatty Acid
Length = 250
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 21/182 (11%)
Query: 121 LQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSM 180
+ D E + +VE+AK IP F L DDQV LL+A E LL+ + SM
Sbjct: 43 ITDVCESMKEQLLVLVEWAKYIPAFCELLLDDQVALLRAHAGEHLLL------GATKRSM 96
Query: 181 ICLNGEVLVRDSI-----------HSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIV 229
+ + +L D I + R L + + F E L + D E +I+
Sbjct: 97 VFKDVLLLGNDYIVPRHCPELAEMSRVSIRILDELVLPFQE----LQIDDNEYACLKAII 152
Query: 230 VISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSE 289
P GL + ++R+R +++ L +N + EL+ +LP L+++ E
Sbjct: 153 FFDPDAKGLSDPGKIKRLRSQVQVSLEDYINDRQYDSRGRFGELLLLLPTLQSITWQMIE 212
Query: 290 KL 291
++
Sbjct: 213 QI 214
>pdb|3CJW|A Chain A, Crystal Structure Of The Human Coup-Tfii Ligand Binding
Domain
Length = 244
Score = 45.4 bits (106), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 44/181 (24%), Positives = 78/181 (43%), Gaps = 6/181 (3%)
Query: 121 LQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA-CMFDSQTNS 179
+++ E + + VE+A+ IP F L DQV LL+ E+ ++ A C
Sbjct: 39 IENICELAARMLFSAVEWARNIPFFPDLQITDQVALLRLTWSELFVLNAAQCSMPLHVAP 98
Query: 180 MICLNGEVLVRDSIHSSNARFLMDSMFDF---AERLNGLHLSDTEIGLFSSIVVISPSRS 236
++ G L + + MD + F E+L LH+ E +IV+ +
Sbjct: 99 LLAAAG--LHASPMSADRVVAFMDHIRIFQEQVEKLKALHVDSAEYSCLKAIVLFTSDAC 156
Query: 237 GLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQM 296
GL + VE ++ K + L + +P Q +L+ LP LRT++ E+L ++
Sbjct: 157 GLSDVAHVESLQEKSQCALEEYVRSQYPNQPTRFGKLLLRLPSLRTVSSSVIEQLFFVRL 216
Query: 297 T 297
Sbjct: 217 V 217
>pdb|1HG4|A Chain A, Ultraspiracle Ligand Binding Domain From Drosophila
Melanogaster
pdb|1HG4|B Chain B, Ultraspiracle Ligand Binding Domain From Drosophila
Melanogaster
pdb|1HG4|C Chain C, Ultraspiracle Ligand Binding Domain From Drosophila
Melanogaster
pdb|1HG4|D Chain D, Ultraspiracle Ligand Binding Domain From Drosophila
Melanogaster
pdb|1HG4|E Chain E, Ultraspiracle Ligand Binding Domain From Drosophila
Melanogaster
pdb|1HG4|F Chain F, Ultraspiracle Ligand Binding Domain From Drosophila
Melanogaster
Length = 279
Score = 45.4 bits (106), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 43/191 (22%), Positives = 85/191 (44%), Gaps = 28/191 (14%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACM---------------------- 172
+VE+A+ +P F+ + DDQV LLKA E+L+ +A
Sbjct: 63 MVEYARMMPHFAQVPLDDQVILLKAAWIELLIANVAWCSIVSLDDGGAGGGGGGLGHDGS 122
Query: 173 FDSQTNSM----ICLNGEVLV-RDSIHSSNARFLMDSMF-DFAERLNGLHLSDTEIGLFS 226
F+ ++ + + LN R+S + + D + + + ++ L+L E+
Sbjct: 123 FERRSPGLQPQQLFLNQSFSYHRNSAIKAGVSAIFDRILSELSVKMKRLNLDRRELSCLK 182
Query: 227 SIVVISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQL 286
+I++ +P G++++ +E R K+ L HP A+L+ LP LR+++
Sbjct: 183 AIILYNPDIRGIKSRAEIEMCREKVYACLDEHCRLEHPGDDGRFAQLLLRLPALRSISLK 242
Query: 287 HSEKLVAFQMT 297
+ L F++T
Sbjct: 243 CQDHLFLFRIT 253
>pdb|3UP0|A Chain A, Nuclear Receptor Daf-12 From Hookworm Ancylostoma
Ceylanicum In Complex With (25s)-Delta7-Dafachronic Acid
pdb|3UP0|B Chain B, Nuclear Receptor Daf-12 From Hookworm Ancylostoma
Ceylanicum In Complex With (25s)-Delta7-Dafachronic Acid
pdb|3UP3|A Chain A, Nuclear Receptor Daf-12 From Hookworm Ancylostoma
Ceylanicum In Complex With (25s)-Cholestenoic Acid
Length = 243
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 22/49 (44%), Positives = 30/49 (61%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
T+R V+ AKR+P F+ L D + LLK G+ E+L VR FDS + S
Sbjct: 53 TMRRFVKMAKRLPAFNDLSQDGKFALLKGGMIEMLTVRGVRRFDSSSGS 101
>pdb|1LV2|A Chain A, Hepatocyte Nuclear Factor 4 Is A Transcription Factor That
Constitutively Binds Fatty Acids
Length = 229
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 42/171 (24%), Positives = 74/171 (43%)
Query: 121 LQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSM 180
+ D E + +VE+AK IP F L DDQV LL+A E LL+ + +
Sbjct: 37 IGDVCESMKQQLLVLVEWAKYIPAFCELPLDDQVALLRAHAGEHLLLGATKRSMMYKDIL 96
Query: 181 ICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRN 240
+ N V+ R+S +R + + + + D E +IV P GL +
Sbjct: 97 LLGNNYVIHRNSCEVEISRVANRVLDELVRPFQEIQIDDNEYACLKAIVFFDPDAKGLSD 156
Query: 241 KELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKL 291
++ MR +++ L +N + EL+ +LP L+++ E++
Sbjct: 157 PVKIKNMRFQVQIGLEDYINDRQYDSRGRFGELLLLLPTLQSITWQMIEQI 207
>pdb|3GYT|A Chain A, Nuclear Receptor Daf-12 From Parasitic Nematode
Strongyloides Stercoralis In Complex With Its
Physiological Ligand Dafachronic Acid Delta 4
Length = 244
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 23/152 (15%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDS-----QT----NSMI 181
T+R +V+ AKR+ F+ + + +LLK G+ E+L +R +F++ QT +S I
Sbjct: 53 TMRRLVKMAKRLGAFNEISEAGKFSLLKGGMIEMLTIRGVTVFNADKGVWQTPVDGHSQI 112
Query: 182 CLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLH----LSDTEIGLFSSIVVISPSRSG 237
N +R I + + F N LH +D I + +V+ R G
Sbjct: 113 SFNMFDKLRPDIKDTQKK-------GFLHFFNLLHSDVRKNDLAIDIIVLMVLFDSKREG 165
Query: 238 L---RNKELVERMRGKLENMLMHVLNQNHPEQ 266
L ++KE VE++ E++L L H E+
Sbjct: 166 LVSQQDKETVEKLHRNYESLLHRYLYSIHKEE 197
>pdb|1PZL|A Chain A, Crystal Structure Of Hnf4a Lbd In Complex With The Ligand
And The Coactivator Src-1 Peptide
Length = 237
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 21/182 (11%)
Query: 121 LQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSM 180
+ D E + +VE+AK IP F L DDQV LL+A E LL+ + SM
Sbjct: 43 IADVCESMKEQLLVLVEWAKYIPAFCELPLDDQVALLRAHAGEHLLL------GATKRSM 96
Query: 181 ICLNGEVLVRDSI-----------HSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIV 229
+ + +L D I + R L + + F E L + D E +I+
Sbjct: 97 VFKDVLLLGNDYIVPRHCPELAEMSRVSIRILDELVLPFQE----LQIDDNEYAYLKAII 152
Query: 230 VISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSE 289
P GL + ++R+R +++ L +N + EL+ +LP L+++ E
Sbjct: 153 FFDPDAKGLSDPGKIKRLRSQVQVSLEDYINDRQYDSRGRFGELLLLLPTLQSITWQMIE 212
Query: 290 KL 291
++
Sbjct: 213 QI 214
>pdb|3FS1|A Chain A, Crystal Structure Of Hnf4a Lbd In Complex With The Ligand
And The Coactivator Pgc-1a Fragment
Length = 230
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 21/182 (11%)
Query: 121 LQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSM 180
+ D E + +VE+AK IP F L DDQV LL+A E LL+ + SM
Sbjct: 37 IADVCESMKEQLLVLVEWAKYIPAFCELPLDDQVALLRAHAGEHLLL------GATKRSM 90
Query: 181 ICLNGEVLVRDSI-----------HSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIV 229
+ + +L D I + R L + + F E L + D E +I+
Sbjct: 91 VFKDVLLLGNDYIVPRHCPELAEMSRVSIRILDELVLPFQE----LQIDDNEYAYLKAII 146
Query: 230 VISPSRSGLRNKELVERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSE 289
P GL + ++R+R +++ L +N + EL+ +LP L+++ E
Sbjct: 147 FFDPDAKGLSDPGKIKRLRSQVQVSLEDYINDRQYDSRGRFGELLLLLPTLQSITWQMIE 206
Query: 290 KL 291
++
Sbjct: 207 QI 208
>pdb|3TX7|B Chain B, Crystal Structure Of Lrh-1BETA-Catenin Complex
Length = 352
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/167 (24%), Positives = 78/167 (46%), Gaps = 7/167 (4%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVR--LACMFDSQTNSMICLNGEVL 188
T+ +VE+A+ F L DDQ+ LL+ E+L++ + + S+ + G+
Sbjct: 163 TLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQ- 221
Query: 189 VRDSIHSSNARFLMDSMFDFAE----RLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELV 244
V SI +S A ++++ A+ +L L E +V+ S L N +LV
Sbjct: 222 VDYSIIASQAGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFSLDVKNLENFQLV 281
Query: 245 ERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKL 291
E ++ ++ L+ N+P+Q +L+ LP++R ++ E L
Sbjct: 282 EGVQEQVNAALLDYTMCNYPQQTEKFGQLLLRLPEIRAISMQAEEYL 328
>pdb|1KV6|A Chain A, X-Ray Structure Of The Orphan Nuclear Receptor Err3
Ligand- Binding Domain In The Constitutively Active
Conformation
pdb|1KV6|B Chain B, X-Ray Structure Of The Orphan Nuclear Receptor Err3
Ligand- Binding Domain In The Constitutively Active
Conformation
pdb|2GP7|A Chain A, Estrogen Related Receptor-Gamma Ligand Binding Domain
pdb|2GP7|B Chain B, Estrogen Related Receptor-Gamma Ligand Binding Domain
pdb|2GP7|C Chain C, Estrogen Related Receptor-Gamma Ligand Binding Domain
pdb|2GP7|D Chain D, Estrogen Related Receptor-Gamma Ligand Binding Domain
pdb|2GPO|A Chain A, Estrogen Related Receptor-Gamma Ligand Binding Domain
Complexed With A Synthetic Peptide From Rip140
pdb|2GPP|A Chain A, Estrogen Related Receptor-Gamma Ligand Binding Domain
Complexed With A Rip140 Peptide And Synthetic Ligand
Gsk4716
pdb|2GPP|B Chain B, Estrogen Related Receptor-Gamma Ligand Binding Domain
Complexed With A Rip140 Peptide And Synthetic Ligand
Gsk4716
pdb|2GPU|A Chain A, Estrogen Related Receptor-gamma Ligand Binding Domain
Complexed With 4-hydroxy-tamoxifen
pdb|2GPV|A Chain A, Estrogen Related Receptor-gamma Ligand Binding Domain
Complexed With 4-hydroxy-tamoxifen And A Smrt Peptide
pdb|2GPV|B Chain B, Estrogen Related Receptor-gamma Ligand Binding Domain
Complexed With 4-hydroxy-tamoxifen And A Smrt Peptide
pdb|2GPV|C Chain C, Estrogen Related Receptor-gamma Ligand Binding Domain
Complexed With 4-hydroxy-tamoxifen And A Smrt Peptide
pdb|2GPV|D Chain D, Estrogen Related Receptor-gamma Ligand Binding Domain
Complexed With 4-hydroxy-tamoxifen And A Smrt Peptide
pdb|2GPV|E Chain E, Estrogen Related Receptor-gamma Ligand Binding Domain
Complexed With 4-hydroxy-tamoxifen And A Smrt Peptide
pdb|2GPV|F Chain F, Estrogen Related Receptor-gamma Ligand Binding Domain
Complexed With 4-hydroxy-tamoxifen And A Smrt Peptide
Length = 230
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 30/147 (20%), Positives = 66/147 (44%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
++ +AK IPGFS L DQ++LL++ E+L++ + S + ++ + ++ D
Sbjct: 51 IIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSK 110
Query: 195 SSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLENM 254
+ L +++ ++ + L E +I + + + + E V++++ L
Sbjct: 111 LAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEA 170
Query: 255 LMHVLNQNHPEQMNLCAELISMLPDLR 281
L H E +++ LP LR
Sbjct: 171 LQDYEAGQHMEDPRRAGKMLMTLPLLR 197
>pdb|2E2R|A Chain A, Crystal Structure Of Human Estrogen-Related Receptor Gamma
Ligand Binding Domain Complex With Bisphenol A
pdb|2ZAS|A Chain A, Crystal Structure Of Human Estrogen-Related Receptor Gamma
Ligand Binding Domain Complex With 4-Alpha-Cumylphenol,
A Bisphenol A Derivative
pdb|2ZBS|A Chain A, Crystal Structure Of Human Estrogen-Related Receptor Gamma
Ligand Binding Domain Apo Form
pdb|2ZKC|A Chain A, Crystal Structure Of Human Estrogen-Related Receptor Gamma
Ligand Binding Domain Complex With Bisphenol Z
Length = 244
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 30/147 (20%), Positives = 66/147 (44%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
++ +AK IPGFS L DQ++LL++ E+L++ + S + ++ + ++ D
Sbjct: 64 IIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSK 123
Query: 195 SSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLENM 254
+ L +++ ++ + L E +I + + + + E V++++ L
Sbjct: 124 LAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEA 183
Query: 255 LMHVLNQNHPEQMNLCAELISMLPDLR 281
L H E +++ LP LR
Sbjct: 184 LQDYEAGQHMEDPRRAGKMLMTLPLLR 210
>pdb|1VJB|A Chain A, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With 4-
Hydroxytamoxifen
pdb|1VJB|B Chain B, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With 4-
Hydroxytamoxifen
pdb|1TFC|A Chain A, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With A
Steroid Receptor Coactivator-1 Peptide
pdb|1TFC|B Chain B, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With A
Steroid Receptor Coactivator-1 Peptide
pdb|2P7A|A Chain A, Crystal Structure Of Estrogen Related Receptor G In
Complex With 3-Methyl Phenol
pdb|2P7G|A Chain A, X-Ray Structure Of Estrogen Related Receptor G In Complex
With Bisphenol A.
pdb|2P7Z|A Chain A, Estrogen Related Receptor Gamma In Complex With 4-Hydroxy-
Tamoxifen
Length = 251
Score = 42.4 bits (98), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 30/147 (20%), Positives = 66/147 (44%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
++ +AK IPGFS L DQ++LL++ E+L++ + S + ++ + ++ D
Sbjct: 72 IIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSK 131
Query: 195 SSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLENM 254
+ L +++ ++ + L E +I + + + + E V++++ L
Sbjct: 132 LAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEA 191
Query: 255 LMHVLNQNHPEQMNLCAELISMLPDLR 281
L H E +++ LP LR
Sbjct: 192 LQDYEAGQHMEDPRRAGKMLMTLPLLR 218
>pdb|1S9Q|A Chain A, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With
4-Hydroxytamoxifen
pdb|1S9Q|B Chain B, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With
4-Hydroxytamoxifen
Length = 251
Score = 42.4 bits (98), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 30/147 (20%), Positives = 66/147 (44%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
++ +AK IPGFS L DQ++LL++ E+L++ + S + ++ + ++ D
Sbjct: 72 IIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSK 131
Query: 195 SSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLENM 254
+ L +++ ++ + L E +I + + + + E V++++ L
Sbjct: 132 LAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEA 191
Query: 255 LMHVLNQNHPEQMNLCAELISMLPDLR 281
L H E +++ LP LR
Sbjct: 192 LQDYEAGQHMEDPRRAGKMLMTLPLLR 218
>pdb|3OS8|C Chain C, Estrogen Receptor
pdb|3OS8|D Chain D, Estrogen Receptor
pdb|3OS9|A Chain A, Estrogen Receptor
pdb|3OS9|B Chain B, Estrogen Receptor
pdb|3OS9|C Chain C, Estrogen Receptor
pdb|3OS9|D Chain D, Estrogen Receptor
pdb|3OSA|A Chain A, Estrogen Receptor
pdb|3OSA|B Chain B, Estrogen Receptor
pdb|3OSA|C Chain C, Estrogen Receptor
pdb|3OSA|D Chain D, Estrogen Receptor
Length = 258
Score = 42.4 bits (98), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 50 LLTNLADR---ELVHMINWAKRVPGFVDLTRHDQVHLLECAWLEILMIGLVWRSMEHPGK 106
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 107 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 154
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 155 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 214
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 215 ILSHIRHMSNKGMEHLYSMK 234
>pdb|1S9P|A Chain A, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With
Diethylstilbestrol
pdb|1S9P|B Chain B, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With
Diethylstilbestrol
pdb|1S9P|C Chain C, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With
Diethylstilbestrol
pdb|1S9P|D Chain D, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With
Diethylstilbestrol
Length = 227
Score = 42.0 bits (97), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 30/147 (20%), Positives = 66/147 (44%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
++ +AK IPGFS L DQ++LL++ E+L++ + S + ++ + ++ D
Sbjct: 48 IIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSK 107
Query: 195 SSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLENM 254
+ L +++ ++ + L E +I + + + + E V++++ L
Sbjct: 108 LAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEA 167
Query: 255 LMHVLNQNHPEQMNLCAELISMLPDLR 281
L H E +++ LP LR
Sbjct: 168 LQDYEAGQHMEDPRRAGKMLMTLPLLR 194
>pdb|2EWP|A Chain A, Crystal Structure Of Estrogen Related Receptor-3
(Err-Gamma) Ligand Binding Domaind With Tamoxifen Analog
Gsk5182
pdb|2EWP|B Chain B, Crystal Structure Of Estrogen Related Receptor-3
(Err-Gamma) Ligand Binding Domaind With Tamoxifen Analog
Gsk5182
pdb|2EWP|C Chain C, Crystal Structure Of Estrogen Related Receptor-3
(Err-Gamma) Ligand Binding Domaind With Tamoxifen Analog
Gsk5182
pdb|2EWP|D Chain D, Crystal Structure Of Estrogen Related Receptor-3
(Err-Gamma) Ligand Binding Domaind With Tamoxifen Analog
Gsk5182
pdb|2EWP|E Chain E, Crystal Structure Of Estrogen Related Receptor-3
(Err-Gamma) Ligand Binding Domaind With Tamoxifen Analog
Gsk5182
Length = 226
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/147 (20%), Positives = 66/147 (44%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
++ +AK IPGFS L DQ++LL++ E+L++ + S + ++ + ++ D
Sbjct: 47 IIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSK 106
Query: 195 SSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKLENM 254
+ L +++ ++ + L E +I + + + + E V++++ L
Sbjct: 107 LAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEA 166
Query: 255 LMHVLNQNHPEQMNLCAELISMLPDLR 281
L H E +++ LP LR
Sbjct: 167 LQDYEAGQHMEDPRRAGKMLMTLPLLR 193
>pdb|2PJL|A Chain A, Crystal Structure Of Human Estrogen-Related Receptor Alpha
In Complex With A Synthetic Inverse Agonist Reveals Its
Novel Molecular Mechanism
pdb|2PJL|B Chain B, Crystal Structure Of Human Estrogen-Related Receptor Alpha
In Complex With A Synthetic Inverse Agonist Reveals Its
Novel Molecular Mechanism
Length = 247
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 33/133 (24%), Positives = 60/133 (45%)
Query: 124 FSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICL 183
S+ F I + +AK IPGFS L DQ+++L++ EVL++ +A + +
Sbjct: 52 LSDLFDREIVVTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLPLQDELAFA 111
Query: 184 NGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKEL 243
VL + ++ L ++ RL L L E L ++ + + + + E
Sbjct: 112 EDLVLDEEGARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANSDSVHIEDAEA 171
Query: 244 VERMRGKLENMLM 256
VE++R L L+
Sbjct: 172 VEQLREALHEALL 184
>pdb|2AA6|A Chain A, Mineralocorticoid Receptor S810l Mutant With Bound
Progesterone
pdb|2AA6|B Chain B, Mineralocorticoid Receptor S810l Mutant With Bound
Progesterone
pdb|2AAX|A Chain A, Mineralocorticoid Receptor Double Mutant With Bound
Cortisone
pdb|2AAX|B Chain B, Mineralocorticoid Receptor Double Mutant With Bound
Cortisone
pdb|2AB2|A Chain A, Mineralocorticoid Receptor Double Mutant With Bound
Spironolactone
pdb|2AB2|B Chain B, Mineralocorticoid Receptor Double Mutant With Bound
Spironolactone
Length = 275
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 47/187 (25%), Positives = 77/187 (41%), Gaps = 20/187 (10%)
Query: 65 LSTVVRAHLDTCAFTADKIEPMLRRAREHPTYTACPSTLACPLNPNSHPLQGQQELLQDF 124
LST+ RA + + IEP + A + L LN L G+Q +
Sbjct: 18 LSTISRALTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNR----LAGKQMI---- 69
Query: 125 SERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLN 184
VV++AK +PGF L +DQ+TL++ +L L+ TNS
Sbjct: 70 ---------QVVKWAKVLPGFKNLPLEDQITLIQYSWMSLLSFALSWRSYKHTNSQFLYF 120
Query: 185 GEVLV--RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISP-SRSGLRNK 241
LV + +H S L M + + L L+ E + ++++S + GL+++
Sbjct: 121 APDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQ 180
Query: 242 ELVERMR 248
E MR
Sbjct: 181 AAFEEMR 187
>pdb|1G2N|A Chain A, Crystal Structure Of The Ligand Binding Domain Of The
Ultraspiracle Protein Usp, The Ortholog Of Rxrs In
Insects
Length = 264
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/139 (25%), Positives = 65/139 (46%), Gaps = 19/139 (13%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACM-----------FDSQTN-- 178
I +V +A+ IP FS L +DQ+ L+K E+LL +A D N
Sbjct: 55 IAALVVWARDIPHFSQLEMEDQILLIKGSWNELLLFAIAWRSMEFLTEERDGVDGTGNRT 114
Query: 179 ----SMICLN-GEVLVRDSIHSSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVIS 232
++CL G L R+S + + D + + + ++ L + E +I++++
Sbjct: 115 TSPPQLMCLMPGMTLHRNSALQAGVGQIFDRVLSELSLKMRTLRVDQAEYVALKAIILLN 174
Query: 233 PSRSGLRNKELVERMRGKL 251
P GL+N++ VE +R K+
Sbjct: 175 PDVKGLKNRQEVEVLREKM 193
>pdb|3VHU|A Chain A, Mineralocorticoid Receptor Ligand-Binding Domain With
Spironolactone
Length = 294
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 47/187 (25%), Positives = 77/187 (41%), Gaps = 20/187 (10%)
Query: 65 LSTVVRAHLDTCAFTADKIEPMLRRAREHPTYTACPSTLACPLNPNSHPLQGQQELLQDF 124
LST+ RA + + IEP + A + L LN L G+Q +
Sbjct: 37 LSTISRALTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNR----LAGKQMI---- 88
Query: 125 SERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLN 184
VV++AK +PGF L +DQ+TL++ +L L+ TNS
Sbjct: 89 ---------QVVKWAKVLPGFKNLPLEDQITLIQYSWMSLLSFALSWRSYKHTNSQFLYF 139
Query: 185 GEVLV--RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISP-SRSGLRNK 241
LV + +H S L M + + L L+ E + ++++S + GL+++
Sbjct: 140 APDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQ 199
Query: 242 ELVERMR 248
E MR
Sbjct: 200 AAFEEMR 206
>pdb|3D24|A Chain A, Crystal Structure Of Ligand-Binding Domain Of Estrogen-
Related Receptor Alpha (Erralpha) In Complex With The
Peroxisome Proliferators-Activated Receptor Coactivator-
1alpha Box3 Peptide (Pgc-1alpha)
pdb|3D24|C Chain C, Crystal Structure Of Ligand-Binding Domain Of Estrogen-
Related Receptor Alpha (Erralpha) In Complex With The
Peroxisome Proliferators-Activated Receptor Coactivator-
1alpha Box3 Peptide (Pgc-1alpha)
Length = 253
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/129 (24%), Positives = 58/129 (44%)
Query: 128 FSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEV 187
F I + +AK IPGFS L DQ+++L++ EVL++ +A + + V
Sbjct: 62 FDREIVVTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLPLQDELAFAEDLV 121
Query: 188 LVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
L + ++ L ++ RL L L E L ++ + + + + E VE++
Sbjct: 122 LDEEGARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANSDSVHIEDAEAVEQL 181
Query: 248 RGKLENMLM 256
R L L+
Sbjct: 182 REALHEALL 190
>pdb|3GYU|A Chain A, Nuclear Receptor Daf-12 From Parasitic Nematode
Strongyloides Stercoralis In Complex With Its
Physiological Ligand Dafachronic Acid Delta 7
Length = 244
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 41/152 (26%), Positives = 66/152 (43%), Gaps = 23/152 (15%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDS-----QT----NSMI 181
T R +V+ AKR+ F+ + + +LLK G E L +R +F++ QT +S I
Sbjct: 53 TXRRLVKXAKRLGAFNEISEAGKFSLLKGGXIEXLTIRGVTVFNADKGVWQTPVDGHSQI 112
Query: 182 CLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLH----LSDTEIGLFSSIVVISPSRSG 237
N +R I + + F N LH +D I + V+ R G
Sbjct: 113 SFNXFDKLRPDIKDTQKK-------GFLHFFNLLHSDVRKNDLAIDIIVLXVLFDSKREG 165
Query: 238 L---RNKELVERMRGKLENMLMHVLNQNHPEQ 266
L ++KE VE++ E++L L H E+
Sbjct: 166 LVSQQDKETVEKLHRNYESLLHRYLYSIHKEE 197
>pdb|1R1K|A Chain A, Crystal Structure Of The Ligand-Binding Domains Of The
Heterodimer EcrUSP BOUND TO PONASTERONE A
pdb|1R20|A Chain A, Crystal Structure Of The Ligand-Binding Domains Of The
Heterodimer EcrUSP BOUND TO THE SYNTHETIC AGONIST
BYI06830
pdb|2R40|A Chain A, Crystal Structure Of 20e Bound Ecr/usp
pdb|3IXP|A Chain A, Crystal Structure Of The Ecdysone Receptor Bound To
Byi08346
Length = 263
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/139 (25%), Positives = 65/139 (46%), Gaps = 19/139 (13%)
Query: 132 IRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACM-----------FDSQTN-- 178
I +V +A+ IP FS L +DQ+ L+K E+LL +A D N
Sbjct: 54 IAALVVWARDIPHFSQLEMEDQILLIKGSWNELLLFAIAWRSMEFLTEERDGVDGTGNRT 113
Query: 179 ----SMICLN-GEVLVRDSIHSSNARFLMDSMF-DFAERLNGLHLSDTEIGLFSSIVVIS 232
++CL G L R+S + + D + + + ++ L + E +I++++
Sbjct: 114 TSPPQLMCLMPGMTLHRNSALQAGVGQIFDRVLSELSLKMRTLRVDQAEYVALKAIILLN 173
Query: 233 PSRSGLRNKELVERMRGKL 251
P GL+N++ VE +R K+
Sbjct: 174 PDVKGLKNRQEVEVLREKM 192
>pdb|2QXS|A Chain A, Crystal Structure Of Antagonizing Mutant 536s Of The
Estrogen Receptor Alpha Ligand Binding Domain Complexed
To Raloxifene
pdb|2QXS|B Chain B, Crystal Structure Of Antagonizing Mutant 536s Of The
Estrogen Receptor Alpha Ligand Binding Domain Complexed
To Raloxifene
Length = 258
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 49 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 105
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 106 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 153
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 154 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 213
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 214 ILSHIRHMSNKGMEHLYSMK 233
>pdb|2QA8|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Mutant 537s Complexed With Genistein
Length = 258
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 49 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 105
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 106 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 153
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 154 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 213
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 214 ILSHIRHMSNKGMEHLYSMK 233
>pdb|2QA8|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Mutant 537s Complexed With Genistein
pdb|2QZO|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With Way-169916
Length = 258
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 49 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEHPGK 105
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 106 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 153
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 154 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 213
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 214 ILSHIRHMSNKGMEHLYSMK 233
>pdb|3ERD|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Diethylstilbestrol And A Glucocorticoid
Receptor Interacting Protein 1 Nr Box Ii Peptide
pdb|3ERD|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Diethylstilbestrol And A Glucocorticoid
Receptor Interacting Protein 1 Nr Box Ii Peptide
pdb|3ERT|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With 4- Hydroxytamoxifen
pdb|1R5K|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Gw5638
pdb|1R5K|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Gw5638
pdb|1R5K|C Chain C, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Gw5638
Length = 261
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 52 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 108
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 109 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 156
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 157 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 216
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 217 ILSHIRHMSNKGMEHLYSMK 236
>pdb|2P15|A Chain A, Crystal Structure Of The Er Alpha Ligand Binding Domain
With The Agonist Ortho-Trifluoromethylphenylvinyl
Estradiol
pdb|2P15|B Chain B, Crystal Structure Of The Er Alpha Ligand Binding Domain
With The Agonist Ortho-Trifluoromethylphenylvinyl
Estradiol
pdb|2Q6J|A Chain A, Crystal Structure Of Estrogen Receptor Alpha Complexed To
A B-N Substituted Ligand
pdb|2Q6J|B Chain B, Crystal Structure Of Estrogen Receptor Alpha Complexed To
A B-N Substituted Ligand
pdb|2QA6|A Chain A, Crystal Structure Of Estrogen Receptor Alpha Mutant 537s
Complexed With
4-(6-Hydroxy-1h-Indazol-3-Yl)benzene-1,3-Diol
pdb|2QA6|B Chain B, Crystal Structure Of Estrogen Receptor Alpha Mutant 537s
Complexed With
4-(6-Hydroxy-1h-Indazol-3-Yl)benzene-1,3-Diol
pdb|2QAB|A Chain A, Crystal Structure Of Estrogen Receptor Alpha Ligand
Binding Domain Mutant 537s Complexed With An Ethyl
Indazole Compound
pdb|2QAB|B Chain B, Crystal Structure Of Estrogen Receptor Alpha Ligand
Binding Domain Mutant 537s Complexed With An Ethyl
Indazole Compound
pdb|2QGT|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed To An Ether Estradiol Compound
pdb|2QGT|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed To An Ether Estradiol Compound
pdb|2QGW|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With A Chloro-Indazole Compound
pdb|2QGW|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With A Chloro-Indazole Compound
pdb|2QH6|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With An Oxabicyclic
Diarylethylene Compound
pdb|2QH6|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With An Oxabicyclic
Diarylethylene Compound
pdb|2QR9|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With An Oxabicyclic Derivative
Compound
pdb|2QR9|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With An Oxabicyclic Derivative
Compound
pdb|2QSE|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With Burned Meat Compound
4-Oh-Phip
pdb|2QSE|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With Burned Meat Compound
4-Oh-Phip
pdb|2QXM|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed To Burned Meat Compound Phip
pdb|2QXM|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed To Burned Meat Compound Phip
Length = 258
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 49 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 105
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 106 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 153
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 154 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 213
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 214 ILSHIRHMSNKGMEHLYSMK 233
>pdb|3Q95|A Chain A, Crystal Structure Of Human Estrogen Receptor Alpha Lbd In
Complex With Grip Peptide And Estriol
Length = 260
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 51 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEHPGK 107
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 108 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 155
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 156 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 215
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 216 ILSHIRHMSNKGMEHLYSMK 235
>pdb|2QZO|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With Way-169916
Length = 258
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/202 (21%), Positives = 88/202 (43%), Gaps = 43/202 (21%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 49 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEHPGK 105
Query: 171 ------CMFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGL 224
+ D C+ G V + D + ++++RF M ++L E
Sbjct: 106 LLFAPNLLLDRNQGK--CVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVC 151
Query: 225 FSSIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAEL 273
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L
Sbjct: 152 LKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQL 211
Query: 274 ISMLPDLRTLNQLHSEKLVAFQ 295
+ +L +R ++ E L + +
Sbjct: 212 LLILSHIRHMSNKGMEHLYSMK 233
>pdb|2IOK|A Chain A, Human Estrogen Receptor Alpha Ligand-binding Domain In
Complex With Compound 1d
pdb|2IOK|B Chain B, Human Estrogen Receptor Alpha Ligand-binding Domain In
Complex With Compound 1d
Length = 254
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 45 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 101
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 102 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 149
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 150 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 209
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 210 ILSHIRHMSNKGMEHLYSMK 229
>pdb|1A52|A Chain A, Estrogen Receptor Alpha Ligand-Binding Domain Complexed To
Estradiol
pdb|1A52|B Chain B, Estrogen Receptor Alpha Ligand-Binding Domain Complexed To
Estradiol
Length = 258
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 49 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 105
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 106 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 153
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 154 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHERLAQLLL 213
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 214 ILSHIRHMSNKGMEHLYSMK 233
>pdb|1ERR|A Chain A, Human Estrogen Receptor Ligand-Binding Domain In Complex
With Raloxifene
pdb|1ERR|B Chain B, Human Estrogen Receptor Ligand-Binding Domain In Complex
With Raloxifene
Length = 253
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 45 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEHPGK 101
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 102 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 149
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 150 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 209
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 210 ILSHIRHMSNKGMEHLYSMK 229
>pdb|3DT3|A Chain A, Human Estrogen Receptor Alpha Lbd With Gw368
pdb|3DT3|B Chain B, Human Estrogen Receptor Alpha Lbd With Gw368
pdb|2YJA|B Chain B, Stapled Peptides Binding To Estrogen Receptor Alpha
Length = 255
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 49 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 105
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 106 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 153
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 154 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 213
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 214 ILSHIRHMSNKGMEHLYSMK 233
>pdb|1ERE|A Chain A, Human Estrogen Receptor Ligand-Binding Domain In Complex
With 17beta-Estradiol
pdb|1ERE|B Chain B, Human Estrogen Receptor Ligand-Binding Domain In Complex
With 17beta-Estradiol
pdb|1ERE|C Chain C, Human Estrogen Receptor Ligand-Binding Domain In Complex
With 17beta-Estradiol
pdb|1ERE|D Chain D, Human Estrogen Receptor Ligand-Binding Domain In Complex
With 17beta-Estradiol
pdb|1ERE|E Chain E, Human Estrogen Receptor Ligand-Binding Domain In Complex
With 17beta-Estradiol
pdb|1ERE|F Chain F, Human Estrogen Receptor Ligand-Binding Domain In Complex
With 17beta-Estradiol
pdb|2OUZ|A Chain A, Crystal Structure Of Estrogen Receptor Alpha-Lasofoxifene
Complex
Length = 253
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 45 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 101
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 102 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 149
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 150 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 209
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 210 ILSHIRHMSNKGMEHLYSMK 229
>pdb|1SJ0|A Chain A, Human Estrogen Receptor Alpha Ligand-binding Domain In
Complex With The Antagonist Ligand 4-d
pdb|1XP1|A Chain A, Human Estrogen Receptor Alpha Ligand-binding Domain In
Complex With Compound 15
pdb|1XP6|A Chain A, Human Estrogen Receptor Alpha Ligand-binding Domain In
Complex With Compound 16
pdb|1XP9|A Chain A, Human Estrogen Receptor Alpha Ligand-binding Domain In
Complex With Compound 18
pdb|1XPC|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Compound 19
pdb|1YIM|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Compound 4
pdb|1YIN|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Compound 3f
Length = 248
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 39 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 95
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 96 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 143
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 144 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 203
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 204 ILSHIRHMSNKGMEHLYSMK 223
>pdb|2IOG|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Compound 11f
Length = 246
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 37 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 93
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 94 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 141
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 142 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 201
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 202 ILSHIRHMSNKGMEHLYSMK 221
>pdb|3VHV|A Chain A, Mineralocorticoid Receptor Ligand-Binding Domain With
Non-Steroidal Antagonist
Length = 260
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 47/187 (25%), Positives = 77/187 (41%), Gaps = 20/187 (10%)
Query: 65 LSTVVRAHLDTCAFTADKIEPMLRRAREHPTYTACPSTLACPLNPNSHPLQGQQELLQDF 124
LST+ RA + + IEP + A + L LN L G+Q +
Sbjct: 3 LSTISRALTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNR----LAGKQMI---- 54
Query: 125 SERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLN 184
VV++AK +PGF L +DQ+TL++ +L L+ TNS
Sbjct: 55 ---------QVVKWAKVLPGFKNLPLEDQITLIQYSWMSLLSFALSWRSYKHTNSQFLYF 105
Query: 185 GEVLV--RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNK 241
LV + +H S L M + + L L+ E + ++++S + GL+++
Sbjct: 106 APDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQ 165
Query: 242 ELVERMR 248
E MR
Sbjct: 166 AAFEEMR 172
>pdb|2BJ4|A Chain A, Estrogen Receptor Alpha Lbd In Complex With A
Phage-Display Derived Peptide Antagonist
pdb|2JF9|A Chain A, Estrogen Receptor Alpha Lbd In Complex With A Tamoxifen-
Specific Peptide Antagonist
pdb|2JF9|B Chain B, Estrogen Receptor Alpha Lbd In Complex With A Tamoxifen-
Specific Peptide Antagonist
pdb|2JF9|C Chain C, Estrogen Receptor Alpha Lbd In Complex With A Tamoxifen-
Specific Peptide Antagonist
pdb|2JFA|A Chain A, Estrogen Receptor Alpha Lbd In Complex With An Affinity-
Selected Corepressor Peptide
Length = 252
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 64 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 120
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 121 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 168
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 169 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 228
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 229 ILSHIRHMSNKGMEHLYSMK 248
>pdb|3UUA|A Chain A, Crystal Structure Of Hera-Lbd (Y537s) In Complex With
Bisphenol-Af
Length = 251
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 44 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEHPGK 100
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 101 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 148
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 149 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 208
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 209 ILSHIRHMSNKGMEHLYSMK 228
>pdb|3UUA|B Chain B, Crystal Structure Of Hera-Lbd (Y537s) In Complex With
Bisphenol-Af
pdb|3UUD|A Chain A, Crystal Structure Of Hera-Lbd (Y537s) In Complex With
Estradiol
Length = 251
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 44 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEHPGK 100
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 101 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 148
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 149 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 208
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 209 ILSHIRHMSNKGMEHLYSMK 228
>pdb|1XB7|A Chain A, X-Ray Structure Of Erralpha Lbd In Complex With A Pgc-
1alpha Peptide At 2.5a Resolution
Length = 247
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 32/129 (24%), Positives = 58/129 (44%)
Query: 128 FSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEV 187
F I + +AK IPGFS L DQ+++L++ EVL++ +A + + V
Sbjct: 56 FDREIVVTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLPLQDELAFAEDLV 115
Query: 188 LVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
L + ++ L ++ RL L L E L ++ + + + + E VE++
Sbjct: 116 LDEEGARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANSDSVHIEDAEAVEQL 175
Query: 248 RGKLENMLM 256
R L L+
Sbjct: 176 REALHEALL 184
>pdb|3UUC|A Chain A, Crystal Structure Of Hera-Lbd (Wt) In Complex With
Bisphenol-C
pdb|3UUC|B Chain B, Crystal Structure Of Hera-Lbd (Wt) In Complex With
Bisphenol-C
pdb|3UUC|C Chain C, Crystal Structure Of Hera-Lbd (Wt) In Complex With
Bisphenol-C
pdb|3UUC|D Chain D, Crystal Structure Of Hera-Lbd (Wt) In Complex With
Bisphenol-C
Length = 251
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 44 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEHPGK 100
Query: 171 CMFDSQT----NSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFS 226
+F N C+ G V + D + ++++RF M ++L E
Sbjct: 101 LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLK 148
Query: 227 SIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELIS 275
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L+
Sbjct: 149 SIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLL 208
Query: 276 MLPDLRTLNQLHSEKLVAFQ 295
+L +R ++ E L + +
Sbjct: 209 ILSHIRHMSNKGMEHLYSMK 228
>pdb|3L03|A Chain A, Crystal Structure Of Human Estrogen Receptor Alpha
Ligand-Binding Domain In Complex With A Glucocorticoid
Receptor Interacting Protein 1 Nr Box Ii Peptide And
Estetrol (Estra-1,3,5(10)-Triene-3,15 Alpha,
16alpha,17beta-Tetrol)
pdb|3L03|B Chain B, Crystal Structure Of Human Estrogen Receptor Alpha
Ligand-Binding Domain In Complex With A Glucocorticoid
Receptor Interacting Protein 1 Nr Box Ii Peptide And
Estetrol (Estra-1,3,5(10)-Triene-3,15 Alpha,
16alpha,17beta-Tetrol)
Length = 253
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 81/187 (43%), Gaps = 40/187 (21%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA---------------CMFDSQTNS 179
++ +AKR+PGF L DQV LL+ E+L++ L + D
Sbjct: 60 MINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGK 119
Query: 180 MICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVV--------I 231
C+ G V + D + ++++RF M ++L E SI++ +
Sbjct: 120 --CVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLKSIILLNSGVYTFL 165
Query: 232 SPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLHS 288
S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 166 SSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGM 225
Query: 289 EKLVAFQ 295
E L + +
Sbjct: 226 EHLYSMK 232
>pdb|1GWQ|A Chain A, Human Oestrogen Receptor Alpha Ligand-Binding Domain In
Complex With Raloxifene Core And Tif2 Nrbox2 Peptide
pdb|1GWQ|B Chain B, Human Oestrogen Receptor Alpha Ligand-Binding Domain In
Complex With Raloxifene Core And Tif2 Nrbox2 Peptide
Length = 248
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 81/187 (43%), Gaps = 40/187 (21%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA---------------CMFDSQTNS 179
++ +AKR+PGF L DQV LL+ E+L++ L + D
Sbjct: 57 MINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGK 116
Query: 180 MICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVV--------I 231
C+ G V + D + ++++RF M ++L E SI++ +
Sbjct: 117 --CVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLKSIILLNSGVYTFL 162
Query: 232 SPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLHS 288
S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 163 SSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGM 222
Query: 289 EKLVAFQ 295
E L + +
Sbjct: 223 EHLYSMK 229
>pdb|3K6P|A Chain A, Estrogen Related Receptor Alpha In Complex With An Ether
Based Ligand
Length = 248
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 32/129 (24%), Positives = 58/129 (44%)
Query: 128 FSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEV 187
F I + +AK IPGFS L DQ+++L++ EVL++ +A + + V
Sbjct: 57 FDREIVVTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLPLQDELAFAEDLV 116
Query: 188 LVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERM 247
L + ++ L ++ RL L L E L ++ + + + + E VE++
Sbjct: 117 LDEEGARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANSDSVHIEDAEAVEQL 176
Query: 248 RGKLENMLM 256
R L L+
Sbjct: 177 REALHEALL 185
>pdb|3HLV|A Chain A, Crystal Structure Of Human Estrogen Receptor Alpha
Ligand-Bi Domain In Complex With A Glucocorticoid
Receptor Interactin 1 Nr Box Ii Peptide And
16-Alpha-Hydroxy-Estrone ((8s,9r,13
16r)-3,16-Dihydroxy-13-Methyl-7,8,9,11,12,14,15,
16-Octahyd Cyclopenta[a]phenanthren-17-One
pdb|3HLV|B Chain B, Crystal Structure Of Human Estrogen Receptor Alpha
Ligand-Bi Domain In Complex With A Glucocorticoid
Receptor Interactin 1 Nr Box Ii Peptide And
16-Alpha-Hydroxy-Estrone ((8s,9r,13
16r)-3,16-Dihydroxy-13-Methyl-7,8,9,11,12,14,15,
16-Octahyd Cyclopenta[a]phenanthren-17-One
Length = 253
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/202 (21%), Positives = 88/202 (43%), Gaps = 43/202 (21%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 48 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 104
Query: 171 ------CMFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGL 224
+ D C+ G V + D + ++++RF M ++L E
Sbjct: 105 LLFAPNLLLDRNQGK--CVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVC 150
Query: 225 FSSIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAEL 273
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L
Sbjct: 151 LKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQL 210
Query: 274 ISMLPDLRTLNQLHSEKLVAFQ 295
+ +L +R ++ E L + +
Sbjct: 211 LLILSHIRHMSNKGMEHLYSMK 232
>pdb|1QKU|A Chain A, Wild Type Estrogen Nuclear Receptor Ligand Binding Domain
Complexed With Estradiol
pdb|1QKU|B Chain B, Wild Type Estrogen Nuclear Receptor Ligand Binding Domain
Complexed With Estradiol
pdb|1QKU|C Chain C, Wild Type Estrogen Nuclear Receptor Ligand Binding Domain
Complexed With Estradiol
Length = 250
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 44/202 (21%), Positives = 88/202 (43%), Gaps = 43/202 (21%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 45 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 101
Query: 171 ------CMFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGL 224
+ D C+ G V + D + ++++RF M ++L E
Sbjct: 102 LLFAPNLLLDRNQGK--CVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVC 147
Query: 225 FSSIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAEL 273
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L
Sbjct: 148 LKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQL 207
Query: 274 ISMLPDLRTLNQLHSEKLVAFQ 295
+ +L +R ++ E L + +
Sbjct: 208 LLILSHIRHMSNKGMEHLYSMK 229
>pdb|1UOM|A Chain A, The Structure Of Estrogen Receptor In Complex With A
Selective And Potent Tetrahydroisochiolin Ligand.
pdb|1XQC|A Chain A, X-Ray Structure Of Eralpha Lbd Bound To A
Tetrahydroisoquinoline Serm Ligand At 2.05a Resolution
pdb|1XQC|B Chain B, X-Ray Structure Of Eralpha Lbd Bound To A
Tetrahydroisoquinoline Serm Ligand At 2.05a Resolution
pdb|1XQC|C Chain C, X-Ray Structure Of Eralpha Lbd Bound To A
Tetrahydroisoquinoline Serm Ligand At 2.05a Resolution
pdb|1XQC|D Chain D, X-Ray Structure Of Eralpha Lbd Bound To A
Tetrahydroisoquinoline Serm Ligand At 2.05a Resolution
Length = 254
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 41/188 (21%), Positives = 85/188 (45%), Gaps = 15/188 (7%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
LL + ++R + ++ +AKR+PGF L DQV LL++ E+L++ L
Sbjct: 46 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGK 102
Query: 180 MICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVV-------- 230
++ +L R+ S + D + + R ++L E SI++
Sbjct: 103 LLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTF 162
Query: 231 ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLH 287
+S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 163 LSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKG 222
Query: 288 SEKLVAFQ 295
E L + +
Sbjct: 223 MEHLYSMK 230
>pdb|1YUC|A Chain A, Human Nuclear Receptor Liver Receptor Homologue-1, Lrh-1,
Bound To Phospholipid And A Fragment Of Human Shp
pdb|1YUC|B Chain B, Human Nuclear Receptor Liver Receptor Homologue-1, Lrh-1,
Bound To Phospholipid And A Fragment Of Human Shp
pdb|4DOR|A Chain A, Human Nuclear Receptor Liver Receptor Homologue-1, Lrh-1,
In Its Apo State Bound To A Fragment Of Human Shp Box1
pdb|4DOR|B Chain B, Human Nuclear Receptor Liver Receptor Homologue-1, Lrh-1,
In Its Apo State Bound To A Fragment Of Human Shp Box1
Length = 255
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 41/167 (24%), Positives = 78/167 (46%), Gaps = 7/167 (4%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVR--LACMFDSQTNSMICLNGEVL 188
T+ +VE+A+ F L DDQ+ LL+ E+L++ + + S+ + G+
Sbjct: 66 TLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQ- 124
Query: 189 VRDSIHSSNARFLMDSMFDFAE----RLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELV 244
V SI +S A ++++ A+ +L L E +V+ S L N +LV
Sbjct: 125 VDYSIIASQAGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFSLDVKNLENFQLV 184
Query: 245 ERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKL 291
E ++ ++ L+ N+P+Q +L+ LP++R ++ E L
Sbjct: 185 EGVQEQVNAALLDYTMCNYPQQTEKFGQLLLRLPEIRAISMQAEEYL 231
>pdb|4DMA|A Chain A, Crystal Structure Of Era Lbd In Complex With Ru100132
pdb|4DMA|B Chain B, Crystal Structure Of Era Lbd In Complex With Ru100132
Length = 247
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 81/187 (43%), Gaps = 40/187 (21%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA---------------CMFDSQTNS 179
++ +AKR+PGF L DQV LL+ E+L++ L + D
Sbjct: 55 MINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGK 114
Query: 180 MICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVV--------I 231
C+ G V + D + ++++RF M ++L E SI++ +
Sbjct: 115 --CVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLKSIILLNSGVYTFL 160
Query: 232 SPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLHS 288
S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 161 SSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGM 220
Query: 289 EKLVAFQ 295
E L + +
Sbjct: 221 EHLYSMK 227
>pdb|2OCF|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Estradiol And The E2#23 Fn3 Monobody
Length = 298
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 40/188 (21%), Positives = 83/188 (44%), Gaps = 15/188 (7%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 48 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEHPGK 104
Query: 180 MICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVV-------- 230
++ +L R+ + D + + R ++L E SI++
Sbjct: 105 LLFAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTF 164
Query: 231 ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLH 287
+S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 165 LSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKG 224
Query: 288 SEKLVAFQ 295
E L + +
Sbjct: 225 MEHLYSMK 232
>pdb|1ZDU|A Chain A, The Crystal Structure Of Human Liver Receptor Homologue-1
Length = 245
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 41/167 (24%), Positives = 78/167 (46%), Gaps = 7/167 (4%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVR--LACMFDSQTNSMICLNGEVL 188
T+ +VE+A+ F L DDQ+ LL+ E+L++ + + S+ + G+
Sbjct: 56 TLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQ- 114
Query: 189 VRDSIHSSNARFLMDSMFDFAE----RLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELV 244
V SI +S A ++++ A+ +L L E +V+ S L N +LV
Sbjct: 115 VDYSIIASQAGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFSLDVKNLENFQLV 174
Query: 245 ERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKL 291
E ++ ++ L+ N+P+Q +L+ LP++R ++ E L
Sbjct: 175 EGVQEQVNAALLDYTMCNYPQQTEKFGQLLLRLPEIRAISMQAEEYL 221
>pdb|1G50|A Chain A, Crystal Structure Of A Wild Type Her Alpha Lbd At 2.9
Angstrom Resolution
pdb|1G50|B Chain B, Crystal Structure Of A Wild Type Her Alpha Lbd At 2.9
Angstrom Resolution
pdb|1G50|C Chain C, Crystal Structure Of A Wild Type Her Alpha Lbd At 2.9
Angstrom Resolution
Length = 247
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 44/202 (21%), Positives = 88/202 (43%), Gaps = 43/202 (21%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA--------- 170
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 42 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 98
Query: 171 ------CMFDSQTNSMICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGL 224
+ D C+ G V + D + ++++RF M ++L E
Sbjct: 99 LLFAPNLLLDRNQGK--CVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVC 144
Query: 225 FSSIVV--------ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAEL 273
SI++ +S + L K+ + R+ K+ + L+H++ + +Q A+L
Sbjct: 145 LKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQL 204
Query: 274 ISMLPDLRTLNQLHSEKLVAFQ 295
+ +L +R ++ E L + +
Sbjct: 205 LLILSHIRHMSNKGMEHLYSMK 226
>pdb|1GWR|A Chain A, Human Oestrogen Receptor Alpha Ligand-Binding Domain In
Complex With 17beta-Oestradiol And Tif2 Nrbox3 Peptide
pdb|1GWR|B Chain B, Human Oestrogen Receptor Alpha Ligand-Binding Domain In
Complex With 17beta-Oestradiol And Tif2 Nrbox3 Peptide
Length = 245
Score = 39.7 bits (91), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 81/187 (43%), Gaps = 40/187 (21%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA---------------CMFDSQTNS 179
++ +AKR+PGF L DQV LL+ E+L++ L + D
Sbjct: 53 MINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGK 112
Query: 180 MICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVV--------I 231
C+ G V + D + ++++RF M ++L E SI++ +
Sbjct: 113 --CVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLKSIILLNSGVYTFL 158
Query: 232 SPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLHS 288
S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 159 SSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGM 218
Query: 289 EKLVAFQ 295
E L + +
Sbjct: 219 EHLYSMK 225
>pdb|3OS8|A Chain A, Estrogen Receptor
pdb|3OS8|B Chain B, Estrogen Receptor
Length = 258
Score = 39.7 bits (91), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 40/188 (21%), Positives = 83/188 (44%), Gaps = 15/188 (7%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 50 LLTNLADR---ELVHMINWAKRVPGFVDLTRHDQVHLLECAWLEILMIGLVWRSMEHPGK 106
Query: 180 MICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVV-------- 230
++ +L R+ + D + + R ++L E SI++
Sbjct: 107 LLFAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTF 166
Query: 231 ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLH 287
+S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 167 LSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKG 226
Query: 288 SEKLVAFQ 295
E L + +
Sbjct: 227 MEHLYSMK 234
>pdb|1X7E|A Chain A, Crystal Structure Of Estrogen Receptor Alpha Complexed
With Way-244
pdb|1X7E|B Chain B, Crystal Structure Of Estrogen Receptor Alpha Complexed
With Way-244
pdb|1X7R|A Chain A, Crystal Structure Of Estrogen Receptor Alpha Complexed
With Genistein
Length = 245
Score = 39.7 bits (91), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 81/187 (43%), Gaps = 40/187 (21%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLA---------------CMFDSQTNS 179
++ +AKR+PGF L DQV LL+ E+L++ L + D
Sbjct: 53 MINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPVKLLFAPNLLLDRNQGK 112
Query: 180 MICLNGEVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVV--------I 231
C+ G V + D + ++++RF M ++L E SI++ +
Sbjct: 113 --CVEGMVEIFDMLLATSSRFRM------------MNLQGEEFVCLKSIILLNSGVYTFL 158
Query: 232 SPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLHS 288
S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 159 SSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGM 218
Query: 289 EKLVAFQ 295
E L + +
Sbjct: 219 EHLYSMK 225
>pdb|2YAT|A Chain A, Crystal Structure Of Estradiol Derived Metal Chelate And
Estrogen Receptor-Ligand Binding Domain Complex
Length = 252
Score = 39.3 bits (90), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 41/188 (21%), Positives = 85/188 (45%), Gaps = 15/188 (7%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
LL + ++R + ++ +AKR+PGF L DQV LL++ E+L++ L
Sbjct: 46 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGK 102
Query: 180 MICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVV-------- 230
++ +L R+ S + D + + R ++L E SI++
Sbjct: 103 LLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTF 162
Query: 231 ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLH 287
+S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 163 LSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKG 222
Query: 288 SEKLVAFQ 295
E L + +
Sbjct: 223 MEHLYSMK 230
>pdb|3PLZ|A Chain A, Human Lrh1 Lbd Bound To Gr470
pdb|3PLZ|B Chain B, Human Lrh1 Lbd Bound To Gr470
Length = 257
Score = 39.3 bits (90), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 41/167 (24%), Positives = 78/167 (46%), Gaps = 7/167 (4%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVR--LACMFDSQTNSMICLNGEVL 188
T+ +VE+A+ F L DDQ+ LL+ E+L++ + + S+ + G+
Sbjct: 68 TLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQ- 126
Query: 189 VRDSIHSSNARFLMDSMFDFAE----RLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELV 244
V SI +S A ++++ A+ +L L E +V+ S L N +LV
Sbjct: 127 VDYSIIASQAGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFSLDVKNLENFQLV 186
Query: 245 ERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKL 291
E ++ ++ L+ N+P+Q +L+ LP++R ++ E L
Sbjct: 187 EGVQEQVNAALLDYTMCNYPQQTEKFGQLLLRLPEIRAISMQAEEYL 233
>pdb|1YOK|A Chain A, Crystal Structure Of Human Lrh-1 Bound With Tif-2 Peptide
And Phosphatidylglycerol
Length = 256
Score = 39.3 bits (90), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 41/167 (24%), Positives = 78/167 (46%), Gaps = 7/167 (4%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVR--LACMFDSQTNSMICLNGEVL 188
T+ +VE+A+ F L DDQ+ LL+ E+L++ + + S+ + G+
Sbjct: 67 TLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQ- 125
Query: 189 VRDSIHSSNARFLMDSMFDFAE----RLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELV 244
V SI +S A ++++ A+ +L L E +V+ S L N +LV
Sbjct: 126 VDYSIIASQAGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFSLDVKNLENFQLV 185
Query: 245 ERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKL 291
E ++ ++ L+ N+P+Q +L+ LP++R ++ E L
Sbjct: 186 EGVQEQVNAALLDYTMCNYPQQTEKFGQLLLRLPEIRAISMQAEEYL 232
>pdb|1Y9R|A Chain A, Crystal Structure Of The Human Mineralocorticoid Receptor
Ligand-Binding Domain Bound To Deoxycorticosterone And
Harboring The S810l Mutation Responsible For A Severe
Form Of Hypertension
pdb|1Y9R|B Chain B, Crystal Structure Of The Human Mineralocorticoid Receptor
Ligand-Binding Domain Bound To Deoxycorticosterone And
Harboring The S810l Mutation Responsible For A Severe
Form Of Hypertension
pdb|1YA3|A Chain A, Crystal Structure Of The Human Mineralocorticoid Receptor
Ligand-Binding Domain Bound To Progesterone And
Harboring The S810l Mutation Responsible For A Severe
Form Of Hypertension
pdb|1YA3|B Chain B, Crystal Structure Of The Human Mineralocorticoid Receptor
Ligand-Binding Domain Bound To Progesterone And
Harboring The S810l Mutation Responsible For A Severe
Form Of Hypertension
pdb|1YA3|C Chain C, Crystal Structure Of The Human Mineralocorticoid Receptor
Ligand-Binding Domain Bound To Progesterone And
Harboring The S810l Mutation Responsible For A Severe
Form Of Hypertension
Length = 255
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 32/117 (27%), Positives = 55/117 (47%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV--RDS 192
VV++AK +PGF L +DQ+TL++ +L L+ TNS LV +
Sbjct: 51 VVKWAKVLPGFKNLPLEDQITLIQYSWMCLLSFALSWRSYKHTNSQFLYFAPDLVFNEEK 110
Query: 193 IHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+H S L M + + L L+ E + ++++S + GL+++ E MR
Sbjct: 111 MHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMR 167
>pdb|3MNO|A Chain A, Crystal Structure Of The Agonist Form Of Mouse
Glucocorticoid Receptor Stabilized By (A611v, F608s)
Mutations At 1.55a
Length = 261
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 29/122 (23%), Positives = 61/122 (50%), Gaps = 15/122 (12%)
Query: 136 VEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACM-FDSQTNSMICLNGEVLVRDSIH 194
V++AK IPGF L DDQ+TLL+ +++ L + + +++C ++++ +
Sbjct: 59 VKWAKAIPGFRNLHLDDQMTLLQYSWMSLMVFALGWRSYRQASGNLLCFAPDLIINEQ-- 116
Query: 195 SSNARFLMDSMFD-------FAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVER 246
R + M+D + L L +S E +++++S + GL+++EL +
Sbjct: 117 ----RMTLPCMYDQCKHMLFISTELQRLQVSYEEYLCMKTLLLLSSVPKEGLKSQELFDE 172
Query: 247 MR 248
+R
Sbjct: 173 IR 174
>pdb|1QKT|A Chain A, Mutant Estrogen Nuclear Receptor Ligand Binding Domain
Complexed With Estradiol
pdb|2AYR|A Chain A, A Serm Designed For The Treatment Of Uterine Leiomyoma
With Unique Tissue Specificity For Uterus And Ovaries In
Rats
pdb|2Q70|A Chain A, Estrogen Receptor Alpha Ligand-Binding Domain Complxed To
A Benzopyran Ligand
pdb|2Q70|B Chain B, Estrogen Receptor Alpha Ligand-Binding Domain Complxed To
A Benzopyran Ligand
pdb|2POG|A Chain A, Benzopyrans As Selective Estrogen Receptor B Agonists
(Serbas). Part 2: Structure Activity Relationship
Studies On The Benzopyran Scaffold.
pdb|2POG|B Chain B, Benzopyrans As Selective Estrogen Receptor B Agonists
(Serbas). Part 2: Structure Activity Relationship
Studies On The Benzopyran Scaffold.
pdb|2QE4|A Chain A, Estrogen Receptor Alpha Ligand-Binding Domain In Complex
With A Benzopyran Agonist
pdb|2QE4|B Chain B, Estrogen Receptor Alpha Ligand-Binding Domain In Complex
With A Benzopyran Agonist
pdb|2R6W|A Chain A, Estrogen Receptor Alpha Ligand-Binding Domain Complexed To
A Serm
pdb|2R6W|B Chain B, Estrogen Receptor Alpha Ligand-Binding Domain Complexed To
A Serm
pdb|2R6Y|A Chain A, Estrogen Receptor Alpha Ligand-Binding Domain In Complex
With A Serm
pdb|2R6Y|B Chain B, Estrogen Receptor Alpha Ligand-Binding Domain In Complex
With A Serm
Length = 248
Score = 38.9 bits (89), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 78/173 (45%), Gaps = 12/173 (6%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
++ +AKR+PGF L DQV LL++ E+L++ L ++ +L R+
Sbjct: 54 MINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGK 113
Query: 195 SSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVV--------ISPSRSGLRNKELVE 245
S + D + + R ++L E SI++ +S + L K+ +
Sbjct: 114 SVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIH 173
Query: 246 RMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQ 295
R+ K+ + L+H++ + +Q A+L+ +L +R ++ E L + +
Sbjct: 174 RVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMK 226
>pdb|4DOS|A Chain A, Human Nuclear Receptor Liver Receptor Homologue-1, Lrh-1,
Bound To Dlpc And A Fragment Of Tif-2
Length = 242
Score = 38.9 bits (89), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 41/167 (24%), Positives = 78/167 (46%), Gaps = 7/167 (4%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVR--LACMFDSQTNSMICLNGEVL 188
T+ +VE+A+ F L DDQ+ LL+ E+L++ + + S+ + G+
Sbjct: 56 TLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQ- 114
Query: 189 VRDSIHSSNARFLMDSMFDFAE----RLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELV 244
V SI +S A ++++ A+ +L L E +V+ S L N +LV
Sbjct: 115 VDYSIIASQAGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFSLDVKNLENFQLV 174
Query: 245 ERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQLHSEKL 291
E ++ ++ L+ N+P+Q +L+ LP++R ++ E L
Sbjct: 175 EGVQEQVNAALLDYTMCNYPQQTEKFGQLLLRLPEIRAISMQAEEYL 221
>pdb|2OAX|A Chain A, Crystal Structure Of The S810l Mutant Mineralocorticoid
Receptor Associated With Sc9420
pdb|2OAX|B Chain B, Crystal Structure Of The S810l Mutant Mineralocorticoid
Receptor Associated With Sc9420
pdb|2OAX|C Chain C, Crystal Structure Of The S810l Mutant Mineralocorticoid
Receptor Associated With Sc9420
pdb|2OAX|D Chain D, Crystal Structure Of The S810l Mutant Mineralocorticoid
Receptor Associated With Sc9420
pdb|2OAX|E Chain E, Crystal Structure Of The S810l Mutant Mineralocorticoid
Receptor Associated With Sc9420
pdb|2OAX|F Chain F, Crystal Structure Of The S810l Mutant Mineralocorticoid
Receptor Associated With Sc9420
Length = 256
Score = 38.9 bits (89), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 32/117 (27%), Positives = 55/117 (47%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV--RDS 192
VV++AK +PGF L +DQ+TL++ +L L+ TNS LV +
Sbjct: 52 VVKWAKVLPGFKNLPLEDQITLIQYSWMCLLSFALSWRSYKHTNSQFLYFAPDLVFNEEK 111
Query: 193 IHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+H S L M + + L L+ E + ++++S + GL+++ E MR
Sbjct: 112 MHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMR 168
>pdb|1PCG|A Chain A, Helix-Stabilized Cyclic Peptides As Selective Inhibitors
Of Steroid Receptor-Coactivator Interactions
pdb|1PCG|B Chain B, Helix-Stabilized Cyclic Peptides As Selective Inhibitors
Of Steroid Receptor-Coactivator Interactions
pdb|2I0J|A Chain A, Benzopyrans Are Selective Estrogen Receptor Beta Agonists
(Serbas) With Novel Activity In Models Of Benign
Prostatic Hyperplasia
pdb|2I0J|B Chain B, Benzopyrans Are Selective Estrogen Receptor Beta Agonists
(Serbas) With Novel Activity In Models Of Benign
Prostatic Hyperplasia
pdb|2I0J|C Chain C, Benzopyrans Are Selective Estrogen Receptor Beta Agonists
(Serbas) With Novel Activity In Models Of Benign
Prostatic Hyperplasia
pdb|2I0J|D Chain D, Benzopyrans Are Selective Estrogen Receptor Beta Agonists
(Serbas) With Novel Activity In Models Of Benign
Prostatic Hyperplasia
Length = 244
Score = 38.9 bits (89), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 78/173 (45%), Gaps = 12/173 (6%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
++ +AKR+PGF L DQV LL++ E+L++ L ++ +L R+
Sbjct: 54 MINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGK 113
Query: 195 SSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVV--------ISPSRSGLRNKELVE 245
S + D + + R ++L E SI++ +S + L K+ +
Sbjct: 114 SVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIH 173
Query: 246 RMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQ 295
R+ K+ + L+H++ + +Q A+L+ +L +R ++ E L + +
Sbjct: 174 RVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMK 226
>pdb|1PK5|A Chain A, Crystal Structure Of The Orphan Nuclear Receptor Lrh-1
pdb|1PK5|B Chain B, Crystal Structure Of The Orphan Nuclear Receptor Lrh-1
pdb|3F5C|A Chain A, Structure Of Dax-1:lrh-1 Complex
Length = 248
Score = 38.9 bits (89), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 38/161 (23%), Positives = 75/161 (46%), Gaps = 7/161 (4%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVR--LACMFDSQTNSMICLNGEVL 188
T+ +VE+A+ F L DDQ+ LL+ E+L++ + + ++ + GE +
Sbjct: 59 TLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVAHGKEGTIFLVTGEHV 118
Query: 189 VRDSIHSSNARFLMDSMFDFAE----RLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELV 244
+I S+ +++ A+ RL L E +V+ S L N +LV
Sbjct: 119 DYSTI-ISHTEVAFNNLLSLAQELVVRLRSLQFDQREFVCLKFLVLFSSDVKNLENLQLV 177
Query: 245 ERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
E ++ ++ L+ N+P+Q +L+ LP+LR +++
Sbjct: 178 EGVQEQVNAALLDYTVCNYPQQTEKFGQLLLRLPELRAISK 218
>pdb|2AA2|A Chain A, Mineralocorticoid Receptor With Bound Aldosterone
pdb|2AA5|A Chain A, Mineralocorticoid Receptor With Bound Progesterone
pdb|2AA5|B Chain B, Mineralocorticoid Receptor With Bound Progesterone
pdb|2AA7|A Chain A, Mineralocorticoid Receptor With Bound Deoxycorticosterone
Length = 275
Score = 38.9 bits (89), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 46/187 (24%), Positives = 76/187 (40%), Gaps = 20/187 (10%)
Query: 65 LSTVVRAHLDTCAFTADKIEPMLRRAREHPTYTACPSTLACPLNPNSHPLQGQQELLQDF 124
LST+ RA + + IEP + A + L LN L G+Q +
Sbjct: 18 LSTISRALTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNR----LAGKQMI---- 69
Query: 125 SERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLN 184
VV++AK +PGF L +DQ+TL++ + L+ TNS
Sbjct: 70 ---------QVVKWAKVLPGFKNLPLEDQITLIQYSWMSLSSFALSWRSYKHTNSQFLYF 120
Query: 185 GEVLV--RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISP-SRSGLRNK 241
LV + +H S L M + + L L+ E + ++++S + GL+++
Sbjct: 121 APDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQ 180
Query: 242 ELVERMR 248
E MR
Sbjct: 181 AAFEEMR 187
>pdb|1NHZ|A Chain A, Crystal Structure Of The Antagonist Form Of Glucocorticoid
Receptor
pdb|1P93|A Chain A, Crystal Structure Of The Agonist Form Of Glucocorticoid
Receptor
pdb|1P93|B Chain B, Crystal Structure Of The Agonist Form Of Glucocorticoid
Receptor
pdb|1P93|C Chain C, Crystal Structure Of The Agonist Form Of Glucocorticoid
Receptor
pdb|1P93|D Chain D, Crystal Structure Of The Agonist Form Of Glucocorticoid
Receptor
Length = 280
Score = 38.5 bits (88), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 30/122 (24%), Positives = 62/122 (50%), Gaps = 15/122 (12%)
Query: 136 VEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS-MICLNGEVLVRDSIH 194
V++AK IPGF L DDQ+TLL+ ++ L Q+++ ++C ++++ +
Sbjct: 78 VKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQSSANLLCFAPDLIINEQ-- 135
Query: 195 SSNARFLMDSMFD-------FAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVER 246
R + M+D + L+ L +S E +++++S + GL+++EL +
Sbjct: 136 ----RMTLPDMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDE 191
Query: 247 MR 248
+R
Sbjct: 192 IR 193
>pdb|3MNP|A Chain A, Crystal Structure Of The Agonist Form Of Mouse
Glucocorticoid Receptor Stabilized By (A611v, V708a,
E711g) Mutations At 1.50a
Length = 261
Score = 38.1 bits (87), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 29/122 (23%), Positives = 61/122 (50%), Gaps = 15/122 (12%)
Query: 136 VEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACM-FDSQTNSMICLNGEVLVRDSIH 194
V++AK IPGF L DDQ+TLL+ +++ L + + +++C ++++ +
Sbjct: 59 VKWAKAIPGFRNLHLDDQMTLLQYSWMFLMVFALGWRSYRQASGNLLCFAPDLIINEQ-- 116
Query: 195 SSNARFLMDSMFD-------FAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVER 246
R + M+D + L L +S E +++++S + GL+++EL +
Sbjct: 117 ----RMTLPCMYDQCKHMLFISTELQRLQVSYEEYLCMKTLLLLSSVPKEGLKSQELFDE 172
Query: 247 MR 248
+R
Sbjct: 173 IR 174
>pdb|3Q95|B Chain B, Crystal Structure Of Human Estrogen Receptor Alpha Lbd In
Complex With Grip Peptide And Estriol
pdb|3Q97|B Chain B, Crystal Structure Of Human Estrogen Receptor Alpha Lbd In
Complex With Grip Peptide And Two Isomers Of Ethoxy
Triphenylethylene
Length = 260
Score = 38.1 bits (87), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 40/188 (21%), Positives = 83/188 (44%), Gaps = 15/188 (7%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 51 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEHPGK 107
Query: 180 MICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVV-------- 230
++ +L R+ + D + + R ++L E SI++
Sbjct: 108 LLFAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTF 167
Query: 231 ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLH 287
+S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 168 LSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKG 227
Query: 288 SEKLVAFQ 295
E L + +
Sbjct: 228 MEHLYSMK 235
>pdb|1L2I|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With (R,R)-5,11-Cis-Diethyl-5,6,11,12-
Tetrahydrochrysene-2,8-Diol And A Glucocorticoid
Receptor Interacting Protein 1 Nr Box Ii Peptide
pdb|1L2I|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With (R,R)-5,11-Cis-Diethyl-5,6,11,12-
Tetrahydrochrysene-2,8-Diol And A Glucocorticoid
Receptor Interacting Protein 1 Nr Box Ii Peptide
Length = 261
Score = 38.1 bits (87), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 40/188 (21%), Positives = 83/188 (44%), Gaps = 15/188 (7%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 52 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 108
Query: 180 MICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVV-------- 230
++ +L R+ + D + + R ++L E SI++
Sbjct: 109 LLFAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTF 168
Query: 231 ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLH 287
+S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 169 LSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKG 228
Query: 288 SEKLVAFQ 295
E L + +
Sbjct: 229 MEHLYSMK 236
>pdb|3Q97|A Chain A, Crystal Structure Of Human Estrogen Receptor Alpha Lbd In
Complex With Grip Peptide And Two Isomers Of Ethoxy
Triphenylethylene
Length = 260
Score = 38.1 bits (87), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 40/188 (21%), Positives = 83/188 (44%), Gaps = 15/188 (7%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 51 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEHPGK 107
Query: 180 MICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVV-------- 230
++ +L R+ + D + + R ++L E SI++
Sbjct: 108 LLFAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTF 167
Query: 231 ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLH 287
+S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 168 LSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKG 227
Query: 288 SEKLVAFQ 295
E L + +
Sbjct: 228 MEHLYSMK 235
>pdb|3MNE|A Chain A, Crystal Structure Of The Agonist Form Of Mouse
Glucocorticoid Receptor Stabilized By F608s Mutation At
1.96a
Length = 261
Score = 38.1 bits (87), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 29/122 (23%), Positives = 60/122 (49%), Gaps = 15/122 (12%)
Query: 136 VEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACM-FDSQTNSMICLNGEVLVRDSIH 194
V++AK IPGF L DDQ+TLL+ ++ L + + +++C ++++ +
Sbjct: 59 VKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQASGNLLCFAPDLIINEQ-- 116
Query: 195 SSNARFLMDSMFD-------FAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVER 246
R + M+D + L L +S E +++++S + GL+++EL +
Sbjct: 117 ----RMTLPCMYDQCKHMLFISTELQRLQVSYEEYLCMKTLLLLSSVPKEGLKSQELFDE 172
Query: 247 MR 248
+R
Sbjct: 173 IR 174
>pdb|3E7C|A Chain A, Glucocorticoid Receptor Lbd Bound To Gsk866
pdb|3E7C|B Chain B, Glucocorticoid Receptor Lbd Bound To Gsk866
Length = 257
Score = 38.1 bits (87), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 30/122 (24%), Positives = 62/122 (50%), Gaps = 15/122 (12%)
Query: 136 VEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS-MICLNGEVLVRDSIH 194
V++AK IPGF L DDQ+TLL+ ++ L Q+++ ++C ++++ +
Sbjct: 55 VKWAKAIPGFRNLHLDDQMTLLQYSWMYLMAFALGWRSYRQSSANLLCFAPDLIINEQ-- 112
Query: 195 SSNARFLMDSMFD-------FAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVER 246
R + M+D + L+ L +S E +++++S + GL+++EL +
Sbjct: 113 ----RMTLPGMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDE 168
Query: 247 MR 248
+R
Sbjct: 169 IR 170
>pdb|3CLD|A Chain A, Ligand Binding Domain Of The Glucocorticoid Receptor
Complexed With Fluticazone Furoate
pdb|3CLD|B Chain B, Ligand Binding Domain Of The Glucocorticoid Receptor
Complexed With Fluticazone Furoate
pdb|3K23|A Chain A, Glucocorticoid Receptor With Bound D-Prolinamide 11
pdb|3K23|B Chain B, Glucocorticoid Receptor With Bound D-Prolinamide 11
pdb|3K23|C Chain C, Glucocorticoid Receptor With Bound D-Prolinamide 11
pdb|3K22|A Chain A, Glucocorticoid Receptor With Bound Alaninamide 10 With
Tif2 Peptide
pdb|3K22|B Chain B, Glucocorticoid Receptor With Bound Alaninamide 10 With
Tif2 Peptide
Length = 259
Score = 38.1 bits (87), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 30/122 (24%), Positives = 62/122 (50%), Gaps = 15/122 (12%)
Query: 136 VEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS-MICLNGEVLVRDSIH 194
V++AK IPGF L DDQ+TLL+ ++ L Q+++ ++C ++++ +
Sbjct: 57 VKWAKAIPGFRNLHLDDQMTLLQYSWMYLMAFALGWRSYRQSSANLLCFAPDLIINEQ-- 114
Query: 195 SSNARFLMDSMFD-------FAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVER 246
R + M+D + L+ L +S E +++++S + GL+++EL +
Sbjct: 115 ----RMTLPGMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDE 170
Query: 247 MR 248
+R
Sbjct: 171 IR 172
>pdb|1M2Z|A Chain A, Crystal Structure Of A Dimer Complex Of The Human
Glucocorticoid Receptor Ligand-Binding Domain Bound To
Dexamethasone And A Tif2 Coactivator Motif
pdb|1M2Z|D Chain D, Crystal Structure Of A Dimer Complex Of The Human
Glucocorticoid Receptor Ligand-Binding Domain Bound To
Dexamethasone And A Tif2 Coactivator Motif
Length = 257
Score = 37.7 bits (86), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 30/122 (24%), Positives = 62/122 (50%), Gaps = 15/122 (12%)
Query: 136 VEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS-MICLNGEVLVRDSIH 194
V++AK IPGF L DDQ+TLL+ ++ L Q+++ ++C ++++ +
Sbjct: 55 VKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQSSANLLCFAPDLIINEQ-- 112
Query: 195 SSNARFLMDSMFD-------FAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVER 246
R + M+D + L+ L +S E +++++S + GL+++EL +
Sbjct: 113 ----RMTLPCMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDE 168
Query: 247 MR 248
+R
Sbjct: 169 IR 170
>pdb|1ZKY|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-3m And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|1ZKY|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-3m And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|2B1V|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-1m And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|2B1V|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-1m And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|2FAI|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-2m And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|2FAI|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-2m And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|2B1Z|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With 17methyl-17alpha-Dihydroequilenin And A
Glucoc Interacting Protein 1 Nr Box Ii Peptide
pdb|2B1Z|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With 17methyl-17alpha-Dihydroequilenin And A
Glucoc Interacting Protein 1 Nr Box Ii Peptide
pdb|2B23|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain And A
Glucocorticoid Receptor-Interacting Protein 1 Nr Box Ii
Peptide
pdb|2B23|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain And A
Glucocorticoid Receptor-Interacting Protein 1 Nr Box Ii
Peptide
pdb|2G44|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-1m-G And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|2G44|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-1m-G And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|2G5O|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With 2- (But-1-Enyl)-17beta-Estradiol And A
Glucocorticoid Receptor Interacting Protein 1 Nr Box Ii
Peptide
pdb|2G5O|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With 2- (But-1-Enyl)-17beta-Estradiol And A
Glucocorticoid Receptor Interacting Protein 1 Nr Box Ii
Peptide
Length = 257
Score = 37.7 bits (86), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 37/173 (21%), Positives = 76/173 (43%), Gaps = 12/173 (6%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
++ +AKR+PGF L DQV LL+ E+L++ L ++ +L R+
Sbjct: 60 MINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGK 119
Query: 195 SSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVV--------ISPSRSGLRNKELVE 245
+ D + + R ++L E SI++ +S + L K+ +
Sbjct: 120 XVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIH 179
Query: 246 RMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQ 295
R+ K+ + L+H++ + +Q A+L+ +L +R ++ E L + +
Sbjct: 180 RVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMK 232
>pdb|3LTX|A Chain A, Crystal Structure Of The Pacific Oyster Estrogen Receptor
Ligand Binding Domain
pdb|3LTX|B Chain B, Crystal Structure Of The Pacific Oyster Estrogen Receptor
Ligand Binding Domain
pdb|3LTX|C Chain C, Crystal Structure Of The Pacific Oyster Estrogen Receptor
Ligand Binding Domain
pdb|3LTX|D Chain D, Crystal Structure Of The Pacific Oyster Estrogen Receptor
Ligand Binding Domain
Length = 243
Score = 37.7 bits (86), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 39/171 (22%), Positives = 77/171 (45%), Gaps = 13/171 (7%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDS---QTNSMICLNGEVLVRD 191
++ +AK +PG++ L DQV L++ E+LL L C F S S+ VL R
Sbjct: 52 LINWAKNVPGYTDLSLSDQVHLIECCWMELLL--LNCAFRSIEHGGKSLAFAPDLVLDRS 109
Query: 192 SIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELVERMRGKL 251
S + + + + +E++ HL E+ L ++V+++ L + + M+ L
Sbjct: 110 SWSTVEMTEIFEQVAAVSEQMMQNHLHKDELLLLQAMVLVNAEVRRLASYNQIFNMQQSL 169
Query: 252 ENMLMHVLNQNHPEQMNLCAELISMLPDLRT--------LNQLHSEKLVAF 294
+ ++ + HP+ + ++ +L +R +L SE +V F
Sbjct: 170 LDAIVDTAQKYHPDNVRHVPAVLLLLTHIRQAGERGIAFFQRLKSEGVVTF 220
>pdb|3BQD|A Chain A, Doubling The Size Of The Glucocorticoid Receptor Ligand
Binding Pocket By Deacylcortivazol
Length = 255
Score = 37.7 bits (86), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 30/122 (24%), Positives = 62/122 (50%), Gaps = 15/122 (12%)
Query: 136 VEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS-MICLNGEVLVRDSIH 194
V++AK IPGF L DDQ+TLL+ ++ L Q+++ ++C ++++ +
Sbjct: 53 VKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQSSANLLCFAPDLIINEQ-- 110
Query: 195 SSNARFLMDSMFD-------FAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVER 246
R + M+D + L+ L +S E +++++S + GL+++EL +
Sbjct: 111 ----RMTLPCMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDE 166
Query: 247 MR 248
+R
Sbjct: 167 IR 168
>pdb|3UU7|B Chain B, Crystal Structure Of Hera-Lbd (Y537s) In Complex With
Bisphenol-A
Length = 251
Score = 37.4 bits (85), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 40/188 (21%), Positives = 83/188 (44%), Gaps = 15/188 (7%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 44 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEHPGK 100
Query: 180 MICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVV-------- 230
++ +L R+ + D + + R ++L E SI++
Sbjct: 101 LLFAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTF 160
Query: 231 ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLH 287
+S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 161 LSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKG 220
Query: 288 SEKLVAFQ 295
E L + +
Sbjct: 221 MEHLYSMK 228
>pdb|3UU7|A Chain A, Crystal Structure Of Hera-Lbd (Y537s) In Complex With
Bisphenol-A
pdb|3UUD|B Chain B, Crystal Structure Of Hera-Lbd (Y537s) In Complex With
Estradiol
Length = 251
Score = 37.4 bits (85), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 40/188 (21%), Positives = 83/188 (44%), Gaps = 15/188 (7%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 44 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEHPGK 100
Query: 180 MICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVV-------- 230
++ +L R+ + D + + R ++L E SI++
Sbjct: 101 LLFAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTF 160
Query: 231 ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLH 287
+S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 161 LSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKG 220
Query: 288 SEKLVAFQ 295
E L + +
Sbjct: 221 MEHLYSMK 228
>pdb|2JFA|B Chain B, Estrogen Receptor Alpha Lbd In Complex With An Affinity-
Selected Corepressor Peptide
pdb|2BJ4|B Chain B, Estrogen Receptor Alpha Lbd In Complex With A
Phage-Display Derived Peptide Antagonist
Length = 252
Score = 37.4 bits (85), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 40/188 (21%), Positives = 83/188 (44%), Gaps = 15/188 (7%)
Query: 120 LLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
LL + ++R + ++ +AKR+PGF L DQV LL+ E+L++ L
Sbjct: 64 LLTNLADR---ELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGK 120
Query: 180 MICLNGEVLVRDSIHSSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVV-------- 230
++ +L R+ + D + + R ++L E SI++
Sbjct: 121 LLFAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTF 180
Query: 231 ISPSRSGLRNKELVERMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLH 287
+S + L K+ + R+ K+ + L+H++ + +Q A+L+ +L +R ++
Sbjct: 181 LSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKG 240
Query: 288 SEKLVAFQ 295
E L + +
Sbjct: 241 MEHLYSMK 248
>pdb|2A3I|A Chain A, Structural And Biochemical Mechanisms For The Specificity
Of Hormone Binding And Coactivator Assembly By
Mineralocorticoid Receptor
Length = 253
Score = 37.4 bits (85), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 31/117 (26%), Positives = 54/117 (46%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV--RDS 192
VV++AK +PGF L +DQ+TL++ + L+ TNS LV +
Sbjct: 49 VVKWAKVLPGFKNLPLEDQITLIQYSWMSLSSFALSWRSYKHTNSQFLYFAPDLVFNEEK 108
Query: 193 IHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+H S L M + + L L+ E + ++++S + GL+++ E MR
Sbjct: 109 MHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMR 165
>pdb|1ZH7|A Chain A, Structural And Biochemical Basis For Selective Repression
Of The Orphan Nuclear Receptor Lrh-1 By Shp
pdb|1ZH7|B Chain B, Structural And Biochemical Basis For Selective Repression
Of The Orphan Nuclear Receptor Lrh-1 By Shp
Length = 243
Score = 37.0 bits (84), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 75/161 (46%), Gaps = 7/161 (4%)
Query: 131 TIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVR--LACMFDSQTNSMICLNGEVL 188
T+ +VE+A+ F L DDQ+ LL+ E+L++ + + ++ + GE +
Sbjct: 54 TLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVAHGKEGTIFLVTGEHV 113
Query: 189 VRDSIHSSNARFLMDSMFDFAE----RLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELV 244
+I S+ +++ A+ RL L E +V+ S L N +LV
Sbjct: 114 DYSTI-ISHTEVAFNNLLSLAQELVVRLRSLQFDQREFVCLKFLVLFSSDVKNLENLQLV 172
Query: 245 ERMRGKLENMLMHVLNQNHPEQMNLCAELISMLPDLRTLNQ 285
E ++ ++ L+ N+P+Q +L+ LP++R +++
Sbjct: 173 EGVQEQVNAALLDYTVCNYPQQTEKFGQLLLRLPEIRAISK 213
>pdb|3HM1|A Chain A, Crystal Structure Of Human Estrogen Receptor Alpha
Ligand-Bi Domain In Complex With A Glucocorticoid
Receptor Interactin 1 Nr Box Ii Peptide And Estrone
((8r,9s,13s,14s)-3-Hydroxy-
7,8,9,11,12,14,15,
16-Octahydro-6h-Cyclopenta[a]phenanthren-
pdb|3HM1|B Chain B, Crystal Structure Of Human Estrogen Receptor Alpha
Ligand-Bi Domain In Complex With A Glucocorticoid
Receptor Interactin 1 Nr Box Ii Peptide And Estrone
((8r,9s,13s,14s)-3-Hydroxy-
7,8,9,11,12,14,15,
16-Octahydro-6h-Cyclopenta[a]phenanthren-
Length = 253
Score = 37.0 bits (84), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 37/173 (21%), Positives = 76/173 (43%), Gaps = 12/173 (6%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
++ +AKR+PGF L DQV LL+ E+L++ L ++ +L R+
Sbjct: 60 MINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGK 119
Query: 195 SSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVV--------ISPSRSGLRNKELVE 245
+ D + + R ++L E SI++ +S + L K+ +
Sbjct: 120 XVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIH 179
Query: 246 RMRGKLENMLMHVLNQ---NHPEQMNLCAELISMLPDLRTLNQLHSEKLVAFQ 295
R+ K+ + L+H++ + +Q A+L+ +L +R ++ E L + +
Sbjct: 180 RVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMK 232
>pdb|2ABI|A Chain A, Crystal Structure Of The Human Mineralocorticoid Receptor
Ligand-Binding Domain Bound To Deoxycorticosterone
pdb|2ABI|B Chain B, Crystal Structure Of The Human Mineralocorticoid Receptor
Ligand-Binding Domain Bound To Deoxycorticosterone
pdb|2ABI|C Chain C, Crystal Structure Of The Human Mineralocorticoid Receptor
Ligand-Binding Domain Bound To Deoxycorticosterone
Length = 256
Score = 36.2 bits (82), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 31/117 (26%), Positives = 54/117 (46%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLV--RDS 192
VV++AK +PGF L +DQ+TL++ + L+ TNS LV +
Sbjct: 52 VVKWAKVLPGFKNLPLEDQITLIQYSWMCLSSFALSWRSYKHTNSQFLYFAPDLVFNEEK 111
Query: 193 IHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+H S L M + + L L+ E + ++++S + GL+++ E MR
Sbjct: 112 MHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMR 168
>pdb|3M6O|A Chain A, Crystal Structure Of Arabidopsis Thaliana Peptide
Deformylase 1b (Atpdf1b)
pdb|3M6O|B Chain B, Crystal Structure Of Arabidopsis Thaliana Peptide
Deformylase 1b (Atpdf1b)
pdb|3M6P|A Chain A, Crystal Structure Of Arabidopsis Thaliana Peptide
Deformylase 1b (Atpdf1b) In Complex With Actinonin
pdb|3M6P|B Chain B, Crystal Structure Of Arabidopsis Thaliana Peptide
Deformylase 1b (Atpdf1b) In Complex With Actinonin
pdb|3O3J|A Chain A, Crystal Structure Of Arabidopsis Thaliana Peptide
Deformylase 1b (Atpdf1b) In Complex With Inhibitor 6b
pdb|3PN2|A Chain A, Crystal Structure Of Arabidopsis Thaliana Petide
Deformylase 1b (Atpdf1b) (Crystallized In Peg-550-Mme)
pdb|3PN3|A Chain A, Crystal Structure Of Arabidopsis Thaliana Petide
Deformylase 1b (Atpdf1b) In Complex With Inhibitor 21
pdb|3PN3|B Chain B, Crystal Structure Of Arabidopsis Thaliana Petide
Deformylase 1b (Atpdf1b) In Complex With Inhibitor 21
pdb|3PN4|A Chain A, Crystal Structure Of Arabidopsis Thaliana Petide
Deformylase 1b (Atpdf1b) In Complex With Actinonin
(Crystallized In Peg-550-Mme)
Length = 193
Score = 35.0 bits (79), Expect = 0.11, Method: Composition-based stats.
Identities = 18/55 (32%), Positives = 31/55 (56%)
Query: 190 RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELV 244
R I N + L+D+MFD + +G+ LS ++GL ++V +P+ KE+V
Sbjct: 17 RIDIFDENLKNLVDAMFDVMYKTDGIGLSAPQVGLNVQLMVFNPAGEPGEGKEIV 71
>pdb|3CPM|A Chain A, Plant Peptide Deformylase Pdf1b Crystal Structure
Length = 193
Score = 34.7 bits (78), Expect = 0.14, Method: Composition-based stats.
Identities = 18/55 (32%), Positives = 31/55 (56%)
Query: 190 RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELV 244
R I N + L+D+MFD + +G+ LS ++GL ++V +P+ KE+V
Sbjct: 33 RIDIFDENLKNLVDAMFDVMYKTDGIGLSAPQVGLNVQLMVFNPAGEPGEGKEIV 87
>pdb|3H52|A Chain A, Crystal Structure Of The Antagonist Form Of Human
Glucocorticoid Receptor
pdb|3H52|B Chain B, Crystal Structure Of The Antagonist Form Of Human
Glucocorticoid Receptor
pdb|3H52|C Chain C, Crystal Structure Of The Antagonist Form Of Human
Glucocorticoid Receptor
pdb|3H52|D Chain D, Crystal Structure Of The Antagonist Form Of Human
Glucocorticoid Receptor
Length = 254
Score = 34.3 bits (77), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 29/122 (23%), Positives = 61/122 (50%), Gaps = 15/122 (12%)
Query: 136 VEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS-MICLNGEVLVRDSIH 194
V++AK IPGF L DDQ+TLL+ ++ L Q+++ ++C ++++ +
Sbjct: 52 VKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQSSANLLCFAPDLIINEQ-- 109
Query: 195 SSNARFLMDSMFD-------FAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVER 246
R + M+D + L+ L +S E +++++S + GL+++ L +
Sbjct: 110 ----RMTLPDMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQALFDA 165
Query: 247 MR 248
+R
Sbjct: 166 IR 167
>pdb|1QKN|A Chain A, Rat Oestrogen Receptor Beta Ligand-Binding Domain In
Complex With Antagonist Raloxifene
pdb|1HJ1|A Chain A, Rat Oestrogen Receptor Beta Ligand-Binding Domain In
Complex With Pure Antioestrogen Ici164,384
Length = 255
Score = 34.3 bits (77), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMI------------- 181
++ +AK+IPGF L DQV LL++ EVL+V L +I
Sbjct: 55 MIGWAKKIPGFVELSLLDQVRLLESCWMEVLMVGLMWRSIDHPGKLIFAPDLVLDRDEGK 114
Query: 182 CLNGEVLVRDSIHSSNARF 200
C+ G + + D + ++ +RF
Sbjct: 115 CVEGILEIFDMLLATTSRF 133
>pdb|2J7X|A Chain A, Structure Of Estradiol-bound Estrogen Receptor Beta Lbd In
Complex With Lxxll Motif From Ncoa5
pdb|2J7Y|A Chain A, Structure Of 17-Epiestriol-Bound Estrogen Receptor Beta
Lbd In Complex With Lxxll Motif From Ncoa5
Length = 255
Score = 34.3 bits (77), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMI------------- 181
++ +AK+IPGF L DQV LL++ EVL+V L +I
Sbjct: 55 MIGWAKKIPGFVELSLLDQVRLLESCWMEVLMVGLMWRSIDHPGKLIFAPDLVLDRDEGK 114
Query: 182 CLNGEVLVRDSIHSSNARF 200
C+ G + + D + ++ +RF
Sbjct: 115 CVEGILEIFDMLLATTSRF 133
>pdb|1YY4|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
1-Chloro-6-(4-Hydroxy-Phenyl)-Naphthalen-2-Ol
pdb|1YY4|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
1-Chloro-6-(4-Hydroxy-Phenyl)-Naphthalen-2-Ol
pdb|1YYE|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-202196
pdb|1YYE|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-202196
Length = 268
Score = 33.9 bits (76), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMI------------- 181
++ +AK+IPGF L DQV LL++ EVL++ L +I
Sbjct: 47 MISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGK 106
Query: 182 CLNGEVLVRDSIHSSNARF 200
C+ G + + D + ++ +RF
Sbjct: 107 CVEGILEIFDMLLATTSRF 125
>pdb|2FSZ|A Chain A, A Second Binding Site For Hydroxytamoxifen Within The
Coactivator-Binding Groove Of Estrogen Receptor Beta
pdb|2FSZ|B Chain B, A Second Binding Site For Hydroxytamoxifen Within The
Coactivator-Binding Groove Of Estrogen Receptor Beta
Length = 246
Score = 33.5 bits (75), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 28/101 (27%), Positives = 45/101 (44%), Gaps = 1/101 (0%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDSIH 194
++ +AK+IPGF L DQV LL++ EVL++ L +I VL RD
Sbjct: 53 MISWAKKIPGFVELSLFDQVRLLESSWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGK 112
Query: 195 SSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS 234
S + D + R L L E ++++++ S
Sbjct: 113 SVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSS 153
>pdb|3OLL|A Chain A, Crystal Structure Of Phosphorylated Estrogen Receptor Beta
Ligand Binding Domain
pdb|3OLL|B Chain B, Crystal Structure Of Phosphorylated Estrogen Receptor Beta
Ligand Binding Domain
Length = 240
Score = 33.1 bits (74), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMI------------- 181
++ +AK+IPGF L DQV LL++ EVL++ L +I
Sbjct: 49 MISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGK 108
Query: 182 CLNGEVLVRDSIHSSNARF 200
C+ G + + D + ++ +RF
Sbjct: 109 CVEGILEIFDMLLATTSRF 127
>pdb|1NDE|A Chain A, Estrogen Receptor Beta With Selective Triazine Modulator
Length = 255
Score = 33.1 bits (74), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMI------------- 181
++ +AK+IPGF L DQV LL++ EVL++ L +I
Sbjct: 63 MISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGK 122
Query: 182 CLNGEVLVRDSIHSSNARF 200
C+ G + + D + ++ +RF
Sbjct: 123 CVEGILEIFDMLLATTSRF 141
>pdb|1X76|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-697
pdb|1X76|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-697
pdb|1X78|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-244
pdb|1X78|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-244
pdb|1X7B|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Erb-041
pdb|1X7B|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Erb-041
pdb|1X7J|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Genistein
pdb|1X7J|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Genistein
pdb|1U3Q|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Cl-272
pdb|1U3Q|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Cl-272
pdb|1U3Q|C Chain C, Crystal Structure Of Estrogen Receptor Beta Complexed With
Cl-272
pdb|1U3Q|D Chain D, Crystal Structure Of Estrogen Receptor Beta Complexed With
Cl-272
pdb|1U3S|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-797
pdb|1U3S|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-797
pdb|3OLS|A Chain A, Crystal Structure Of Estrogen Receptor Beta Ligand Binding
Domain
pdb|3OLS|B Chain B, Crystal Structure Of Estrogen Receptor Beta Ligand Binding
Domain
pdb|3OMO|A Chain A, Fragment-Based Design Of Novel Estrogen Receptor Ligands
pdb|3OMO|B Chain B, Fragment-Based Design Of Novel Estrogen Receptor Ligands
pdb|3OMP|A Chain A, Fragment-Based Design Of Novel Estrogen Receptor Ligands
pdb|3OMP|B Chain B, Fragment-Based Design Of Novel Estrogen Receptor Ligands
pdb|3OMQ|A Chain A, Fragment-Based Design Of Novel Estrogen Receptor Ligands
pdb|3OMQ|B Chain B, Fragment-Based Design Of Novel Estrogen Receptor Ligands
pdb|2YJD|A Chain A, Stapled Peptide Bound To Estrogen Receptor Beta
pdb|2YJD|B Chain B, Stapled Peptide Bound To Estrogen Receptor Beta
Length = 240
Score = 33.1 bits (74), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMI------------- 181
++ +AK+IPGF L DQV LL++ EVL++ L +I
Sbjct: 49 MISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGK 108
Query: 182 CLNGEVLVRDSIHSSNARF 200
C+ G + + D + ++ +RF
Sbjct: 109 CVEGILEIFDMLLATTSRF 127
>pdb|1U9E|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-397
pdb|1U9E|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-397
pdb|1U3R|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-338
pdb|1U3R|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-338
Length = 241
Score = 33.1 bits (74), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMI------------- 181
++ +AK+IPGF L DQV LL++ EVL++ L +I
Sbjct: 49 MISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGK 108
Query: 182 CLNGEVLVRDSIHSSNARF 200
C+ G + + D + ++ +RF
Sbjct: 109 CVEGILEIFDMLLATTSRF 127
>pdb|2NV7|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-555
pdb|2NV7|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-555
Length = 238
Score = 33.1 bits (74), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMI------------- 181
++ +AK+IPGF L DQV LL++ EVL++ L +I
Sbjct: 47 MISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGK 106
Query: 182 CLNGEVLVRDSIHSSNARF 200
C+ G + + D + ++ +RF
Sbjct: 107 CVEGILEIFDMLLATTSRF 125
>pdb|2YLY|A Chain A, Sulfonamides As Selective Estrogen Receptor Beta Agonists.
pdb|2YLY|B Chain B, Sulfonamides As Selective Estrogen Receptor Beta Agonists
Length = 240
Score = 33.1 bits (74), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMI------------- 181
++ +AK+IPGF L DQV LL++ EVL++ L +I
Sbjct: 50 MISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGK 109
Query: 182 CLNGEVLVRDSIHSSNARF 200
C+ G + + D + ++ +RF
Sbjct: 110 CVEGILEIFDMLLATTSRF 128
>pdb|2GIU|A Chain A, Human Estrogen Receptor Beta Ligand-Binding Domain In
Complex With Compound 45
Length = 241
Score = 33.1 bits (74), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMI------------- 181
++ +AK+IPGF L DQV LL++ EVL++ L +I
Sbjct: 50 MISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGK 109
Query: 182 CLNGEVLVRDSIHSSNARF 200
C+ G + + D + ++ +RF
Sbjct: 110 CVEGILEIFDMLLATTSRF 128
>pdb|1ZAF|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
3-Bromo-6-Hydroxy-2-(4-Hydroxy-Phenyl)-Inden-1-One
pdb|1ZAF|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
3-Bromo-6-Hydroxy-2-(4-Hydroxy-Phenyl)-Inden-1-One
Length = 238
Score = 33.1 bits (74), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMI------------- 181
++ +AK+IPGF L DQV LL++ EVL++ L +I
Sbjct: 47 MISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGK 106
Query: 182 CLNGEVLVRDSIHSSNARF 200
C+ G + + D + ++ +RF
Sbjct: 107 CVEGILEIFDMLLATTSRF 125
>pdb|1L2J|A Chain A, Human Estrogen Receptor Beta Ligand-Binding Domain In
Complex With (R,
R)-5,11-Cis-Diethyl-5,6,11,12-Tetrahydrochrysene-2,
8-Diol
pdb|1L2J|B Chain B, Human Estrogen Receptor Beta Ligand-Binding Domain In
Complex With (R,
R)-5,11-Cis-Diethyl-5,6,11,12-Tetrahydrochrysene-2,
8-Diol
Length = 271
Score = 33.1 bits (74), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMI------------- 181
++ +AK+IPGF L DQV LL++ EVL++ L +I
Sbjct: 75 MISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGK 134
Query: 182 CLNGEVLVRDSIHSSNARF 200
C+ G + + D + ++ +RF
Sbjct: 135 CVEGILEIFDMLLATTSRF 153
>pdb|2I0G|A Chain A, Benzopyrans Are Selective Estrogen Receptor Beta Agonists
(Serbas) With Novel Activity In Models Of Benign
Prostatic Hyperplasia
pdb|2I0G|B Chain B, Benzopyrans Are Selective Estrogen Receptor Beta Agonists
(Serbas) With Novel Activity In Models Of Benign
Prostatic Hyperplasia
pdb|2JJ3|A Chain A, Estrogen Receptor Beta Ligand Binding Domain In Complex
With A Benzopyran Agonist
pdb|2JJ3|B Chain B, Estrogen Receptor Beta Ligand Binding Domain In Complex
With A Benzopyran Agonist
pdb|2Z4B|A Chain A, Estrogen Receptor Beta Ligand-Binding Domain Complexed To
A Benzopyran Ligand
pdb|2Z4B|B Chain B, Estrogen Receptor Beta Ligand-Binding Domain Complexed To
A Benzopyran Ligand
pdb|2QTU|A Chain A, Estrogen Receptor Beta Ligand-Binding Domain Complexed To
A Benzopyran Ligand
pdb|2QTU|B Chain B, Estrogen Receptor Beta Ligand-Binding Domain Complexed To
A Benzopyran Ligand
Length = 257
Score = 33.1 bits (74), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMI------------- 181
++ +AK+IPGF L DQV LL++ EVL++ L +I
Sbjct: 61 MISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGK 120
Query: 182 CLNGEVLVRDSIHSSNARF 200
C+ G + + D + ++ +RF
Sbjct: 121 CVEGILEIFDMLLATTSRF 139
>pdb|4E2J|A Chain A, X-Ray Crystal Structure Of The Ancestral Glucocorticoid
Receptor 2 Ligand Binding Domain In Complex With
Mometasone Furoate And Tif-2 Coactivator Fragment
pdb|4E2J|B Chain B, X-Ray Crystal Structure Of The Ancestral Glucocorticoid
Receptor 2 Ligand Binding Domain In Complex With
Mometasone Furoate And Tif-2 Coactivator Fragment
Length = 250
Score = 33.1 bits (74), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 18/57 (31%), Positives = 33/57 (57%), Gaps = 1/57 (1%)
Query: 136 VEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN-SMICLNGEVLVRD 191
V++AK +PGF L DDQ+TLL+ ++ L Q+N +M+C ++++ +
Sbjct: 49 VKWAKALPGFRNLHLDDQMTLLQYSWMSLMAFSLGWRSYKQSNGNMLCFAPDLVINE 105
>pdb|1QKM|A Chain A, Human Oestrogen Receptor Beta Ligand-Binding Domain In
Complex With Partial Agonist Genistein
Length = 255
Score = 33.1 bits (74), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMI------------- 181
++ +AK+IPGF L DQV LL++ EVL++ L +I
Sbjct: 55 MISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGK 114
Query: 182 CLNGEVLVRDSIHSSNARF 200
C+ G + + D + ++ +RF
Sbjct: 115 CVEGILEIFDMLLATTSRF 133
>pdb|3GN8|A Chain A, X-Ray Crystal Structure Of Ancgr2 In Complex With
Dexamethasone
pdb|3GN8|B Chain B, X-Ray Crystal Structure Of Ancgr2 In Complex With
Dexamethasone
Length = 249
Score = 33.1 bits (74), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 18/57 (31%), Positives = 33/57 (57%), Gaps = 1/57 (1%)
Query: 136 VEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTN-SMICLNGEVLVRD 191
V++AK +PGF L DDQ+TLL+ ++ L Q+N +M+C ++++ +
Sbjct: 47 VKWAKALPGFRNLHLDDQMTLLQYSWMSLMAFSLGWRSYKQSNGNMLCFAPDLVINE 103
>pdb|4FNE|A Chain A, X-Ray Crystal Structure Of The Ancestral 3-Keto Steroid
Receptor - Doc Complex
pdb|4FN9|A Chain A, X-Ray Crystal Structure Of The Ancestral 3-Keto Steroid
Receptor - Progesterone Complex
pdb|4FN9|B Chain B, X-Ray Crystal Structure Of The Ancestral 3-Keto Steroid
Receptor - Progesterone Complex
Length = 254
Score = 32.3 bits (72), Expect = 0.78, Method: Compositional matrix adjust.
Identities = 26/117 (22%), Positives = 56/117 (47%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS-MICLNGEVLVRDSI 193
VV++AK +PGF L DDQ+TL++ ++ + TN M+ +++ +
Sbjct: 50 VVKWAKALPGFRNLHLDDQMTLIQYSWMGLMAFAMGWRSYKHTNGQMLYFAPDLIFNEQR 109
Query: 194 HSSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+A + L M ++ L ++ E +++++S + GL+++ + MR
Sbjct: 110 MQQSAMYDLCQGMQQISQEFVRLQVTQEEFLCMKALLLLSTVPKEGLKSQASFDEMR 166
>pdb|3M6Q|A Chain A, Crystal Structure Of Arabidopsis Thaliana Peptide
Deformylase 1b (Atpdf1b) G41q Mutant In Complex With
Actinonin
pdb|3PN5|A Chain A, Crystal Structure Of Arabidopsis Thaliana Petide
Deformylase 1b (Atpdf1b) G41q Mutant
Length = 193
Score = 32.0 bits (71), Expect = 0.98, Method: Composition-based stats.
Identities = 17/55 (30%), Positives = 30/55 (54%)
Query: 190 RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELV 244
R I N + L+D+MFD + + + LS ++GL ++V +P+ KE+V
Sbjct: 17 RIDIFDENLKNLVDAMFDVMYKTDQIGLSAPQVGLNVQLMVFNPAGEPGEGKEIV 71
>pdb|1E3K|A Chain A, Human Progesteron Receptor Ligand Binding Domain In
Complex With The Ligand Metribolone (R1881)
pdb|1E3K|B Chain B, Human Progesteron Receptor Ligand Binding Domain In
Complex With The Ligand Metribolone (R1881)
pdb|3D90|A Chain A, Crystal Structure Of The Human Progesterone Receptor
Ligand- Binding Domain Bound To Levonorgestrel
pdb|3D90|B Chain B, Crystal Structure Of The Human Progesterone Receptor
Ligand- Binding Domain Bound To Levonorgestrel
Length = 258
Score = 32.0 bits (71), Expect = 0.99, Method: Compositional matrix adjust.
Identities = 26/117 (22%), Positives = 57/117 (48%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACM-FDSQTNSMICLNGEVLVRDS- 192
VV+++K +PGF L DDQ+TL++ +++ L + + M+ ++++ +
Sbjct: 54 VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQR 113
Query: 193 IHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+ S+ L +M+ + L +S E +++++ GLR++ E MR
Sbjct: 114 MKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR 170
>pdb|1SR7|A Chain A, Progesterone Receptor Hormone Binding Domain With Bound
Mometasone Furoate
pdb|1SR7|B Chain B, Progesterone Receptor Hormone Binding Domain With Bound
Mometasone Furoate
pdb|1ZUC|B Chain B, Progesterone Receptor Ligand Binding Domain In Complex
With The Nonsteroidal Agonist Tanaproget
pdb|1ZUC|A Chain A, Progesterone Receptor Ligand Binding Domain In Complex
With The Nonsteroidal Agonist Tanaproget
Length = 259
Score = 32.0 bits (71), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 26/117 (22%), Positives = 57/117 (48%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACM-FDSQTNSMICLNGEVLVRDS- 192
VV+++K +PGF L DDQ+TL++ +++ L + + M+ ++++ +
Sbjct: 55 VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQR 114
Query: 193 IHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+ S+ L +M+ + L +S E +++++ GLR++ E MR
Sbjct: 115 MKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR 171
>pdb|2W8Y|A Chain A, Ru486 Bound To The Progesterone Receptor In A Destabilized
Agonistic Conformation
pdb|2W8Y|B Chain B, Ru486 Bound To The Progesterone Receptor In A Destabilized
Agonistic Conformation
pdb|3ZR7|A Chain A, Structural Basis For Agonism And Antagonism For A Set Of
Chemically Related Progesterone Receptor Modulators
pdb|3ZR7|B Chain B, Structural Basis For Agonism And Antagonism For A Set Of
Chemically Related Progesterone Receptor Modulators
pdb|3ZRA|A Chain A, Structural Basis For Agonism And Antagonism For A Set Of
Chemically Related Progesterone Receptor Modulators
pdb|3ZRA|B Chain B, Structural Basis For Agonism And Antagonism For A Set Of
Chemically Related Progesterone Receptor Modulators
pdb|3ZRB|A Chain A, Structural Basis For Agonism And Antagonism For A Set Of
Chemically Related Progesterone Receptor Modulators
pdb|3ZRB|B Chain B, Structural Basis For Agonism And Antagonism For A Set Of
Chemically Related Progesterone Receptor Modulators
pdb|4A2J|A Chain A, Pr X-Ray Structures In Agonist Conformations Reveal Two
Different Mechanisms For Partial Agonism In 11beta-
Substituted Steroids
pdb|4A2J|B Chain B, Pr X-Ray Structures In Agonist Conformations Reveal Two
Different Mechanisms For Partial Agonism In 11beta-
Substituted Steroids
pdb|4APU|A Chain A, Pr X-Ray Structures In Agonist Conformations Reveal Two
Different Mechanisms For Partial Agonism In
11beta-Substituted Steroid
pdb|4APU|B Chain B, Pr X-Ray Structures In Agonist Conformations Reveal Two
Different Mechanisms For Partial Agonism In
11beta-Substituted Steroid
Length = 260
Score = 31.6 bits (70), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 26/117 (22%), Positives = 57/117 (48%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACM-FDSQTNSMICLNGEVLVRDS- 192
VV+++K +PGF L DDQ+TL++ +++ L + + M+ ++++ +
Sbjct: 56 VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQR 115
Query: 193 IHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+ S+ L +M+ + L +S E +++++ GLR++ E MR
Sbjct: 116 MKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR 172
>pdb|1SQN|A Chain A, Progesterone Receptor Ligand Binding Domain With Bound
Norethindrone
pdb|1SQN|B Chain B, Progesterone Receptor Ligand Binding Domain With Bound
Norethindrone
Length = 261
Score = 31.6 bits (70), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 26/117 (22%), Positives = 57/117 (48%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACM-FDSQTNSMICLNGEVLVRDS- 192
VV+++K +PGF L DDQ+TL++ +++ L + + M+ ++++ +
Sbjct: 57 VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQR 116
Query: 193 IHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+ S+ L +M+ + L +S E +++++ GLR++ E MR
Sbjct: 117 MKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR 173
>pdb|3G8O|A Chain A, Progesterone Receptor With Bound Pyrrolidine 1
pdb|3G8O|B Chain B, Progesterone Receptor With Bound Pyrrolidine 1
Length = 263
Score = 31.6 bits (70), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 26/117 (22%), Positives = 57/117 (48%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACM-FDSQTNSMICLNGEVLVRDS- 192
VV+++K +PGF L DDQ+TL++ +++ L + + M+ ++++ +
Sbjct: 59 VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQR 118
Query: 193 IHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+ S+ L +M+ + L +S E +++++ GLR++ E MR
Sbjct: 119 MKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR 175
>pdb|3M6R|A Chain A, Crystal Structure Of Arabidopsis Thaliana Peptide
Deformylase 1b (Atpdf1b) G41m Mutant In Complex With
Actinonin
pdb|3M6R|B Chain B, Crystal Structure Of Arabidopsis Thaliana Peptide
Deformylase 1b (Atpdf1b) G41m Mutant In Complex With
Actinonin
pdb|3M6R|C Chain C, Crystal Structure Of Arabidopsis Thaliana Peptide
Deformylase 1b (Atpdf1b) G41m Mutant In Complex With
Actinonin
pdb|3M6R|D Chain D, Crystal Structure Of Arabidopsis Thaliana Peptide
Deformylase 1b (Atpdf1b) G41m Mutant In Complex With
Actinonin
pdb|3PN6|A Chain A, Crystal Structure Of Arabidopsis Thaliana Petide
Deformylase 1b (Atpdf1b) G41m Mutant
pdb|3PN6|B Chain B, Crystal Structure Of Arabidopsis Thaliana Petide
Deformylase 1b (Atpdf1b) G41m Mutant
Length = 193
Score = 31.6 bits (70), Expect = 1.3, Method: Composition-based stats.
Identities = 17/55 (30%), Positives = 30/55 (54%)
Query: 190 RDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPSRSGLRNKELV 244
R I N + L+D+MFD + + + LS ++GL ++V +P+ KE+V
Sbjct: 17 RIDIFDENLKNLVDAMFDVMYKTDMIGLSAPQVGLNVQLMVFNPAGEPGEGKEIV 71
>pdb|1A28|A Chain A, Hormone-Bound Human Progesterone Receptor Ligand-Binding
Domain
pdb|1A28|B Chain B, Hormone-Bound Human Progesterone Receptor Ligand-Binding
Domain
pdb|2OVH|A Chain A, Progesterone Receptor With Bound Asoprisnil And A Peptide
From The Co-Repressor Smrt
pdb|2OVM|A Chain A, Progesterone Receptor With Bound Asoprisnil And A Peptide
From The Co-Repressor Ncor
pdb|3HQ5|A Chain A, Progesterone Receptor Bound To An Alkylpyrrolidine Ligand.
pdb|3HQ5|B Chain B, Progesterone Receptor Bound To An Alkylpyrrolidine Ligand
Length = 256
Score = 31.6 bits (70), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 26/117 (22%), Positives = 57/117 (48%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACM-FDSQTNSMICLNGEVLVRDS- 192
VV+++K +PGF L DDQ+TL++ +++ L + + M+ ++++ +
Sbjct: 52 VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQR 111
Query: 193 IHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+ S+ L +M+ + L +S E +++++ GLR++ E MR
Sbjct: 112 MKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR 168
>pdb|3KBA|A Chain A, Progesterone Receptor Bound To Sulfonamide Pyrrolidine
Partial Agonist
pdb|3KBA|B Chain B, Progesterone Receptor Bound To Sulfonamide Pyrrolidine
Partial Agonist
Length = 253
Score = 31.6 bits (70), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 26/117 (22%), Positives = 57/117 (48%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACM-FDSQTNSMICLNGEVLVRDS- 192
VV+++K +PGF L DDQ+TL++ +++ L + + M+ ++++ +
Sbjct: 49 VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQR 108
Query: 193 IHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+ S+ L +M+ + L +S E +++++ GLR++ E MR
Sbjct: 109 MKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR 165
>pdb|2Q1H|A Chain A, Ancestral Corticoid Receptor In Complex With Aldosterone
pdb|2Q1V|A Chain A, Ancestral Corticoid Receptor In Complex With Cortisol
Length = 250
Score = 30.8 bits (68), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 27/117 (23%), Positives = 55/117 (47%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS-MICLNGEVLVRDSI 193
VV++AK +PGF L DDQ+TL++ ++ L TN M+ +++ +
Sbjct: 46 VVKWAKALPGFRNLHLDDQMTLIQYSWMSLMAFSLGWRSYKHTNGQMLYFAPDLIFNEER 105
Query: 194 HSSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+A + L M ++ L ++ E ++++S + GL+++ + MR
Sbjct: 106 MQQSAMYDLCQGMRQISQEFVRLQVTYEEFLCMKVLLLLSTVPKDGLKSQASFDEMR 162
>pdb|2Q3Y|A Chain A, Ancestral Corticiod Receptor In Complex With Doc
Length = 249
Score = 30.4 bits (67), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 27/117 (23%), Positives = 55/117 (47%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS-MICLNGEVLVRDSI 193
VV++AK +PGF L DDQ+TL++ ++ L TN M+ +++ +
Sbjct: 46 VVKWAKALPGFRNLHLDDQMTLIQYSWMSLMAFSLGWRSYKHTNGQMLYFAPDLIFNEER 105
Query: 194 HSSNARF-LMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+A + L M ++ L ++ E ++++S + GL+++ + MR
Sbjct: 106 MQQSAMYDLCQGMRQISQEFVRLQVTYEEFLCMKVLLLLSTVPKDGLKSQASFDEMR 162
>pdb|2AX8|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain W741l Mutant In Complex With S-1
Length = 256
Score = 30.0 bits (66), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 65/149 (43%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++ +
Sbjct: 21 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSLM 79
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 80 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 139
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 140 EFLCMKALLLFSIIPVDGLKNQKFFDELR 168
>pdb|2AM9|A Chain A, Crystal Structure Of Human Androgen Receptor Ligand
Binding Domain In Complex With Testosterone
pdb|2AMA|A Chain A, Crystal Structure Of Human Androgen Receptor Ligand
Binding Domain In Complex With Dihydrotestosterone
pdb|2AMB|A Chain A, Crystal Structure Of Human Androgen Receptor Ligand
Binding Domain In Complex With Tetrahydrogestrinone
pdb|2PNU|A Chain A, Crystal Structure Of Human Androgen Receptor
Ligand-Binding Domain In Complex With Em-5744
pdb|3V49|A Chain A, Structure Of Ar Lbd With Activator Peptide And Sarm
Inhibitor 1
Length = 266
Score = 29.6 bits (65), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 31 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 89
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 90 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 149
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 150 EFLCMKALLLFSIIPVDGLKNQKFFDELR 178
>pdb|1Z95|A Chain A, Crystal Structure Of The Androgen Receptor Ligand-Binding
Domain W741l Mutant Complex With R-Bicalutamide
Length = 246
Score = 29.6 bits (65), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 65/149 (43%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++ +
Sbjct: 13 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSLM 71
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 72 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 131
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 132 EFLCMKALLLFSIIPVDGLKNQKFFDELR 160
>pdb|1XJ7|A Chain A, Complex Androgen Receptor Lbd And Rac3 Peptide
pdb|2Q7I|A Chain A, The Wild Type Androgen Receptor Ligand Binding Domain
Bound With Testosterone And An Ar 20-30 Peptide
pdb|2Q7J|A Chain A, The Wild Type Androgen Receptor Ligand Binding Domain
Bound With Testosterone And A Tif2 Box 3 Coactivator
Peptide 740-753
Length = 257
Score = 29.6 bits (65), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 22 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 80
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 81 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 140
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 141 EFLCMKALLLFSIIPVDGLKNQKFFDELR 169
>pdb|1T73|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With A Fxxff Motif
pdb|1T74|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With A Wxxlf Motif
pdb|1T76|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With A Wxxvw Motif
pdb|1T79|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With A Fxxlw Motif
pdb|1T7F|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With A Lxxll Motif
pdb|1T7M|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With A Fxxyf Motif
pdb|1T7R|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With A Fxxlf Motif
pdb|1T7T|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With 5-Alpha Dihydrotestosterone
Length = 269
Score = 29.6 bits (65), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 34 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 92
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 93 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 152
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 153 EFLCMKALLLFSIIPVDGLKNQKFFDELR 181
>pdb|1E3G|A Chain A, Human Androgen Receptor Ligand Binding In Complex With The
Ligand Metribolone (R1881)
Length = 263
Score = 29.6 bits (65), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 28 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 86
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 87 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 146
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 147 EFLCMKALLLFSIIPVDGLKNQKFFDELR 175
>pdb|1I37|A Chain A, Crystal Structure Of The Rat Androgen Receptor Ligand
Binding Domain Complex With Dihydrotestosterone
pdb|2IHQ|A Chain A, Crystal Structure Of The Rat Androgen Receptor Ligand
Binding Domian Complex With An N-Aryl-
Hydroxybicyclohydantoin
pdb|2NW4|A Chain A, Crystal Structure Of The Rat Androgen Receptor Ligand
Binding Domain Complex With Bms-564929
pdb|3G0W|A Chain A, Crystal Structure Of The Rat Androgen Receptor Ligand
Binding Domain Complex With An N-Aryl-Oxazolidin 2-Imine
Inhibitor
Length = 260
Score = 29.6 bits (65), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 25 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 83
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 84 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 143
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 144 EFLCMKALLLFSIIPVDGLKNQKFFDELR 172
>pdb|1I38|A Chain A, Crystal Structure Of The Rat Androgen Receptor Ligand
Binding Domain T877a Mutant Complex With
Dihydrotestosterone
pdb|1XNN|A Chain A, Crystal Structure Of The Rat Androgen Receptor Ligand
Binding Domain T877a Mutant Complex With (3a-Alpha-,4-
Alpha
7-Alpha-,7a-Alpha-)-3a,4,7,7a-Tetrahydro-2-(4-Nitro-
1-Naphthalenyl)-4,7-Ethano-1h-Isoindole-1,3(2h)-Dione
Length = 260
Score = 29.6 bits (65), Expect = 5.3, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 25 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 83
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 84 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 143
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 144 EFLCMKALLLFSIIPVDGLKNQKFFDELR 172
>pdb|2AX9|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With R-3
pdb|2AXA|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With S-1
pdb|2YLO|A Chain A, Targeting The Binding Function 3 Site Of The Androgen
Receptor Through In Silico Molecular Modeling
pdb|2YLP|A Chain A, Targeting The Binding Function 3 Site Of The Androgen
Receptor Through In Silico Molecular Modeling
pdb|2YLQ|A Chain A, Targeting The Binding Function 3 Site Of The Androgen
Receptor Through In Silico Molecular Modeling
pdb|3ZQT|A Chain A, Targeting The Binding Function 3 Site Of The Androgen
Receptor Through In Silico Molecular Modeling
pdb|4HLW|A Chain A, Targeting The Binding Function 3 (bf3) Site Of The Human
Androgen Receptor Through Virtual Screening. 2.
Development Of 2-((2- Phenoxyethyl)
Thio)-1h-benzoimidazole Derivatives
Length = 256
Score = 29.6 bits (65), Expect = 5.5, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 21 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 79
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 80 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 139
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 140 EFLCMKALLLFSIIPVDGLKNQKFFDELR 168
>pdb|2AX6|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain T877a Mutant In Complex With Hydroxyflutamide
pdb|2AX7|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain T877a Mutant In Complex With S-1
Length = 256
Score = 29.3 bits (64), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 21 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 79
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 80 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 139
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 140 EFLCMKALLLFSIIPVDGLKNQKFFDELR 168
>pdb|1T5Z|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain (Lbd) With Dht And A Peptide Derived From Its
Physiological Coactivator Ara70
pdb|1T63|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain With Dht And A Peptide Derived From Its
Physiological Coactivator Grip1 Nr Box3
pdb|1T65|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain With Dht And A Peptide Derived Form Its
Physiological Coactivator Grip1 Nr Box 2 Bound In A Non-
Helical Conformation
pdb|2PIO|A Chain A, Androgen Receptor Lbd With Small Molecule
pdb|2PIP|L Chain L, Androgen Receptor Lbd With Small Molecule
pdb|2PIQ|A Chain A, Androgen Receptor Lbd With Small Molecule
pdb|2PIR|A Chain A, Androgen Receptor Lbd With Small Molecule
pdb|2PIT|A Chain A, Androgen Receptor Lbd With Small Molecule
pdb|2PIU|A Chain A, Androgen Receptor Lbd With Small Molecule
pdb|2PIV|A Chain A, Androgen Receptor With Small Molecule
pdb|2PIW|A Chain A, Androgen Receptor With Small Molecule
pdb|2PIX|A Chain A, Ar Lbd With Small Molecule
pdb|2PKL|A Chain A, Androgen Receptor Lbd With Small Molecule
pdb|2QPY|A Chain A, Ar Lbd With Small Molecule
Length = 251
Score = 29.3 bits (64), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 16 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 74
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 75 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 134
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 135 EFLCMKALLLFSIIPVDGLKNQKFFDELR 163
>pdb|3RY9|A Chain A, Crystal Structure Of The Resurrected Ancestral
Glucocorticoid Receptor 1 In Complex With Doc
pdb|3RY9|B Chain B, Crystal Structure Of The Resurrected Ancestral
Glucocorticoid Receptor 1 In Complex With Doc
Length = 250
Score = 29.3 bits (64), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 16/44 (36%), Positives = 23/44 (52%)
Query: 136 VEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNS 179
V++AK +PGF L DDQ+TLL+ ++ L TN
Sbjct: 47 VKWAKALPGFRNLHLDDQMTLLQYSWMSLMAFSLGWRSYQHTNG 90
>pdb|2Q7K|A Chain A, The Androgen Receptor Prostate Cancer Mutant H874y Ligand
Binding Domain Bound With Testosterone And An Ar 20-30
Peptide
pdb|2Q7L|A Chain A, The Androgen Receptor Prostate Cancer Mutant H874y Ligand
Binding Domain Bound With Testosterone And A Tif2 Box3
Coactivator Peptide 740-753
Length = 257
Score = 29.3 bits (64), Expect = 5.7, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 22 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 80
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 81 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 140
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 141 EFLCMKALLLFSIIPVDGLKNQKFFDELR 169
>pdb|1XOW|A Chain A, Crystal Structure Of The Human Androgen Receptor Ligand
Binding Domain Bound With An Androgen Receptor Nh2-
Terminal Peptide, Ar20-30, And R1881
pdb|1XQ3|A Chain A, Crystal Structure Of The Human Androgen Receptor Ligand
Binding Domain Bound With R1881
pdb|2AO6|A Chain A, Crystal Structure Of The Human Androgen Receptor Ligand
Binding Domain Bound With Tif2(Iii) 740-753 Peptide And
R1881
pdb|3B5R|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With Sarm C-31
pdb|3B65|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With Sarm S-24
pdb|3B66|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With Sarm S-21
pdb|3B67|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With Sarm C-23
pdb|3B68|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With Sarm S-4
pdb|2YHD|A Chain A, Human Androgen Receptor In Complex With Af2 Small Molecule
Inhibitor
pdb|3V4A|A Chain A, Structure Of Ar Lbd With Activator Peptide And Sarm
Inhibitor 2
Length = 249
Score = 29.3 bits (64), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 14 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 72
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 73 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 132
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 133 EFLCMKALLLFSIIPVDGLKNQKFFDELR 161
>pdb|3L3X|A Chain A, Crystal Structure Of Dht-Bound Androgen Receptor In
Complex With The First Motif Of Steroid Receptor
Coactivator 3
pdb|3L3Z|A Chain A, Crystal Structure Of Dht-Bound Androgen Receptor In
Complex With The Third Motif Of Steroid Receptor
Coactivator 3
Length = 250
Score = 29.3 bits (64), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 16 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 74
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 75 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 134
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 135 EFLCMKALLLFSIIPVDGLKNQKFFDELR 163
>pdb|2OZ7|A Chain A, Crystal Structure Of The Human Androgen Receptor T877a
Mutant Ligand- Binding Domain With Cyproterone Acetate
Length = 249
Score = 29.3 bits (64), Expect = 6.1, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 14 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 72
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 73 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 132
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 133 EFLCMKALLLFSIIPVDGLKNQKFFDELR 161
>pdb|2Z4J|A Chain A, Crystal Structure Of Ar Lbd With Shp Peptide Nr Box 2
Length = 248
Score = 29.3 bits (64), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 14 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 72
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 73 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 132
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 133 EFLCMKALLLFSIIPVDGLKNQKFFDELR 161
>pdb|2HVC|A Chain A, The Crystal Structure Of Ligand-Binding Domain (Lbd) Of
Human Androgen Receptor In Complex With A Selective
Modulator Lgd2226
Length = 250
Score = 29.3 bits (64), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 16 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 74
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 75 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 134
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 135 EFLCMKALLLFSIIPVDGLKNQKFFDELR 163
>pdb|1Y6H|A Chain A, Crystal Structure Of Lipdf
pdb|1Y6H|B Chain B, Crystal Structure Of Lipdf
pdb|1SV2|A Chain A, Crystal Structure Of Peptide Deformylase From Leptospira
Interrogans (lipdf) At Ph7.5
pdb|1SV2|B Chain B, Crystal Structure Of Peptide Deformylase From Leptospira
Interrogans (lipdf) At Ph7.5
pdb|1VEV|A Chain A, Crystal Structure Of Peptide Deformylase From Leptospira
Interrogans (Lipdf) At Ph6.5
pdb|1VEV|B Chain B, Crystal Structure Of Peptide Deformylase From Leptospira
Interrogans (Lipdf) At Ph6.5
pdb|1VEY|A Chain A, Crystal Structure Of Peptide Deformylase From Leptospira
Interrogans (Lipdf) At Ph7.0
pdb|1VEY|B Chain B, Crystal Structure Of Peptide Deformylase From Leptospira
Interrogans (Lipdf) At Ph7.0
pdb|1VEZ|A Chain A, Crystal Structure Of Peptide Deformylase From Leptospira
Interrogans(lipdf) At Ph8.0
pdb|1VEZ|B Chain B, Crystal Structure Of Peptide Deformylase From Leptospira
Interrogans(lipdf) At Ph8.0
Length = 177
Score = 29.3 bits (64), Expect = 6.4, Method: Composition-based stats.
Identities = 14/46 (30%), Positives = 23/46 (50%)
Query: 186 EVLVRDSIHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVI 231
E + D I + + L+ MFD G+ L+ +IG+ IVV+
Sbjct: 18 EPVTEDEIQTKEFKKLIRDMFDTMRHAEGVGLAAPQIGILKQIVVV 63
>pdb|3RLJ|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With Sarm S-22
Length = 247
Score = 29.3 bits (64), Expect = 6.5, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 14 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 72
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 73 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 132
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 133 EFLCMKALLLFSIIPVDGLKNQKFFDELR 161
>pdb|1GS4|A Chain A, Structural Basis For The Glucocorticoid Response In A
Mutant Human Androgen Receptor (Arccr) Derived From An
Androgen-Independent Prostate Cancer
Length = 248
Score = 29.3 bits (64), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 25/117 (21%), Positives = 53/117 (45%), Gaps = 3/117 (2%)
Query: 135 VVEFAKRIPGFSLLCHDDQVTLLKAGVFEVLLVRLACMFDSQTNSMICLNGEVLVRDS-- 192
VV++AK +PGF L DDQ+ +++ +++ + + NS + LV +
Sbjct: 46 VVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYR 105
Query: 193 IHSSNARFLMDSMFDFAERLNGLHLSDTEIGLFSSIVVISPS-RSGLRNKELVERMR 248
+H S M ++ L ++ E ++++ S GL+N++ + +R
Sbjct: 106 MHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELR 162
>pdb|3RLL|A Chain A, Crystal Structure Of The T877a Androgen Receptor Ligand
Binding Domain In Complex With
(S)-N-(4-Cyano-3-(Trifluoromethyl)phenyl)-3-(4-
Cyanonaphthalen-1-Yloxy)-2-Hydroxy-2-Methylpropanamide
Length = 247
Score = 29.3 bits (64), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 4/149 (2%)
Query: 103 LACPLNPNSHPLQGQQELLQDFSERFSPTIRDVVEFAKRIPGFSLLCHDDQVTLLKAGVF 162
+ C + N+ P LL +E + VV++AK +PGF L DDQ+ +++
Sbjct: 14 VVCAGHDNNQP-DSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWM 72
Query: 163 EVLLVRLACMFDSQTNSMICLNGEVLVRDS--IHSSNARFLMDSMFDFAERLNGLHLSDT 220
+++ + + NS + LV + +H S M ++ L ++
Sbjct: 73 GLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQ 132
Query: 221 EIGLFSSIVVISPS-RSGLRNKELVERMR 248
E ++++ S GL+N++ + +R
Sbjct: 133 EFLCMKALLLFSIIPVDGLKNQKFFDELR 161
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.315 0.128 0.367
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 15,452,966
Number of Sequences: 62578
Number of extensions: 590995
Number of successful extensions: 1894
Number of sequences better than 100.0: 322
Number of HSP's better than 100.0 without gapping: 298
Number of HSP's successfully gapped in prelim test: 24
Number of HSP's that attempted gapping in prelim test: 1423
Number of HSP's gapped (non-prelim): 341
length of query: 585
length of database: 14,973,337
effective HSP length: 104
effective length of query: 481
effective length of database: 8,465,225
effective search space: 4071773225
effective search space used: 4071773225
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.6 bits)
S2: 54 (25.4 bits)